
<html lang="en"     class="pb-page"  data-request-id="5f4b1c9b-6415-491e-96cc-0241e76374a0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.8b00322;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-14;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification and Pharmacological Profile of an Indane Based Series of Ghrelin Receptor Full Agonists" /></meta><meta name="dc.Creator" content="Cristina  Gardelli" /></meta><meta name="dc.Creator" content="Hiroki  Wada" /></meta><meta name="dc.Creator" content="Asim  Ray" /></meta><meta name="dc.Creator" content="Moya  Caffrey" /></meta><meta name="dc.Creator" content="Antonio  Llinas" /></meta><meta name="dc.Creator" content="Igor  Shamovsky" /></meta><meta name="dc.Creator" content="Joakim  Tholander" /></meta><meta name="dc.Creator" content="Joakim  Larsson" /></meta><meta name="dc.Creator" content="Ulf  Sivars" /></meta><meta name="dc.Creator" content="Leif  Hultin" /></meta><meta name="dc.Creator" content="Ulf  Andersson" /></meta><meta name="dc.Creator" content="Hitesh J.  Sanganee" /></meta><meta name="dc.Creator" content="Kristina  Stenvall" /></meta><meta name="dc.Creator" content="Brith  Leidvik" /></meta><meta name="dc.Creator" content="Karin  Gedda" /></meta><meta name="dc.Creator" content="Lisa  Jinton" /></meta><meta name="dc.Creator" content="Marie  Rydén Landergren" /></meta><meta name="dc.Creator" content="Kostas  Karabelas" /></meta><meta name="dc.Description" content="Cachexia and muscle wasting are very common among patients suffering from cancer, chronic obstructive pulmonary disease, and other chronic diseases. Ghrelin stimulates growth hormone secretion via ..." /></meta><meta name="Description" content="Cachexia and muscle wasting are very common among patients suffering from cancer, chronic obstructive pulmonary disease, and other chronic diseases. Ghrelin stimulates growth hormone secretion via ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 17, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00322" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00322" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00322" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00322" /></link>
        
    
    

<title>Identification and Pharmacological Profile of an Indane Based Series of Ghrelin Receptor Full Agonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00322" /></meta><meta property="og:title" content="Identification and Pharmacological Profile of an Indane Based Series of Ghrelin Receptor Full Agonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0020.jpeg" /></meta><meta property="og:description" content="Cachexia and muscle wasting are very common among patients suffering from cancer, chronic obstructive pulmonary disease, and other chronic diseases. Ghrelin stimulates growth hormone secretion via the ghrelin receptor, which subsequently leads to increase of IGF-1 plasma levels. The activation of the GH/IGF-1 axis leads to an increase of muscle mass and functional capacity. Ghrelin further acts on inflammation, appetite, and adipogenesis and for this reason was considered an important target to address catabolic conditions. We report the synthesis and properties of an indane based series of ghrelin receptor full agonists; they have been shown to generate a sustained increase of IGF-1 levels in dog and have been thoroughly investigated with respect to their functional activity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00322"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00322">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00322&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00322&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00322&amp;href=/doi/10.1021/acs.jmedchem.8b00322" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 5974-5987</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00256" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00335" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification and Pharmacological Profile of an Indane Based Series of Ghrelin Receptor Full Agonists</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Cristina Gardelli</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cristina Gardelli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +46 31 7761567. Fax: +46 31 7763792. E-mail: <a href="/cdn-cgi/l/email-protection#ed8e9f849e9984838cc38a8c9f8988818184ad8c9e999f8c978883888e8cc38e8280"><span class="__cf_email__" data-cfemail="0e6d7c677d7a67606f20696f7c6a6b6262674e6f7d7a7c6f746b606b6d6f206d6163">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Gardelli">Cristina Gardelli</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1169-2180" title="Orcid link">http://orcid.org/0000-0003-1169-2180</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hiroki Wada</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hiroki Wada</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hiroki++Wada">Hiroki Wada</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Asim Ray</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Asim Ray</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Asim++Ray">Asim Ray</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Moya Caffrey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Moya Caffrey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Moya++Caffrey">Moya Caffrey</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Antonio Llinas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonio Llinas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">DMPK Department, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Llinas">Antonio Llinas</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4620-9363" title="Orcid link">http://orcid.org/0000-0003-4620-9363</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Igor Shamovsky</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Igor Shamovsky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Igor++Shamovsky">Igor Shamovsky</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2881-9531" title="Orcid link">http://orcid.org/0000-0002-2881-9531</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joakim Tholander</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joakim Tholander</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, Cardiovascular and Metabolic Diseases IMED Biotech Unit, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joakim++Tholander">Joakim Tholander</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joakim Larsson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joakim Larsson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joakim++Larsson">Joakim Larsson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ulf Sivars</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ulf Sivars</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioscience Department, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ulf++Sivars">Ulf Sivars</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Leif Hultin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leif Hultin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Precision Medicine Laboratories, Precision Medicine and Genomics IMED Biotech Unit, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leif++Hultin">Leif Hultin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ulf Andersson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ulf Andersson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Safety and Metabolism IMED Biotech Unit, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ulf++Andersson">Ulf Andersson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hitesh J. Sanganee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hitesh J. Sanganee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Scientific Partnering & Alliances IMED Biotech Unit, AstraZeneca, SK10 4TF Cambridge, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hitesh+J.++Sanganee">Hitesh J. Sanganee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kristina Stenvall</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kristina Stenvall</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Projects Department, Respiratory, Inflammation and Autoimmunity IMED Biotech Unit, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kristina++Stenvall">Kristina Stenvall</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brith Leidvik</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brith Leidvik</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences IMED Biotech Unit, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brith++Leidvik">Brith Leidvik</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karin Gedda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karin Gedda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences IMED Biotech Unit, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karin++Gedda">Karin Gedda</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lisa Jinton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lisa Jinton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioscience Department, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Jinton">Lisa Jinton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marie Rydén Landergren</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marie Rydén Landergren</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marie++Ryd%C3%A9n+Landergren">Marie Rydén Landergren</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Kostas Karabelas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kostas Karabelas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Projects Department, Respiratory, Inflammation and Autoimmunity IMED Biotech Unit, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kostas++Karabelas">Kostas Karabelas</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00322&amp;href=/doi/10.1021%2Facs.jmedchem.8b00322" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 5974–5987</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 17, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 February 2018</li><li><span class="item_label"><b>Published</b> online</span>17 June 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 July 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00322" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00322</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5974%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DCristina%2BGardelli%252C%2BHiroki%2BWada%252C%2BAsim%2BRay%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D14%26contentID%3Dacs.jmedchem.8b00322%26title%3DIdentification%2Band%2BPharmacological%2BProfile%2Bof%2Ban%2BIndane%2BBased%2BSeries%2Bof%2BGhrelin%2BReceptor%2BFull%2BAgonists%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5987%26publicationDate%3DJuly%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00322"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1354</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00322" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification and Pharmacological Profile of an Indane Based Series of Ghrelin Receptor Full Agonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Gardelli&quot;},{&quot;first_name&quot;:&quot;Hiroki&quot;,&quot;last_name&quot;:&quot;Wada&quot;},{&quot;first_name&quot;:&quot;Asim&quot;,&quot;last_name&quot;:&quot;Ray&quot;},{&quot;first_name&quot;:&quot;Moya&quot;,&quot;last_name&quot;:&quot;Caffrey&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Llinas&quot;},{&quot;first_name&quot;:&quot;Igor&quot;,&quot;last_name&quot;:&quot;Shamovsky&quot;},{&quot;first_name&quot;:&quot;Joakim&quot;,&quot;last_name&quot;:&quot;Tholander&quot;},{&quot;first_name&quot;:&quot;Joakim&quot;,&quot;last_name&quot;:&quot;Larsson&quot;},{&quot;first_name&quot;:&quot;Ulf&quot;,&quot;last_name&quot;:&quot;Sivars&quot;},{&quot;first_name&quot;:&quot;Leif&quot;,&quot;last_name&quot;:&quot;Hultin&quot;},{&quot;first_name&quot;:&quot;Ulf&quot;,&quot;last_name&quot;:&quot;Andersson&quot;},{&quot;first_name&quot;:&quot;Hitesh&quot;,&quot;last_name&quot;:&quot;J. Sanganee&quot;},{&quot;first_name&quot;:&quot;Kristina&quot;,&quot;last_name&quot;:&quot;Stenvall&quot;},{&quot;first_name&quot;:&quot;Brith&quot;,&quot;last_name&quot;:&quot;Leidvik&quot;},{&quot;first_name&quot;:&quot;Karin&quot;,&quot;last_name&quot;:&quot;Gedda&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Jinton&quot;},{&quot;first_name&quot;:&quot;Marie&quot;,&quot;last_name&quot;:&quot;Rydén Landergren&quot;},{&quot;first_name&quot;:&quot;Kostas&quot;,&quot;last_name&quot;:&quot;Karabelas&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5974-5987&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00322&quot;},&quot;abstract&quot;:&quot;Cachexia and muscle wasting are very common among patients suffering from cancer, chronic obstructive pulmonary disease, and other chronic diseases. Ghrelin stimulates growth hormone secretion via the ghrelin receptor, which subsequently leads to increase of IGF-1 plasma levels. The activation of the GH/IGF-1 axis leads to an increase of muscle mass and functional capacity. Ghrelin further acts on inflammation, appetite, and adipogenesis and for this reason was considered an important target to address catabolic conditions. We report the synthesis and properties of an indane based series of ghrelin receptor full agonists; they have been shown to generate a sustained increase of IGF-1 levels in dog and have been thoroughly investigated with respect to their functional activity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00322&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00322" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00322&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00322" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00322&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00322" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00322&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00322&amp;href=/doi/10.1021/acs.jmedchem.8b00322" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00322" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00322" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00322%26sid%3Dliteratum%253Aachs%26pmid%3D29909635%26genre%3Darticle%26aulast%3DGardelli%26date%3D2018%26atitle%3DIdentification%2Band%2BPharmacological%2BProfile%2Bof%2Ban%2BIndane%2BBased%2BSeries%2Bof%2BGhrelin%2BReceptor%2BFull%2BAgonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D14%26spage%3D5974%26epage%3D5987%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/jmcmar.2018.61.issue-14/20180726/jmcmar.2018.61.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cachexia and muscle wasting are very common among patients suffering from cancer, chronic obstructive pulmonary disease, and other chronic diseases. Ghrelin stimulates growth hormone secretion via the ghrelin receptor, which subsequently leads to increase of IGF-1 plasma levels. The activation of the GH/IGF-1 axis leads to an increase of muscle mass and functional capacity. Ghrelin further acts on inflammation, appetite, and adipogenesis and for this reason was considered an important target to address catabolic conditions. We report the synthesis and properties of an indane based series of ghrelin receptor full agonists; they have been shown to generate a sustained increase of IGF-1 levels in dog and have been thoroughly investigated with respect to their functional activity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15282" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15282" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ghrelin is a 28 amino acid peptidic hormone, characterized by a post-translational <i>n</i>-octanoylation on the serine 3 residue. It is synthesized and secreted by X/A-like cells localized within the oxyntic glands of the mucosa of the gastric fundus.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It is highly conserved across several species, indicating its physiological importance.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Its pharmacological properties are mediated by the type 1a growth hormone secretagogue receptor (GHS-R1a), a seven transmembrane G-protein-coupled receptor (GPCR) expressed predominantly in the hypothalamus and in the pituitary gland. Ghrelin exhibits several biological activities: it is an orexigenic agent, stimulates secretion of growth hormone (GH, an anabolic hormone that stimulates body growth), enhances gastric motility, and acts on the cardiovascular system to increase cardiac output. With this wide range of biological activities, the ghrelin receptor represents an interesting target for drug discovery. We were particularly interested in the capability of ghrelin to increase endogenous GH and to elevate the plasma level of a second hormone called insulin-like growth factor-1 (IGF-1); consequently, it could have exciting applications in diseases where skeletal muscles are impaired as in cachexia which is associated with many chronic diseases such as cancer, chronic obstructive pulmonary disease (COPD), chronic heart failure, HIV, and many others. The use of ghrelin to reduce cachexia and to increase functional capacity in cachectic patients with COPD has clinical precedence. First, Nagaya et al.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> demonstrated, in an open-label pilot study, that intravenous administration of human ghrelin for 3 weeks to cachectic patients with COPD markedly increased growth hormone secretion, food intake, body weight, lean body mass, peripheral and respiratory muscle strength, the Karnofsky performance status score (a marker for functional capacity), as well as distance walked in 6 min. Later SUN11031,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> a synthetic human ghrelin form, was brought into a phase 2 study where 224 cachectic patients with COPD were treated to determine whether it could enhance body weight, lean body mass, and physical performance. Treatment resulted in a rapid and significant increase in body weight and lean body mass although without significant improvement in functional performance measures. However, subgroup analysis revealed a statistically significant increase in functional performance in subjects with more advanced cachexia. Studies in other chronic disease conditions showed reduced muscle wasting and improved exercise capacity after ghrelin treatment in patients with chronic heart failure.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Employing exogenous ghrelin administration shows that the half-life of total ghrelin is between 10 and 31 min in the mammalian bloodstream;<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> therefore, a number of programs were dedicated to identifying long acting growth hormone secretagogues (GHS) with the potential to increase 24 h IGF-1 levels.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> A number of short acting GHSs have been previously described as full agonists of the ghrelin receptor; a few of them have reached advanced clinical stages for cancer cachexia, frailty in the elderly, and gastrointestinal diseases.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14 ref15">(9−15)</a></div><div class="NLM_p">A high-throughput screening (HTS) campaign of AstraZeneca’s proprietary collection to identify ghrelin agonists, followed by a hit to lead program, led to the discovery of a series of indane diamides (compounds <b>1</b>–<b>3</b>) with submicromolar potency (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). This lead series showed partial agonism expressed by the effect of the compounds as a percentage of maximal effect of growth hormone-releasing peptide 6 (GHRP-6). We then embarked on a lead optimization project to switch from partial to full agonism by structural alterations as previously reported for other GPCRs.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> Furthermore, we optimized against a poor selectivity of the chemical series toward the hERG channel.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Initial leads in the indane series <b>1</b>–<b>3</b> and optimized compound <b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Potency in Binding and Functional Assay, Agonism, and Potency in hERG Assay of Compounds <b>1</b>–<b>7</b>, Ghrelin, Capromorelin, and Ibutamoren</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">binding<a class="ref internalNav" href="#t1fn1" aria-label="[a]">[a]</a></th><th class="rowsep1 colsep0" colspan="2" align="center">functional assay<a class="ref internalNav" href="#t1fn2" aria-label="[b]">[b]</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center" char=".">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> and agonism (%)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">hERG pIC<sub>50</sub><a class="ref internalNav" href="#t1fn4" aria-label="[c]">[c]</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="center">6.8 (75)</td><td class="colsep0 rowsep0" align="char" char=".">0.160</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char=".">0.098</td><td class="colsep0 rowsep0" align="center">7.5 (52)</td><td class="colsep0 rowsep0" align="char" char=".">0.035</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">0.189</td><td class="colsep0 rowsep0" align="center">7.3 (61)</td><td class="colsep0 rowsep0" align="char" char=".">0.047</td><td class="colsep0 rowsep0" align="char" char="."><5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="center">7.7 (54)</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">0.93</td><td class="colsep0 rowsep0" align="center">6.6 (40)</td><td class="colsep0 rowsep0" align="char" char=".">0.226</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">0.069</td><td class="colsep0 rowsep0" align="center">7.0 (84)</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">1.26</td><td class="colsep0 rowsep0" align="center">5.8 (101)</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ghrelin<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></td><td class="colsep0 rowsep0" align="char" char=".">8.05</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="center">7.7 (82%) <i>n</i> = 40</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">capromorelin<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="center">9.04 (87%) <i>n</i> = 9</td><td class="colsep0 rowsep0" align="char" char=".">0.0009</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ibutamoren<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></td><td class="colsep0 rowsep0" align="char" char=".">8.7</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="center">9.4 (90%) <i>n</i> = 42</td><td class="colsep0 rowsep0" align="char" char=".">0.0004</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">In vitro assay. Binding assay to detect compounds binding to the GHS-R1a expressed in HEK293 cells, by competing with [<sup>125</sup>I]-ghrelin. Values are the mean of at least 2 independent determinations; for reference compounds, <i>n</i> ≥ 8.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">In vitro assay. Agonist activation of the ghrelin receptor results in a production of IP1. IP1 is accumulated in the cell in the presence of LiCl and measured by time-resolved fluorescence. Values are the mean of at least 2 independent determinations. The assay validation resulted in a CIR value of ±0.07 and the MDR value of 0.1 (on a log scale) when tested at 2 separate occasions. For reference compounds, <i>n</i> ≥ 9.</p></div><div class="footnote" id="t1fn4"><sup><sup>c</sup></sup><p class="last">Effect of the compounds on the voltage-dependent potassium channel encoded by the human ether-a-go-go-related gene (hERG).</p></div></div></div><div class="NLM_p last">Herein, we report our efforts and SAR analysis leading to the identification of compound <b>39</b>, showing the required pharmacological profile for in vivo studies to predict GH/IGF-1 activity in humans.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Indane 1,2 diaminoamides <b>4</b>, <b>6</b>, <b>8</b>–<b>21</b>, and <b>51</b> were synthesized in seven steps in overall yield of around 50% from the commercially available (1<i>S</i>,2<i>R</i>) and (1<i>R</i>,2<i>R</i>)-aminoindanols following <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> 1-Amino-2-hydroxyindane <b>44</b> and <b>52</b> were Boc protected, and an azide group was inserted through mesylation and displacement with NaN<sub>3</sub> to give intermediates <b>47</b> and <b>54</b>. Hydrogenation with Pd/C provided amines <b>48</b> and <b>55</b> which were coupled with the diverse carboxylic acids to provide intermediates <b>49</b> and <b>56</b>. Boc deprotection with t-butyldimethylsilyltriflate and a second amide coupling provided the desired analogues <b>4</b>, <b>6</b>, <b>8</b>–<b>21</b>, and <b>51</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Indane Diamino Derivatives <b>4</b>, <b>6</b>, <b>8</b>–<b>21</b>, and <b>51</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt, o/n; (b) MsCl, Et<sub>3</sub>N, DCM, 0° to rt, 3 h; (c) NaN<sub>3</sub>, dry DMF, 90 °C, o/n. (d) H<sub>2</sub>, 10% Pd/C, o/n; (e) RCOOH or 5-methyl-1<i>H</i>-indole-2-carboxylic acid, DIPEA, HOBT, DCM, EDCI, rt; (f) TBDMSOTf, DCM, 6 h, rt; (g) R<sub>1</sub>COOH, HATU, Et<sub>3</sub>N, DMF.</p></p></figure><div class="NLM_p">These overall sequences were also applied to provide enantiomers <b>5</b> and <b>7</b> starting from the opposite enantiomers of 1-amino-2-hydroxyindanes.</div><div class="NLM_p">Compounds reported in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> were obtained from compound <b>51</b> or analogues. As an example, <b>51</b> was submitted to Boc deprotection of the corresponding morpholine to give compound <b>32</b> and methylated through reductive amination to give <b>23</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Homomorpholines, piperidine, homopiperidine, and pyrrolidine derivatives were treated similarly to yield compounds <b>22</b>–<b>33</b> and <b>35</b>–<b>38</b>. Compound <b>34</b> was obtained by acetylation of <b>32</b> with acetic anhydride.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>23</b> (as Representative of the Synthesis of Compounds <b>22</b>–<b>33</b> and <b>35</b>–<b>38</b>) and <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TBDMSOTf, DCM, 6 h, rt; (b) HCHO, MeOH, NaBH<sub>3</sub>CN; (c) Ac<sub>2</sub>O.</p></p></figure><div class="NLM_p">The reverse amide <b>39</b>–<b>43</b> were synthesized from the commercially available ketoester <b>58</b>, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Condensation of compound <b>58</b> with NH<sub>4</sub>OAc gave enamine <b>59</b> that was reduced with NaBH<sub>4</sub> and TFA in THF (<b>caution: exothermic reaction</b>). Boc protection yielded beta amino protected ester <b>60</b>, in a cis:trans ratio of 1:1. The mixture was submitted to hydrolysis to obtain acid <b>61</b> as a cis:trans 1:6.3 ratio. After HPLC, the pure trans acid <b>62</b> was submitted to amide coupling with diverse amines and Boc deprotected. Chiral HPLC separation gave the pure enantiomers <b>63a</b> and <b>63b</b>. The desired enantiomer <b>63b</b> was then coupled with a variety of carboxylic acids to give final compounds <b>39</b>–<b>43</b>, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of β-Amino Acids Derivatives <b>39</b>–<b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NH<sub>4</sub>OAc, MeOH, 50°; (b) TFA, NaBH<sub>4</sub>, THF; (c) Boc<sub>2</sub>O; (d) MeONa, H<sub>2</sub>O, MeOH; (e) HPLC; (f) N<sub>1</sub>,N<sub>1</sub>-dimethylethane-1,2-diamine or NH<sub>2</sub>R, HATU, Et<sub>3</sub>N, DMF-DCM; (g) HCl, dioxane; (h) chiral HPLC; (i) R<sub>1</sub>COOH, HATU, Et<sub>3</sub>N, DMF-DCM.</p></p></figure><div class="NLM_p">Absolute configuration of key compound <b>39</b> and its enantiomer <b>40</b> was assigned by vibrational circular dichroism (VCD) analyses in an indirect way. Direct VCD analysis of the final compounds <b>39</b> and <b>40</b> gave inconclusive results, and therefore smaller analogue intermediates <b>65a</b> and <b>65b</b> were prepared for VCD analyses, <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The pure trans racemic ester <b>62</b> was submitted to chiral separation to obtain the two enantiomers <b>62a</b> and <b>62b</b>. Further manipulation of these two enantiomers led to <i>N</i>,<i>N</i>-dimethyl amides <b>65a</b> and <b>65b</b> whose absolute configuration was assigned by VCD. Once the absolute configuration of the analogues <b>65a</b> and <b>65b</b> was assigned, the absolute configuration of the Boc protected acids <b>62a</b> and <b>62b</b> was revealed as well. Compounds <b>39</b> and <b>40</b> were resynthesized starting from these intermediates and their respective 1<i>S</i>,2<i>S</i> and 1<i>R</i>,2<i>R</i> absolute configuration was assigned. For VCD spectra, see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00322/suppl_file/jm8b00322_si_001.pdf" class="ext-link">Supporting Information</a>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Intermediates <b>65a</b> and <b>65b</b> for the Elucidation of the Absolute Configuration of the Indane Compounds <b>39</b>–<b>40</b> through VCD<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chiral HPLC; (b) NHMe<sub>2</sub>, DIPEA, HATU, PyBOP, dry DMF; (c) HCl 4 M in dioxane.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71754" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71754" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The binding activity of the compounds to the GHS-R1a receptor was measured in a competition experiment with [<sup>125</sup>I]-ghrelin in membranes prepared from HEK293 cell line. The agonistic activity of the compounds was assessed by measuring intracellular myo-inositol 1 phosphate (IP1). <span class="smallcaps smallerCapital">d</span>-Myo-inositol 1-phosphate as a surrogate of <span class="smallcaps smallerCapital">d</span>-myo-inositol 1,4,5-triphosphate serves to monitor G protein-coupled receptor activation. As a comparison, ghrelin, capromorelin, and ibutamoren data are reported as well.</div><div class="NLM_p">The indane lead series showed pEC<sub>50</sub> between 6.8 and 7.5 in the functional assay and a moderate metabolic stability in human liver microsomes. The compounds were characterized by a low agonism and a lack of human ERG selectivity. The initial medicinal chemistry work focused on extending the chemical diversity of the series. It confirmed the required stereochemistry in positions 1 and 2 of the indane core and assessed the characteristics of the pharmacophoric features for further optimization.</div><div class="NLM_p">The preferred stereochemistry was assessed through the synthesis of the four diastereoisomers <b>4</b>–<b>7</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. The (1<i>S</i>,2<i>S</i>) trans enantiomer <b>4</b> proved to have higher affinity than its enantiomer <b>5</b> with a pIC<sub>50</sub> of 7.8 vs 6.0 in the binding assay. The cis diastereoisomers <b>6</b> and <b>7</b> showed higher agonism but lower potency.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compounds <b>4</b>–<b>7</b> made to assess the desired stereochemistry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The preferred conformations of nine ghrelin full agonists reported in the literature including SM-130686,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> MK-677 (ibutamoren),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> ONO-7643 (anamorelin),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> CP-424391 (capromorelin),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> CP-464709,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> SB791016 and GSK894490A,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> L-163540,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and aryl sulphonamide<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> were superimposed with those of our leads, using the software Phase (Schrödinger LLC).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The calculations indicate three pharmacophoric features, a basic (A), an aromatic residue (B), and a H-bond acceptor (C) which are likely relevant for the interaction with the ghrelin receptor, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. These features are consistent with the putative binding site proposed by a published homology model of the ghrelin receptor that was built based on (1) the X-ray structure of the inactive state of rhodopsin and (2) results of site-directed mutagenesis studies.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> To understand the origin for the observed structure–activity relationships, the identified pharmacophore features and established mutational hits<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> have to be linked to a putative binding mode of the compounds in the binding site of the receptor. The basic center A likely forms a salt bridge to the acidic residue Glu-124 of the receptor, a very important mutational hit, which is used as a major anchoring site for agonists, antagonists, and inverse agonists in many published attempts to derive potency and efficacy from binding mode.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28−30)</a> The aromatic moiety B forms π–π and/or hydrophobic interactions with the Phe-309 residue, and the H-bond acceptor C forms a charge-reinforced H-bond donor with the basic residue, Arg-283, two other important mutational hits.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Conformation of <b>2</b> mapped into the pharmacophore model. Color spheres illustrate the optimal locations of the three points pharmacophore features: <b>A</b> (basic, red), <b>B</b> (aromatic, amber), and <b>C</b> (H-bond acceptor, green). Only polar hydrogens are illustrated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the course of the optimization we then identified compound <b>8</b>, reasonably potent and, for the first time, showing a 93% maximal response associated with pEC<sub>50</sub> of 7.8, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. This encouraging result led to further docking studies in a homology model now based on the newly available X-ray crystallographic structure of A2a agonist bound to the human adenosine A2a receptor (Brookhaven PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QAK">3QAK</a>),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> guiding the design of further molecules.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Potency in Binding, Functional Assay, Agonism, and log <i>D</i> of Compounds <b>8</b>, <b>14</b>–<b>21</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0014.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">In vitro assay. Binding assay to detect compounds binding to the GHS-R1a expressed in HEK293 cells, by competing with [<sup>125</sup>I]-ghrelin. Values are the mean of at least 2 independent determinations; for reference compounds, <i>n</i> ≥ 8.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">In vitro assay. Agonist activation of the ghrelin receptor results in a production of IP1. IP1 is accumulated in the cell in the presence of LiCl and measured by time-resolved fluorescence. Values are the mean of at least 2 independent determinations. The assay validation resulted in a CIR value of ±0.07 and the MDR value of 0.1 (on a log scale) when tested at 2 separate occasions. For reference compounds, <i>n</i> ≥ 9.</p></div><div class="footnote" id="t2fn4"><sup><sup>c</sup></sup><p class="last">Distribution coefficient expressing partitioning of compounds between 1-octanol and aqueous buffer at pH 7.4.</p></div></div><div></div></div><div class="NLM_p">Compound <b>8</b> was studied in detail in respect of the bicyclic heteroaryl moiety; indole showed to be one of the best groups and its substitution pattern was quickly investigated, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. The presence of the aminopyridine usually led to compounds with a high percentage of agonism as in compounds <b>14</b>–<b>17</b> and <b>19</b>–<b>21</b>, only compound <b>18</b> being an outlier.</div><div class="NLM_p">The SAR around the 4-amino pyridine moiety was very narrow. <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> shows several analogues with replacements of the amino pyridine ring (<b>9</b>–<b>13</b>), all with pIC<sub>50</sub> < 6.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. SAR around the aminopyridine moiety of compound <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The interactions of the amino pyridine moiety with residues Gln-120, Phe-121, and Glu-124 seem to be crucial for full agonism at the ghrelin receptor and minor structural alterations lead to interconversion of full agonists to partial agonists or antagonists as has been previously observed with other GPCRs,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. Consistent with previous observations, the agonists under study form a superficial binding mode with no interactions with a more deeply located mutational hit Asp-99, which are thought to be an interaction site for more profoundly bound antagonists and inverse agonists.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28−30)</a> Residue Phe-286, which has been shown to be a mutational hit for more bulky peptidic agonists and inverse agonists are located far from the putative binding mode of the compact indane-based agonists, consistent with suggested binding modes for other small-molecule agonists.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Interactions of compound <b>8</b> with the homology model of ghrelin receptor as structural drivers for full agonism. The binding mode of <b>8</b> was obtained by energy minimization of the complex using the OPLS3 force field.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, the aminopyridine based derivatives, although full agonists, were quite lipophilic, and during the work to explore the influence of individual residues on ghrelin receptor agonism, we designed the morpholine compound <b>23</b>. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, the interaction with Gln-120 is now engaged by the morpholine oxygen atom. Both epimers at the morpholine ring stereocenter were investigated (compounds <b>23</b> and <b>24</b>), <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Compound <b>23</b> with <i>S</i> configuration at the morpholine ring maintained a potency with pEC<sub>50</sub> of 7.7 in the functional assay and showed the desired full agonism (91), while the epimer <b>24</b> showed a drop both in pEC<sub>50</sub> (6.6) and in agonism (65%). To challenge the role of the morpholine oxygen, piperidine analogues were prepared (compounds <b>25</b> and <b>26</b>) and they showed lower agonism, 70 and 69%, respectively. The more potent analogue <b>22</b> with higher lipophilicity and metabolic instability was not further elaborated.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Residues of human ghrelin receptor within the homology model that interact with compounds <b>8</b> and <b>23</b>. Ionic, polar, charge-reinforced H-bonding, and hydrophobic interactions are shown in red, amber, purple, and green, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Potency in Binding, Functional Assay, Agonism, and log <i>D</i> of Compounds <b>22</b>–<b>38</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0016.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0017.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">In vitro assay. Binding assay to detect compounds binding to the GHS-R1a expressed in HEK293 cells, by competing with [<sup>125</sup>I]-ghrelin. Values are the mean of at least 2 independent determinations; for reference compounds, <i>n</i> ≥ 8.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">In vitro assay. Agonist activation of the ghrelin receptor results in a production of IP1. IP1 is accumulated in the cell in the presence of LiCl and measured by time-resolved fluorescence. Values are the mean of at least 2 independent determinations. The assay validation resulted in a CIR value of ±0.07 and the MDR value of 0.1 (on a log scale) when tested at 2 separate occasions. For reference compounds, <i>n</i> ≥ 9.</p></div><div class="footnote" id="t3fn4"><sup><sup>c</sup></sup><p class="last">Distribution coefficient expressing partitioning of compounds between 1-octanol and aqueous buffer at pH 7.4.</p></div></div><div></div></div><div class="NLM_p">Increase of lipophilicity, in order to fill the hydrophobic pocket with a homopiperidine ring as in compound <b>27</b> gave the desired agonism of 97%. The (<i>S</i>)-configured homomorpholine derivative <b>29</b> showed a pEC<sub>50</sub> of 8 and 91% agonism, while the epimer <b>30</b> was lower in potency and agonism. The position of the oxygen in this ring is relevant as shown by the loss in agonism of the regioisomeric compound <b>31</b> and the corresponding demethylated compound <b>33</b>. Acetylation of the basic nitrogen led to the inactive acetyl derivative <b>34</b>. Pyrrolidine derivatives <b>35</b>–<b>38</b> did not offer any advantage in terms of potency or agonism.</div><div class="NLM_p">Unfortunately, the morpholine derivative <b>23</b>, although being a potent full agonist, was not a candidate to progress. The compound showed a significant amount of reactive metabolites formed in human microsomes and rat hepatocytes. Metabolite identification using KCN and MeONH<sub>2</sub> as trapping agents confirmed the formation of iminium ions and aldehyde adducts on the morpholine ring in both the parent and the demethylated morpholine <b>32</b> (main metabolite) (hydroxylation of the morpholine ring and dehydration result in the formation of iminium ions that are unstable, but can be trapped by forming cyanide stable adducts which can be detected by LC-MS/MS). The mechanism of formation of iminium intermediates and aldehydes by oxidative dealkylation on morpholine groups has been previously described,<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33−35)</a> more recently in the case of the bioactivation of foretinib.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Moreover, all the morpholine derivatives showed quite significant brain penetration, which according to our hypothesis at that point of time was unnecessary to achieve the desired effect (see below) but could cause undesired side effects. Brain penetration was measured as <i>K</i><sub>pu,u</sub>, which is the ratio between the compound free concentration in brain and its free concentration in plasma.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">Looking for a morpholine bioisoster, we designed the reverse amide <b>39</b> where the carbonyl directly attached to the indane might engage in the same interaction with Gln-120 as the morpholine oxygen to maintain full agonism (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). At the same time, we hoped that reducing permeability and increasing efflux would keep these compounds out of the brain.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Morpholine diamide <b>23</b> and reverse amide <b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> shows a series of reverse amides. The stereochemistry was confirmed with the enantiomer <b>40</b> and the isomer cis (1<i>R</i>,2<i>S</i>) <b>42</b> being less potent. By increasing lipophilicity (as with compound <b>41</b>), a very high potency could be obtained, pIC<sub>50</sub> of 10 but at the cost of metabolic instability. Methylation of the NH of the reverse amide as in compound <b>43</b> was possible, but the resulting compound was less metabolically stable.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Potency in Binding, Functional Assay, Agonism, log <i>D</i>, and Metabolic Stability of Compounds <b>39</b>–<b>43</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0018.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0019.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">In vitro assay. Binding assay to detect compounds binding to the GHS-R1a expressed in HEK293 cells, by competing with [<sup>125</sup>I]-ghrelin. Values are the mean of at least 2 independent determinations; for reference compounds, <i>n</i> ≥ 8.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">In vitro assay. Agonist activation of the ghrelin receptor results in a production of IP1. IP1 is accumulated in the cell in the presence of LiCl and measured by time-resolved fluorescence. Values are the mean of at least 2 independent determinations. The assay validation resulted in a CIR value of ±0.07 and the MDR value of 0.1 (on a log scale) when tested at 2 separate occasions. For reference compounds, <i>n</i> ≥ 9.</p></div><div class="footnote" id="t4fn4"><sup><sup>c</sup></sup><p class="last">Distribution coefficient expressing partitioning of compounds between 1-octanol and aqueous buffer at pH 7.4.</p></div><div class="footnote" id="t4fn5"><sup><sup>d</sup></sup><p class="last">In vitro clearance in human liver microsomes (μL/min/mg).</p></div><div class="footnote" id="t4fn6"><sup><sup>e</sup></sup><p class="last">Effect of the compounds on the voltage-dependent potassium channel encoded by the human ether-a-go-go-related gene (hERG).</p></div></div><div></div></div><div class="NLM_p">Compound <b>39</b> (MW 404, log <i>D</i> 2.4, PSA 81, solubility 100 μM) without significant inhibition of the hERG channel (pEC<sub>50</sub> 4.5) showed a promising profile. Its plasma protein binding is 4, 8, and 12% in rat, dog, and human, respectively. The intrinsic metabolic clearance is variable depending on the species. Compound <b>39</b> is quite stable in vitro with low hepatic intrinsic clearance in human (<4 μL/min/mg) but medium in dog (9 μL/min/mg) and high in rat (48 μL/min/mg). <b>39</b> did not inhibit the major CyP450 enzymes with pIC<sub>50</sub> < 4.7 in CyP 3A4, 2D6, 1A2, 2C9, and 2C19. No time dependent inhibition was observed in human liver microsomes, suggesting a low risk of drug–drug interactions. Compound <b>39</b>, despite showing a very high clearance (above hepatic blood flow) in rat (170 mL/min/kg), showed an acceptable in vivo pharmacokinetic profile in dog with a clearance of 18.8 mL/min/kg, a volume of distribution of 4.8 L/kg, and an oral half-life of 16.6 h. The oral bioavailability was 13% with absorbed fraction 20%.</div><div class="NLM_p">The in vivo clearance in dog was well predicted from the dog in vitro hepatic Cl<sub>int</sub>, indicating an elimination pathway dominated by hepatic CyP-metabolism. Bile and urine elimination studies confirmed that only around 2% of the dose was eliminated via urine in dog, but active secretion was taking place in rat because the renal clearance (<i>F</i><sub>e</sub> > 5%) was measured to be far above (∼10-fold higher) the filtration clearance. This extrahepatic clearance mechanism, together with a significant bile clearance, explained the underprediction of clearance in vivo (rather than a misleading low rat hepatic clint in hepatocytes due to the low permeability and high efflux in rat hepatocytes). Metabolite identification in vivo in urine, bile, and plasma showed that the main metabolite was not the <i>N</i>-demethylation of the tertiary amine as expected but the hydroxylation of the 5-methyl of the indole ring, first to the aldehyde and finally to the carboxylic acid. Cyp reaction phenotyping showed that hydroxylation of the methyl group of the indole was catalyzed mainly by CYP 2C19.</div><div class="NLM_p">On the basis of its properties, <b>39</b> was considered an appropriate tool compound to be studied in a dog pharmacokinetic/pharmacodynamic model to understand the relationship between the plasma concentration of the drug and its effect on GH and IGF-1 after a single dose of compound. We further were interested in probing the importance of CNS penetration for the efficacy of a ghrelin agonist. Literature has discordant hypotheses about the relevance of CNS penetration for efficacy. Compound <b>39</b> was designed for low CNS penetration. It presented a low intrinsic permeability (0.64 × 10<sup>–6</sup> cm/s) and a high efflux (67.2), sufficient to keep the compound effectively out of the brain (<i>K</i><sub>pu,u</sub> < 0.020) while still getting an adequate absorption in dog, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. As a comparator, compound <b>22</b> with higher CNS penetration was added to the study. CNS penetration is expressed as brain<sub>unbound</sub>/plasma<sub>unbound</sub> ratio, which was 0.292 for compound <b>22</b> and <0.020 for compound <b>39</b>. Compound <b>22</b> with a short half-life (1.2 h in dog) and high CNS penetration and compound <b>39</b> with an oral half-life of 13.2 h and low CNS penetration were profiled against ghrelin, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> and <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Dog Pharmacokinetics Data and CNS Penetration Value of Compounds <b>39</b> and <b>22</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">dog PK<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> Cl, Vd, <i>t</i><sub>1/2</sub>, <i>F</i></th><th class="colsep0 rowsep0" align="center" char=".">Caco-2 <i>P</i><sub>app</sub>A–B<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> pH = 7.4 (1 × 10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">Caco-2 <i>P</i><sub>app</sub>B–A<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> pH = 7.4 (1 × 10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">Caco-2 efflux ratio<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">Caco-2 <i>P</i><sub>erm</sub>A–B<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a> pH = 6.5 (1 × 10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">CNS<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">28, 2.1, 1.2, 39</td><td class="colsep0 rowsep0" align="char" char=".">15.3<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">7.5<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">0.5<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">44.4</td><td class="colsep0 rowsep0" align="char" char=".">0.292</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">26, 5.8, 13.2, 9</td><td class="colsep0 rowsep0" align="char" char=".">0.6<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">17.7<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">67.2<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="."><2.4<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char="."><0.020</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Pharmacokinetic study in dogs: clearance, volume of distribution, terminal half-life and bioavailability, <i>n</i> = 4 po; <i>n</i> = 4 iv.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Apparent permeability across Caco-2 cell monolayers: <i>P</i><sub>app</sub>A–B = apparent permeability coefficient in apical to basolateral direction; <i>P</i><sub>app</sub>B–A = apparent permeability coefficient in basolateral to apical direction; Efflux ratio = <i>P</i><sub>app</sub>B−A/<i>P</i><sub>app</sub>A–B.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last"><i>n</i> = 4.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last"><i>n</i> = 8.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">Apparent intrinsic permeability across Caco-2 cell monolayers in the presence of a cocktail of inhibitors toward the major efflux transporters.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></p></div><div class="footnote" id="t5fn6"><sup><sup>f</sup></sup><p class="last"><i>n</i> = 2.</p></div><div class="footnote" id="t5fn7"><sup><sup>g</sup></sup><p class="last">brain<sub>unbound</sub>/plasma<sub>unbound</sub> ratio.</p></div></div></div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Increase in IGF-1 plasma levels (mean ± SEM) from baseline after oral administration of 8 mg/kg of <b>39</b>, 4 mg/kg of <b>22</b>, and 30 μg/kg (iv) of ghrelin, four dogs per group. All compounds caused a significant (<i>p</i> < 0.05) increase in IGF-1 compared to vehicle, 4 and 7 h after administration. <b>39</b> caused a significant IGF-1 increase 24 h after administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0009.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Plasma concentration from baseline after oral administration of compound <b>39</b>, 8 mg/kg, and <b>22</b>, 4 mg/kg, <i>n</i> = 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Dogs were dosed with compounds <b>39</b> and <b>22</b> orally at 8 and 4 mg/kg, respectively. Results are reported in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>; compounds <b>39</b> and <b>22</b> both showed a sustained IGF-1 response.</div><div class="NLM_p">The comparison of the two compounds supports the hypothesis that compounds with low unbound brain/plasma ratios can show efficacy, indicating that CNS penetration is not a requirement for affecting GH/IGF-I axis.</div><div class="NLM_p last">In spite of all positive intrinsic properties, in vitro and in vivo pharmacokinetics and efficacy in our dog model, compound <b>39</b> unfortunately showed activity on the μ1-opioid receptor both in a binding assay (pIC<sub>50</sub> 7.1) and in a cell based assay evaluating its agonistic activity (pIC<sub>50</sub> 6.63). The primary μ-opioid agonism risk is constipation by reducing gut motility, which is a well-known side effect of opioid use; this will be of particular concern of the intended patient population which includes primarily elderly people. In addition, μ-opioid agonists are likely to become highly addictive with resulting prescription limitations on the label. These considerations led to stopping this compound from further progression. Work to overcome this off target effect is ongoing and will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">This study describes a new series of ghrelin receptor full agonists based on an indane scaffold. The chemical evolution from partial to full agonists was possible due to the identification of the structural features that drive full agonism. The optimized compounds show limited brain/plasma levels, long half-life, and increased IGF-1 secretion in dog. This last effect may be beneficial in a variety of clinical conditions where skeletal muscles are impaired as in cachexia, which is associated with many chronic diseases. We have identified a drug-like potent ghrelin full agonist, compound <b>39</b>, with beneficial in vivo efficacy and acceptable pharmacokinetic profile. This molecule suffers from off target activities that forced us to stop the development of this series. Further studies are needed to address the specificity of the compound, and further development will be disclosed in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Chemistry</h3><div class="NLM_p">All chemicals purchased from commercial suppliers were used as received. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen atmosphere using dry solvents. All compounds were purified to ≥95% purity as judged by HPLC with UV and MS analysis. Proton (<sup>1</sup>H) and carbon (<sup>13</sup>C) NMR spectra were recorded at room temperature unless otherwise specified. Solutions were typically prepared in deuterated dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>), with chemical shifts referenced to solvent as an internal standard. <sup>1</sup>H NMR data are reported indicating the chemical shift (δ), the multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; p, quintet; m, multiplet; br, broad; dd, doublet of doublets; etc.), the coupling constant (<i>J</i>) in Hz, and the integration (e.g., 1H). HRMS experiments were performed on a Waters Acquity, Waters 2777, or Waters 2700 UV–HPLC system and a Waters Xevo G2 TOF, Waters LCT Premiere, Waters LCT, or Waters QTOFmicro mass spectrometer. Compounds were named using ACD/Laboratories 2015 IUPAC name.</div><div class="NLM_p">Representative chemistry is reported for the synthesis of compound <b>23</b>. Similar procedure was applied to the synthesis of compounds <b>4</b>–<b>38</b>.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 1-Methyl-<i>N</i>-[(1<i>S</i>,2<i>S</i>)-1-{[(2<i>S</i>)-4-methylmorpholine-2-carbonyl]amino}-2,3-dihydro-1<i>H</i>-inden-2-yl]-1<i>H</i>-indole-5-carboxamide (<b>23</b>)</h4><div class="NLM_p last">To a solution of 1-methyl-<i>N</i>-((1<i>S</i>,2<i>S</i>)-1-((<i>S</i>)-morpholine-2-carboxamido)-2,3-dihydro-1<i>H</i>-inden-2-yl)-1<i>H</i>-indole-5-carboxamide <b>32</b> (245 mg, 0.59 mmol) in MeOH (10 mL) was added HCHO (53 mg, 1.76 mmol, 3.0 equiv) and AcOH (5 drops). The mixture was stirred at rt for 1 h. Then NaBH<sub>3</sub>CN (110 mg, 1.76 mmol) was added. The reaction mixture was stirred at rt for 15 h. The mixture was concentrated, and the residue was subjected to prep-HPLC for purification to afford compound <b>23</b> (30 mg, 12% yield) as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.64 (d, <i>J</i> = 8.38 Hz, 1H), 8.18 (d, <i>J</i> = 8.91 Hz, 1H), 8.14 (d, <i>J</i> = 1.28 Hz, 1H), 7.70 (dd, <i>J</i> = 1.61 and 8.63 Hz, 1H), 7.49 (d, <i>J</i> = 8.66 Hz, 1H), 7.41 (d, <i>J</i> = 3.09 Hz, 1H), 7.31–7.14 (m, 3H), 7.10–6.97 (m, 1H), 6.54 (d, <i>J</i> = 3.01 Hz, 1H), 5.56 (t, <i>J</i> = 8.78 Hz, 1H), 4.80 (p, <i>J</i> = 8.70 and 8.71 Hz, 1H), 3.95 (dd, <i>J</i> = 2.66 and 10.02 Hz, 1H), 3.90–3.78 (m, 1H), 3.82 (s, 3H), 3.55 (td, <i>J</i> = 2.39 and 11.11 Hz, 1H), 3.23 (dd, <i>J</i> = 8.26 and 15.47 Hz, 1H), 3.01–2.77 (m, 2H), 2.57 (d, <i>J</i> = 10.58 Hz, 1H), 2.19 (s, 3H), 2.08–1.86 (m, 2H). Mass spectrum (ESI) <i>m</i>/<i>z</i> 433 (M + H). HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>25</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> [M + H]: 433.2240, found 433.2227.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 1-Methyl-<i>N</i>-((1<i>S</i>,2<i>S</i>)-1-((S)-morpholine-2-carboxamido)-2,3-dihydro-1<i>H</i>-inden-2-yl)- 1<i>H</i>-indole-5-carboxamide (<b>32</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl (2<i>S</i>)-2-({(1<i>S</i>,2<i>S</i>)-2-[(1-methyl-1<i>H</i>-indole-5-carbonyl)amino]-2,3-dihydro-1<i>H</i>-inden-1-yl}carbamoyl)morpholine-4-carboxylate <b>51</b> (308 mg, 0.59 mmol, 1.0 equiv) in DCM (15 mL) was added TBDMSOTf (165 mg, 0.62 mmol, 1.05 equiv) dropwise. The reaction mixture was stirred at rt for 6 h. Then Et<sub>3</sub>N (3 mL) was added, and the mixture was extracted with DCM and saturated NaHCO<sub>3</sub> aq three times. The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuum to afford the crude title compound that was subjected to <i>prep</i>-HPLC for purification to afford compound <b>32</b> (245 mg) as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.63 (d, <i>J</i> = 8.36 Hz, 1H), 8.13 (d, <i>J</i> = 1.34 Hz, 1H), 8.09 (d, <i>J</i> = 8.96 Hz, 1H), 7.70 (dd, <i>J</i> = 1.63 and 8.62 Hz, 1H), 7.49 (d, <i>J</i> = 8.66 Hz, 1H), 7.41 (d, <i>J</i> = 3.09 Hz, 1H), 7.28–7.15 (m, 3H), 7.04 (d, <i>J</i> = 5.62 Hz, 1H), 6.54 (d, <i>J</i> = 3.08 Hz, 1H), 5.55 (t, <i>J</i> = 8.78 Hz, 1H), 4.82 (p, <i>J</i> = 8.70 and 8.67 Hz, 1H), 3.85 (dd, <i>J</i> = 2.76 and 9.94 Hz, 1H), 3.82 (s, 3H), 3.78 (d, <i>J</i> = 10.99 Hz, 1H), 3.47 (td, <i>J</i> = 3.21, 10.80, and 10.81 Hz, 1H), 3.22 (dd, <i>J</i> = 8.22 and 15.46 Hz, 1H), 3.04 (dd, <i>J</i> = 2.60 and 12.32 Hz, 1H), 2.88 (dd, <i>J</i> = 9.15 and 15.42 Hz, 1H), 2.73–2.54 (m, 3H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 419 (M + 1). HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>26</sub>N<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> [M + H]: 419.2083, found 419.2102.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-((1<i>S</i>, 2<i>S</i>)-1-(2-(Dimethylamino)ethylcarbamoyl)-2,3-dihydro-1<i>H</i>-inden-2-yl)-1<i>H</i>-indole-2-carboxamide (<b>39</b>)</h4><div class="NLM_p last">1<i>S</i>,2<i>S</i>-2-Amino-<i>N</i>-(2-(dimethylamino)ethyl)-2,3-dihydro-1<i>H</i>-indene-1-carboxamide <b>63b</b> (194 mg, 0.78 mmol), 5-methyl-1<i>H</i>-indole-2-carboxylic acid (151 mg, 0.86 mmol), and 2-(3<i>H</i>-[1,2,3]triazolo[4,5-<i>b</i>]pyridin-3-yl)-1,1,3,3-tetramethylisouronium hexafluorophosphate(V) (HATU) (388 mg, 1.18 mmol) were taken up in dry DMF (8 mL). DIEA (0.9 mL, 668 mg, 5.17 mmol) was added, and the mixture was stirred overnight at rt. It was evaporated, and the residue was purified by HPLC (x-bridge, C-18, CH<sub>3</sub>CN–H<sub>2</sub>O 10:90 to 45:55, 25 min gradient with 0.2% formic acid on aq solvent, fraction size 40 mL). The pure fractions were combined and freeze-dried to compound <b>39</b> as a light-brown solid (152 mg, as formic acid salt, ee 99.58%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.42 (s, 1H), 8.66 (d, <i>J</i> = 7.70 Hz, 1H), 8.17 (t, <i>J</i> = 5.61 Hz, 1H), 7.36 (bs, 1H), 7.31 (d, <i>J</i> = 8.37 Hz, 1H), 7.28–7.15 (m, 4H), 7.06 (d, <i>J</i> = 1.45 Hz, 1H), 7.00 (dd, <i>J</i> = 1.40 and 8.45 Hz, 1H), 4.97 (p, <i>J</i> = 7.01 and 7.06 Hz, 1H), 4.05 (d, <i>J</i> = 6.39 Hz, 1H), 3.40–3.22 (m, 2H), 3.13 (dq, <i>J</i> = 6.44, 6.58, and 13.30 Hz, 1H), 2.99 (dd, <i>J</i> = 6.82 and 16.04 Hz, 1H), 2.35 (s, 3H), 2.37–2.25 (m, 2H), 2.14 (s, 6H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 171.32, 160.94, 141.43, 141.21, 134.80, 131.62, 128.19, 127.26, 127.20, 126.46, 125.10, 124.40, 124.01, 120.69, 111.98, 102.25, 58.16, 57.05, 52.97, 45.11, 38.26, 36.93, 21.12. Mass spectrum (ESI) <i>m</i>/<i>e</i> = 405 (M+1). HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> [M + H]: 405.2290, found 405.2308. Optical rotation in MeOH [α]<sup>20</sup><sub>D</sub> = +112.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-((1<i>R</i>, 2<i>R</i>)-1-(2-(Dimethylamino)ethylcarbamoyl)-2,3-dihydro-1<i>H</i>-inden-2-yl)-1<i>H</i>-indole-2-carboxamide (<b>40</b>)</h4><div class="NLM_p last">1<i>R</i>,2<i>R</i>-2-Amino-<i>N</i>-(2-(dimethylamino)ethyl)-2,3-dihydro-1<i>H</i>-indene-1-carboxamide <b>63a</b> (224 mg, 0.91 mmol), 5-methyl-1<i>H</i>-indole-2-carboxylic acid (175 mg, 1.0 mmol), and 2-(3<i>H</i>-[1,2,3]triazolo[4,5-<i>b</i>]pyridin-3-yl)-1,1,3,3-tetramethylisouronium hexafluorophosphate(V) (HATU) (448 mg, 1.18 mmol) were put in dry DMF (8 mL), and DIPEA (1.0 mL, 5.74 mmol) was added. The mixture was stirred overnight at rt. It was evaporated and the residue, taken up in DMSO, was purified by HPLC (x-bridge, C-18, CH<sub>3</sub>CN–H<sub>2</sub>O from 10:90 to 45:55, 25 min gradient with 0.2% formic acid on aq solvent). The pure fractions were combined and freeze-dried to compound <b>40</b> as a light-brown solid (isolated yield: 98 mg, as formic acid salt, ee 99.58%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.42 (s, 1H), 8.66 (d, <i>J</i> = 7.70 Hz, 1H), 8.17 (t, <i>J</i> = 5.61 Hz, 1H), 7.36 (s, 1H), 7.31 (d, <i>J</i> = 8.37 Hz, 1H), 7.28–7.15 (m, 4H), 7.06 (d, <i>J</i> = 1.42 Hz, 1H), 7.00 (dd, <i>J</i> = 1.40 and 8.45 Hz, 1H), 4.98 (p, <i>J</i> = 7.00 Hz, 1H), 4.05 (d, <i>J</i> = 6.39 Hz, 1H), 3.45–3.21 (m, 2H), 3.13 (dq, <i>J</i> = 6.58, 6.50, and 13.31 Hz, 1H), 2.99 (dd, <i>J</i> = 6.82 and 16.05 Hz, 1H), 2.35 (s, 3H), 2.30 (tt, <i>J</i> = 6.01 and 11.99 Hz, 2H), 2.14 (s, 6H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 405 (M + 1). HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> [M + H]: 405.2290, found 405.2321. Optical rotation in MeOH [α]<sup>20</sup><sub>D</sub> = −113.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>tert</i>-Butyl [(1<i>S</i>,2<i>R</i>)-2-Hydroxy-2,3-dihydro-1<i>H</i>-inden-1-yl]carbamate (<b>45</b>)</h4><div class="NLM_p last">To a solution of the commercially available (1<i>S</i>,2<i>R</i>)-1-amino-2,3-dihydro-1<i>H</i>-inden-2-ol (21 g, 141 mmol, 1.0 equiv) in anhydrous DCM (500 mL), Et<sub>3</sub>N (28 g, 282 mmol, 2.0 equiv), and Boc<sub>2</sub>O (36.9 g, 169 mmol, 1.2 equiv) were added sequentially. The mixture was stirred at rt overnight. The reaction mixture was concentrated, and the residue was purified by column chromatography with 0–25% EtOAc in PE to afford compound <b>45</b> as a white solid (32 g, 91.2% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.24–7.12 (m, 4H), 6.35 (d, <i>J</i> = 8.4 Hz, 1H), 4.97 (d, <i>J</i> = 4.8 Hz, 1H), 4.86 (dd, <i>J</i> = 8.6, 4.6 Hz, 1H), 2.99 (dd, <i>J</i> = 16.0, 5.2 Hz, 1H), 2.77 (dd, <i>J</i> = 16.0, 1.0 Hz, 1H), 1.43 (s, 9H).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (1<i>S</i>,2<i>R</i>)-1-[(<i>tert</i>-Butoxycarbonyl)amino]-2,3-dihydro-1<i>H</i>-inden-2-yl methanesulfonate (<b>46</b>)</h4><div class="NLM_p last">To a mixture of <i>tert</i>-butyl [(1<i>S</i>,2<i>R</i>)-2-hydroxy-2,3-dihydro-1<i>H</i>-inden-1-yl]carbamate <b>45</b> (32 g, 129 mmol, 1.0 equiv) and Et<sub>3</sub>N (26.1 g, 258 mmol, 2.0 equiv) in dry DCM (400 mL) at 0 °C, a solution of methanesulfonyl chloride (22.1 g, 193 mmol, 1.5 equiv) in DCM (100 mL) was added slowly. The resulting mixture was stirred at rt for 3 h. Water was added to the mixture, then the aqueous phase was extracted with DCM 3 times. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford the intermediate mesylate <b>46</b> (41 g, 97.2%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.41 (d, <i>J</i> = 8.8 Hz, 1H), 7.30–7.20 (m, 4H), 5.32–5.28 (m, 1H), 5.20 (dd, <i>J</i> = 8.8, 5.2 Hz, 1H), 3.24 (dd, <i>J</i> = 17.2, 4.8 Hz, 1H), 3.14 (s, 3H), 3.11–3.03 (m, 1H), 1.42 (s, 9H).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>tert</i>-Butyl [(1<i>S</i>,2<i>S</i>)-2-Amino-2,3-dihydro-1<i>H</i>-inden-1-yl]carbamate (<b>48</b>)</h4><div class="NLM_p last">To a solution of the mesylate <b>46</b> (41 g, 125 mmol, 1.0 equiv) in DMF (500 mL), sodium azide (9.8 g, 151 mmol, 1.2 equiv) was added and the mixture was stirred at 90 °C overnight. After cooling to rt, the mixture was diluted with EtOAc (1 L), washed with H<sub>2</sub>O (3 × 200 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered to obtain the crude compound <b>47</b>. To this crude, 10% Pd/C (4 g, wet) was added and the mixture was stirred under a H<sub>2</sub> atmosphere overnight. The reaction mixture was then filtered through Celite and concentrated, and the residue was purified by column chromatography with 50–100% EtOAc in PE as eluent to afford compound <b>48</b> (22 g, 71%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.18–7.10 (m, 4H), 7.05 (d, <i>J</i> = 4.0 Hz, 2H), 4.52 (t, <i>J</i> = 8.2 Hz, 1H), 3.35–3.26 (m, 1H), 2.97 (dd, <i>J</i> = 17.4, 7.4 Hz, 1H), 2.52 (dd, <i>J</i> = 17.4, 9.2 Hz, 1H), 1.81–1.71 (bs, 2H), 1.43 (s, 9H).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>tert</i>-Butyl {(1<i>S</i>,2<i>S</i>)-2-[(1-Methyl-1<i>H</i>-indole-5-carbonyl)amino]-2,3-dihydro-1<i>H</i>-inden-1-yl}carbamate (<b>49</b>, RCOOH = 1-Methyl-1<i>H</i>-indole-5-carboxylic Acid)</h4><div class="NLM_p last">To a solution of 1-methyl-1<i>H</i>-indole-5-carboxylic acid (374 mg, 2.1 mmol, 1.1 equiv) in DCM (20 mL) was added HOBt (288 mg, 2.1 mmol, 1.1 equiv), EDCI (410 mg, 2.1 mmol, 1.1 equiv), and DIEA (501 mg, 3.8 mmol, 2.0 equiv) sequentially. The resulting solution was stirred at rt for 30 min. Then <i>tert</i>-butyl (1<i>S</i>,2<i>S</i>)-2-amino-2,3-dihydro-1<i>H</i>-inden-1-yl carbamate <b>48</b> (482 mg, 1.9 mmol, 1.0 equiv) was added. The reaction mixture was stirred at rt overnight. The mixture was diluted with DCM and washed with aq NaOH three times. The combined organic phase was concentrated to afford the title compound <b>49</b> (724 mg, 92% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.62 (d, <i>J</i> = 8.0 Hz, 1H), 8.13 (s, 1H), 7.69 (d, <i>J</i> = 8.4 Hz, 1H), 7.48 (d, <i>J</i> = 4.8 Hz, 1H), 7.41–7.36 (m, 2H), 7.21 (d, <i>J</i> = 8.4 Hz, 3H), 7.12 (d, <i>J</i> = 4.0 Hz, 1H), 6.52 (d, <i>J</i> = 3.2 Hz, 1H), 5.20 (t, <i>J</i> = 8.8 Hz, 1H), 4.67–4.58 (m, 1H), 3.81 (s, 3H), 3.19–3.13 (m, 1H), 2.84–2.78 (m, 1H), 1.38 (s, 9H).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-((1<i>S</i>,2<i>S</i>)-1-Amino-2,3-dihydro-1<i>H</i>-inden-2-yl)-1-methyl-1<i>H</i>-indole-5-carboxamide (<b>50</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl {(1<i>S</i>,2<i>S</i>)-2-[(1-methyl-1<i>H</i>-indole-5-carbonyl)amino]-2,3-dihydro-1<i>H</i>-inden-1-yl}carbamate <b>49</b> (200 mg, 0.49 mmol, 1.0 equiv) in DCM (7 mL) was added TBDMSOTf (137 mg, 0.52 mmol, 1.05 equiv) dropwise. The reaction mixture was stirred at rt for 6 h. Then Et<sub>3</sub>N (2 mL) was added, and the mixture was extracted with DCM and saturated aq NaHCO<sub>3</sub> for 3 times. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuum to afford title compound <b>50</b> (145 mg, 96% yield) as a yellow solid. Mass spectrum (ESI) <i>m</i>/<i>e</i> = 306 (M + 1).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>tert</i>-Butyl (2<i>S</i>)-2-({(1<i>S</i>,2<i>S</i>)-2-[(1-Methyl-1<i>H</i>-indole-5-carbonyl)amino]-2,3-dihydro-1<i>H</i>-inden-1-yl}carbamoyl)morpholine-4-carboxylate (<b>51</b>)</h4><div class="NLM_p last">To a solution of (<i>S</i>)-4-(<i>tert</i>-butoxycarbonyl)morpholine-2-carboxylic acid (158 mg, 0.68 mmol, 1.1 equiv) in DMF (10 mL) was added HATU (260 mg, 0.68 mmol, 1.1 equiv) and Et<sub>3</sub>N (126 mg, 1.24 mmol, 2.0 equiv) sequentially. The resulting solution was stirred at rt for 0.5 h. Then <i>N</i>-((1<i>S</i>,2<i>S</i>)-1-amino-2,3-dihydro-1<i>H</i>-inden-2-yl)-1-methyl-1<i>H</i>-indole-5-carboxamide <b>50</b> (190 mg, 0.62 mmol, 1.0 equiv) was added. The reaction mixture was stirred at rt overnight. The mixture was concentrated and extracted with DCM and NaOH aq (0.5 mol/L) for 3 times. The combined organic phase was concentrated to afford the title compound <b>51</b> (308 mg, 95% yield) as a yellow solid. Mass spectrum (ESI) <i>m</i>/<i>z</i> 519 (M + H).</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl 2-Amino-1<i>H</i>-indene-3-carboxylate (<b>59</b>)</h4><div class="NLM_p last">A 3-neck round-bottom flask was charged with the commercially available keto ester <b>58</b> (5.00 g, 26.29 mmol), and ammonium acetate (6.08 g, 78.88 mmol) was added, followed by the addition of MeOH (50 mL). The reaction mixture was heated to 55 °C, and vacuum was gradually applied until MeOH started to distill over. Pressure and oil bath temperature were adjusted to make sure that <i>T</i> was not far from 45 °C. After 18 h, all solvent had distilled over and MeOH (50 mL) was added to the solid in the flask and the temperature in the oil bath was adjusted to ca. 50 °C for 2 more hours. The reaction mixture was allowed to slowly reach rt, and it was stirred overnight. The precipitate was filtered off and rinsed with MeOH (15 mL) to give a sand-colored solid (3.03 g). The filtrate, in which a second crop of crystals had begun to precipitate, was concentrated to dryness to yield a dark-brown/red semisolid that was taken up in DCM (60 mL) and water (30 mL). The organic phase was dried over MgSO<sub>4</sub> and concentrated to yield a dark solid (1.83 g) that was recrystallized from MeOH to obtain compound <b>59</b> as a mustard-colored powder (0.632 g) for an overall yield of 73.6%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88 (bs, 1H), 7.46 (d, J= 7.62 Hz, 1H), 7.45 (bs, 1H), 7.16 (d, <i>J</i> = 7.24 Hz, 1H), 7.09 (t, <i>J</i> = 7.55 Hz, 1H), 6.85 (td, <i>J</i> = 7.41 and 1 Hz, 1H), 3.74 (s, 3H), 3.55 (s, 2H).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Methyl 2-(<i>tert</i>-Butoxycarbonylamino)-2,3-dihydro-1<i>H</i>-indene-1-carboxylate (<b>60</b>)</h4><div class="NLM_p last">An oven-dried 2-neck round-bottom flask under nitrogen was charged with the NaBH<sub>4</sub> (0.75 g, 26.29 mmol) and THF (15 mL). The mixture was cooled down to −17 °C. At that <i>T</i>, the addition of trifluoroacetic acid (8.14g, 71.35 mmol) was initiated at such a rate that the <i>T</i> was maintained below −10 °C (<b>Caution: exothermic reaction</b>). Temperature was kept below −10 °C for 1 h, then the enaminoester <b>59</b> (1.50 g, 7.93 mmol) was added in six rapid portions; <i>T</i> hardly rose (<b>Caution!</b>). Immediately after the addition, the flask was moved to an oil bath set to +10 °C and stirred overnight. The reaction <i>T</i> was lowered to 2 °C, and the mixture was quenched by the addition of water (15 mL) via a syringe pump during 1 h (15 mL/h). (<b>Caution: immediate gas evolution</b>). <i>T</i><sub>max</sub> seemed to end up at around +10 °C. Upon completion of the addition, the reaction mixture was stirred at 7 °C overnight. To the crude reaction mixture at 7 °C, NaOH (aq, 50% w/w, 2.15 mL) was added dropwise at such a rate that <i>T</i> was kept <10 °C. The pH was measured to ca. 8. Boc<sub>2</sub>O (2.265 g, 10.38 mmol) was added in one portion. More NaOH (aq, 50% w/w, 0.40 mL) was added. Some gas evolution could be observed. The reaction mixture was stirred at rt overnight. The reaction mixture was taken up with iPrOAc (30 mL), THF (15 mL), and water (15 mL). The aqueous phase was extracted with iPrOAc (15 mL), dried over MgSO<sub>4</sub>, and concentrated to give compound <b>60</b>, a 1:1 cis:trans mixture, as a purple viscous oil (3.82 g).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>trans</i>-2-[(<i>tert</i>-Butoxycarbonyl)amino]-2,3-dihydro-1<i>H</i>-indene-1-carboxylic Acid (<b>62</b>)</h4><div class="NLM_p last">A 1:1 mixture of cis and trans methyl 2-(<i>tert</i>-butoxycarbonylamino)-2,3-dihydro-1<i>H</i>-indene-1-carboxylate <b>60</b> (1.65 g, 5.66 mmol) was dissolved in MeOH:water (20 mL, 4:1) and sodium methoxide (0.521 g, 9.63 mmol) was added in five portions, carefully monitoring the reaction until full conversion. The reaction was taken up in MTBE (50 mL) and water (50 mL). The aqueous phase was acidified with KHSO<sub>4</sub> (aq soln 1M) to pH 3 and extracted with MTBE. The organic phase was dried over MgSO<sub>4</sub> and evaporated to give compound <b>61</b> as a mixture of trans and cis (1.467 g) compounds in ratio 6.3:1. The mixture was separated by HPLC to give the pure racemic trans diastereoisomer <b>62</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.54 (bs, 1H), 7.26 (d, 1H), 7.16–7.22 (m, 4H), 4.47 (p, 1H), 3.87 (d, <i>J</i> = 6.60 Hz, 1H), 3.22 (dd, <i>J</i> = 8.12 and 15.77 Hz, 1H), 1.39 (s, 9H).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1<i>R</i>,2<i>R</i>-2-Amino-<i>N</i>-(2-(dimethylamino)ethyl)-2,3-dihydro-1<i>H</i>-indene-1-carboxamide (<b>63a</b>) and 1<i>S</i>,2<i>S</i>-2-Amino-<i>N</i>-(2-(dimethylamino)ethyl)-2,3-dihydro-1<i>H</i>-indene-1-carboxamide (<b>63b</b>)</h4><div class="NLM_p last">Compound <i>trans</i>-2-(<i>tert</i>-butoxycarbonylamino)-2,3-dihydro-1<i>H</i>-indene-1-carboxylic acid <b>62</b> (1.0 g, 3.16 mmol) was dissolved in dry DMF (20 mL), DIPEA (1.484 g, 11.5 mmol), 2-(1<i>H</i>-benzo[<i>d</i>][1,2,3]triazol-1-yl)-1,1,3,3-tetramethylisouronium hexafluorophosphate(V) (HBTU) (1.782 g, 4.69 mmol), and <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine (0.65 g, 7.32 mmol) were added and stirred at rt overnight. The reaction mixture was concentrated to 2 mL (ca), diluted with DMSO (6 mL), and purified by HPLC. The pure fractions were combined and freeze-dried to give the Boc-protected intermediate (802 mg, 64% yield). <sup>1</sup>H NMR (500 MHz, DMSO) δ 8.09 (bs, 1H), 7.15–7.17 (m, 5H), 4.48 (p, <i>J</i> = 7.64 and 7.73 Hz, 1H), 3.81 (d, <i>J</i> = 6.74 Hz, 1H), 3.09–3.28 (m, 3H), 2.76 (dd, <i>J</i> = 7.66 and 15.46 Hz, 1H), 2.24–2.38 (m, 2H), 2.16 (s, 6H), 1.38 (s, 9H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 348 (M + 1). This compound (797 mg, 2.29 mmol) was dissolved in dry dioxane (6 mL), and 4 M HCl in dioxane (8 mL) was added. The reaction mixture was stirred for 2 h, then evaporated and coevaporated with dioxane (4 × 10 mL) and then freeze-dried to give a residue <b>63</b> (980 mg) that was submitted to chiral SFC, Chiralpak AD, 250 mm × 20 mm, particle size 5 μm, mobil phase 25% EtOH/DEA 100/0.5 in CO<sub>2</sub>, 150 bar, flow 70 mL/min, to give the two enantiomers <b>63a</b> (0.276 g, 99.5% ee) and <b>63b</b> (0.246 g, 97.8% ee). For assignment of the absolute configuration, see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00322/suppl_file/jm8b00322_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Biological Evaluation</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Protocol for Ghrelin Receptor Binding Assay</h4><div class="NLM_p last">The assay detects compound binding to the GHS-R1a receptor when competing with [<sup>125</sup>I]-ghrelin in membranes prepared from HEK293s cell line. Test compounds or DMSO (1 μL per well, final DMSO concentration 0.5%) were plated in 96-well assay plates (Greiner V-bottom PP). Then 150 μL of cell membranes (final concentration 8 μg/well) in assay buffer (50 mM Tris, 5 mM MgCl<sub>2</sub>, 0.01% BSA, pH 7.4) supplemented with methyl arachidonyl fluorophosphonate (MAFP, 1 μg/well; Sigma) was added to the plates. Then 50 μL of [His[<sup>125</sup>I]]-h-ghrelin (final concentration 75 pM; PerkinElmer) in assay buffer was added followed by 1 h incubation at room temperature. The bound and unbound isotope was separated by filtration, using polyethylenimine (PEI) pretreated (200 μL of 50% PEI per well; Aldrich) filter plates (96-well Millipore, catalogue no. MSFCNXB50). Following filtration, the plates were washed 8 times with 200 μL/well of ice-cold wash buffer (50 mM Tris, 5 mM MgCl<sub>2</sub>, 50 mM NaCl, pH 7.4). The amount of membrane-bound radioligand was then quantified (Wallac Trilux Microbeta). Effect of the compounds was expressed as a percentage of maximal effect of (<span class="smallcaps smallerCapital">d</span>-Arg1, <span class="smallcaps smallerCapital">d</span>-Phe5, <span class="smallcaps smallerCapital">d</span>-Trp7,9, Leu11)-SubstanceP. The concentration and percent effect of the test compound was fitted using a sigmoidal dose–response model (Genedata Screener) and potency (IC<sub>50</sub>) determined. The results obtained in this assay are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Compounds were considered active in the agonist assay when efficacy >30% and as full agonists when efficacy >85%.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Protocol for Ghrelin IP1 Agonist Assay</h4><div class="NLM_p last">In HEK293s cells stably expressing human GHS receptor,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> agonist activity was assessed by measuring intracellular myo-inositol 1 phosphate (IP1) using the IP-One Tb (HTRF) assay kit (Cisbio International).<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> Solutions were prepared as described by the supplier. Test compounds or DMSO (200 nL per well, final DMSO concentration 0.2%) were plated in 384-well assay plates (Greiner Lumitrac 200). Cryopreserved cells were thawed, washed in Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen) containing 10% fetal calf serum (FCS; Hyclone) and resuspended in stimulation buffer (10 mM HEPES, 1 mM CaCl<sub>2</sub>, 0.5 mM MgCl<sub>2</sub>, 4.2 mM KCl, 146 mM NaCl, 5.5 mM glucose, 50 mM LiCl, pH 7.4, supplied in the assay kit) supplemented with 0.02% bovine serum albumin (BSA; Sigma) to a density of 0.75E6 cells/mL. Cell suspension (20 μL/well) was added to the compound plate and incubated for 90 min at 37 °C in 5% CO<sub>2</sub>/95% air. Following lysis of cells using lysis buffer (supplied in the assay kit) in the presence of IP1-d2 (5 μL/well) and anti-IP1 cryptate (5 μL/well) for 60 min at room temperature, fluorescence was measured on the Pherastar (BMG Labtech) at 612 and 665 nm, respectively. The effect of the compounds was expressed as a percentage of maximal effect of GHRP-6 (5 μM; Bachem). The concentration and percent effect of the test compound was fitted using a sigmoidal dose–response model (Genedata Screener) and potency (EC<sub>50</sub>) and efficacy (% agonism) were determined. The results obtained in this assay are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Pharmacokinetics in Male Han–Wister Rats</h4><div class="NLM_p">Male Han–Wister rats (7–8 weeks old, body weight 200–300 g) were kept in plastic cages with free access to standard rat diet and water. The animals were maintained at a temperature of 20–25 °C with a 12 h light/dark cycle and relative humidity of 40–70% before the experiment. All studies were approved by the corresponding local ethical committees.</div><div id="sec5_2_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> IV Formulation</h5><div class="NLM_p last">Appropriate weight of compound was weighed and dissolved into the required volume of vehicle with vortex and sonication applied to reach the target concentration. The vehicle was composed of 5% DMSO, 95% SBE-B-CD (30% w/v in water). This solution was pH adjusted with 1 M HCl and 1 M NaOH to the final pH of 7.5. This IV bolus was filtered before administration with formulations stirred at room temperature for at least 2 min before dosing. The final measured dose was typically ca. 1 mg/kg. Two animals were administered the IV bolus via tail vein. The cannulation of the jugular vein was pretreated to the rats 2–3 days prior to the study. Blood samples (0.2 mL) were collected from the jugular vein at the following intervals: predose, 2, 5, 10, and 30 min and 1, 2, 4, 8, and 24 h post dose.</div></div><div id="sec5_2_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> PO Formulations</h5><div class="NLM_p last">Appropriate weight of compound was weighed and dissolved into the required volume of vehicle with vortex and sonication applied to reach the target concentration. The vehicle was composed of 5% DMSO, 95% SBE-B-CD (30% w/v in water). The final measured dose was typically ca. 2 mg/kg. Blood samples (0.2 mL) were collected from the jugular vein at the following time intervals: predose, 15 and 30 min, and 1, 1.5, 2, 3, 4, 8, and 24 h after oral dosing. Each sample was transferred into plastic microcentrifuge tubes containing K2-EDTA and placed on wet ice prior to centrifugation for plasma. Blood samples were centrifuged at 10000 rpm for 2 min at 4 °C to obtain plasma. Samples were stored in a freezer at −75 ± 15 °C prior to analysis. Plasma samples were analyzed by an LC-MS/MS method. Pharmacokinetic calculations were performed using WinNonlin (PhoenixTM, version 6.1)</div></div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Pharmacokinetics in Male Beagle Dogs</h4><div class="NLM_p">Group-housed male/female beagle dogs (2–5 years old, body weight 12–15 kg) were fasted overnight prior to dosing, food was offered ca. 4 h postdose following collection of the 4 h blood sample (oral phase) and ca. 3 h post dose following collection of the 3 h blood sample (intravenous phase). Tap water was available ad libitum. All studies were approved by the corresponding local ethical committees.</div><div id="sec5_2_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> IV Formulation</h5><div class="NLM_p last">Appropriate weight of compound was weighed and dissolved into the required volume of vehicle with vortex and sonication applied to reach the target concentration. The vehicle was composed of 5% DMSO, 95% SBE-B-CD (30% w/v in water). This solution was pH adjusted with 1 M HCl and 1 M NaOH to a final pH of 7.5 and filtered before administration with formulations stirred overnight at room temperature before dosing. The final measured dose was typically ca. 1 mg/kg. Compound was administered to two animals as a 15 min intravenous infusion via the cephalic vein. The cannulation of the jugular vein was pretreated to the rats 2–3 days prior to the study. Blood samples (ca. 1 mL) were collected from the jugular vein at the following intervals: 0.03, 0.08, 0.17, 0.33, 0.67, 1, 2, 4, 6, 12, and 24 h post dose.</div></div><div id="sec5_2_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> PO Formulations</h5><div class="NLM_p last">Appropriate weight of compound was weighed and dissolved into the required volume of vehicle with vortex and sonication applied to reach the target concentration. The vehicle was composed of 5% DMSO, 95% SBE-B-CD (30% w/v in water), or 0.5% HPMC/0.1% Tween 80 in water (when oral suspension was required). The final measured dose was typically ca. 2 mg/kg. Compound was administered orally via gastric gavage. Blood samples (ca. 1 mL) were collected from the jugular vein at the following time intervals: 0.17, 0.33, 0.67, 1, 2, 3, 4, 6, 12, and 24 h after oral dosing. Each sample was transferred into plastic microcentrifuge tubes containing K2-EDTA and placed on wet ice prior to centrifugation for plasma. Blood samples were centrifuged at 10000 rpm for 2 min at 4 °C to obtain plasma. Samples were stored in a freezer at −75 ± 15 °C prior to analysis. Plasma samples were analyzed by an LC-MS/MS method. Pharmacokinetic calculations were performed using WinNonlin (PhoenixTM, version 6.1)</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> CNS Penetration (<i>K</i><sub>p,uu</sub>)</h4><div class="NLM_p last">The amount (as free concentration in brain) of compound <b>22</b> and <b>39</b> present in the brain at steady state in relation to that in blood was measured according to the method described in literature.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Animal Study Protocol</h4><div class="NLM_p last">The present study was approved by the local Ethical committee in Gothenburg, Sweden (2010-04-01).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Experimental Procedures</h4><div class="NLM_p last">Female, 4–8 years old beagles from Kennel Rååhöjden were used in these studies. Four dogs were included in each group. All dogs were fed at 14:30 each day, starting at least 1 week before the first experiment, and after the last sample on study day. All dogs were weighed and orally dosed at 7:30. Blood samples were obtained before dosing, 15, 30, and 45 min, and 1, 2, 4, 7, 12, and 24 h after dose. The blood was collected in K2E EDTA coated BD Vacutainer 2 mL vials and centrifuged at 4 °C, 3.0<i>g</i>, for 5 min, and 125 μL of plasma was transferred to 0.5 mL Eppendorf tubes or 96-well plates (compound level) and kept frozen (< −20 °C compound level, < −80 °C, IGF-1) until analysis. The total blood volume obtained was minimized for each blood sample. The maximally allowed volume was 13 mL per experiment. Dogs were allowed to rest for at least 3 weeks when 10% of circulating blood volume (80 mL for a 13 kg dog) was obtained.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Bioanalytical Procedures</h4><div class="NLM_p last">IGF-1 was determined with an IGF-1 ELISA kit purchased from Mediagnost, Germany, catalogue no. E20. The assay is performed according to the manufacturer’s instructions. The primary readout is the change in IGF-1 levels from baseline in relation to plasma levels of the compound. Paired student <i>t</i> test is used for statistical check at each time point. Changes with <i>P</i> values below 5% were considered to be significant.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> hERG Assay</h4><div class="NLM_p last">hERG currents are recorded from hERG-expressing CHO cells.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-8"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00322" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00322" class="ext-link">10.1021/acs.jmedchem.8b00322</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Vibrational circular dichroism assignment of absolute configuration of compounds <b>65a</b> and <b>65b</b>; homology model of ghrelin receptor with bound compound <b>8</b> in pdb format; analytical data of compounds <b>1</b>–<b>22</b>, <b>24</b>–<b>31</b>, <b>33</b>–<b>38</b>, and <b>41</b>–<b>43</b>; representative curves for a full and a partial agonist (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00322/suppl_file/jm8b00322_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00322/suppl_file/jm8b00322_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00322/suppl_file/jm8b00322_si_001.pdf">jm8b00322_si_001.pdf (703.2 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00322/suppl_file/jm8b00322_si_002.csv">jm8b00322_si_002.csv (3.12 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00322" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Gardelli</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , , AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1169-2180" title="Orcid link">http://orcid.org/0000-0003-1169-2180</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6f0c1d061c1b06010e41080e1d0b0a0303062f0e1c1b1d0e150a010a0c0e410c0002"><span class="__cf_email__" data-cfemail="c8abbaa1bbbca1a6a9e6afa9baacada4a4a188a9bbbcbaa9b2ada6adaba9e6aba7a5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroki Wada</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , , AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span>; 
    <span>Present Address:
                        H.W. now at Sygnature Discovery Limited, BioCity, Pennyfoot Street, Nottingham, UK</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Asim Ray</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , , AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Moya Caffrey</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , , AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Llinas</span> - <span class="hlFld-Affiliation affiliation">DMPK Department, , , , AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4620-9363" title="Orcid link">http://orcid.org/0000-0003-4620-9363</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Igor Shamovsky</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , , AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2881-9531" title="Orcid link">http://orcid.org/0000-0002-2881-9531</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joakim Tholander</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, Cardiovascular and Metabolic Diseases IMED Biotech
Unit, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span>; 
    <span>Present Address:
                        J.T. now at Gothenburg University, Gothenburg, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joakim Larsson</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , , AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span>; 
    <span>Present Address:
                        J.L. now at Red Glead Discovery AB, Lund, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulf Sivars</span> - <span class="hlFld-Affiliation affiliation">Bioscience Department, , , , AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leif Hultin</span> - <span class="hlFld-Affiliation affiliation">Precision
Medicine Laboratories, Precision Medicine and Genomics IMED Biotech
Unit, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulf Andersson</span> - <span class="hlFld-Affiliation affiliation">Drug
Safety and Metabolism IMED Biotech Unit, AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hitesh J. Sanganee</span> - <span class="hlFld-Affiliation affiliation">Scientific
Partnering & Alliances IMED Biotech Unit, AstraZeneca, SK10 4TF Cambridge, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristina Stenvall</span> - <span class="hlFld-Affiliation affiliation">Projects Department,
Respiratory, Inflammation and Autoimmunity IMED Biotech Unit, , , , AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brith Leidvik</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences IMED Biotech Unit, AstraZeneca
Gothenburg, 43183 Mölndal, Sweden</span>; 
    <span>Present Address:
                        B.L. now at Sahlgrenska University Hospital, Gothenburg, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karin Gedda</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences IMED Biotech Unit, AstraZeneca
Gothenburg, 43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Jinton</span> - <span class="hlFld-Affiliation affiliation">Bioscience Department, , , , AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marie Rydén Landergren</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , , AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kostas Karabelas</span> - <span class="hlFld-Affiliation affiliation">Projects Department,
Respiratory, Inflammation and Autoimmunity IMED Biotech Unit, , , , AstraZeneca Gothenburg, 43183 Mölndal, Sweden</span>; 
    <span>Present Address:
                        K.K. now at Bioglan AB, Malmö, Sweden</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions from C.G., A.L., I.S., L.H., U.A., and L.J. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3643-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Wuxi chemists for their work in the synthesis and purification of many of the reported compounds. We thank our colleagues at AstraZeneca R&D whose testing of the compounds in hERG, log <i>D</i>, Caco, metabolic stability, CNS assays, and PK studies provided the results which are described and the analytical team for purity and HRMS data. We thank Werngard Czechtizky for her insightful comments in the preparation of the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">Boc<sub>2</sub>O</td><td class="NLM_def"><p class="first last">di<i>tert</i>-butyl dicarbonate</p></td></tr><tr><td class="NLM_term">CH<sub>3</sub>CN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DEA</td><td class="NLM_def"><p class="first last">diethylamine</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">Et<sub>3</sub>N</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">GH</td><td class="NLM_def"><p class="first last">growth hormone</p></td></tr><tr><td class="NLM_term">GHS-R</td><td class="NLM_def"><p class="first last">growth hormone secretagogue receptor</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein coupled receptor</p></td></tr><tr><td class="NLM_term">HCHO</td><td class="NLM_def"><p class="first last">formaldehyde</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectroscopy</p></td></tr><tr><td class="NLM_term">iPrOAc</td><td class="NLM_def"><p class="first last">isopropyl acetate</p></td></tr><tr><td class="NLM_term">IGF</td><td class="NLM_def"><p class="first last">insulin growth factor</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">KCl</td><td class="NLM_def"><p class="first last">potassium chloride</p></td></tr><tr><td class="NLM_term">KHSO<sub>4</sub></td><td class="NLM_def"><p class="first last">potassium hydrogen sulfate</p></td></tr><tr><td class="NLM_term">LC-MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MgCl<sub>2</sub></td><td class="NLM_def"><p class="first last">magnesium chloride</p></td></tr><tr><td class="NLM_term">MgSO<sub>4</sub></td><td class="NLM_def"><p class="first last">magnesium sulfate</p></td></tr><tr><td class="NLM_term">MTBE</td><td class="NLM_def"><p class="first last">methyl <i>tert</i>-butyl ether</p></td></tr><tr><td class="NLM_term">NaHCO<sub>3</sub></td><td class="NLM_def"><p class="first last">sodium bicarbonate</p></td></tr><tr><td class="NLM_term">NaCl</td><td class="NLM_def"><p class="first last">sodium chloride</p></td></tr><tr><td class="NLM_term">NaBH<sub>3</sub>CN</td><td class="NLM_def"><p class="first last">sodium cyanoborohydride</p></td></tr><tr><td class="NLM_term">NaBH<sub>4</sub></td><td class="NLM_def"><p class="first last">sodium borohydride</p></td></tr><tr><td class="NLM_term">Na<sub>2</sub>SO<sub>4</sub></td><td class="NLM_def"><p class="first last">sodium sulfate</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">TBDMSOTf</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl triflate</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">VCD</td><td class="NLM_def"><p class="first last">vibrational circular dichroism.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsubara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span> <span> </span><span class="NLM_article-title">Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1016/S0196-9781(01)00633-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2FS0196-9781%2801%2900633-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=11836003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVKrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=531-536&author=I.+Sakataauthor=K.+Nakamuraauthor=M.+Yamazakiauthor=M.+Matsubaraauthor=Y.+Hayashiauthor=K.+Kangawaauthor=T.+Sakai&title=Ghrelin-producing+cells+exist+as+two+types+of+cells%2C+closed-+and+opened-type+cells%2C+in+the+rat+gastrointestinal+tract&doi=10.1016%2FS0196-9781%2801%2900633-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract</span></div><div class="casAuthors">Sakata, Ichiro; Nakamura, Kazuaki; Yamazaki, Mami; Matsubara, Maki; Hayashi, Yuijiro; Kangawa, Kenji; Sakai, Takafumi</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">531-536</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Ghrelin was recently isolated from the rat stomach as an endogenous ligand for the growth-hormone secretagogue receptor (GHS-R) and is known to exist in the gastrointestinal tract and hypothalamus.  In this study, the authors investigated in detail the distribution and morphol. characteristics of ghrelin-contg. cells (ghrelin cells) in the gastrointestinal tract by immunohistochem. and in situ hybridization.  Ghrelin cells were found to be localized in the mucous membrane of the stomach, duodenum, ileum, cecum and colon but not in myenteric plexus, and they can be classified into open- and closed-type cells.  The greatest no. of ghrelin cells was found in the stomach, and it was found that the no. of the opened-type cells gradually increased in the direction from stomach to the lower gastrointestinal tract.  These results suggest that the two types of ghrelin cells may be distinctly regulated and play different physiol. roles in various regions of the gastrointestinal tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPPBfgaJT_67Vg90H21EOLACvtfcHk0ljcROHrMmpQBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVKrsb8%253D&md5=1624e2c509d4cc8f7711834a18c09877</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2801%2900633-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252801%252900633-7%26sid%3Dliteratum%253Aachs%26aulast%3DSakata%26aufirst%3DI.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DMatsubara%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKangawa%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DT.%26atitle%3DGhrelin-producing%2520cells%2520exist%2520as%2520two%2520types%2520of%2520cells%252C%2520closed-%2520and%2520opened-type%2520cells%252C%2520in%2520the%2520rat%2520gastrointestinal%2520tract%26jtitle%3DPeptides%26date%3D2002%26volume%3D23%26spage%3D531%26epage%3D536%26doi%3D10.1016%2FS0196-9781%2801%2900633-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
der Lely, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschöp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, E.</span></span> <span> </span><span class="NLM_article-title">Biological, physiological, pathophysiological and pharmacological aspects of ghrelin</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">426</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1210/er.2002-0029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1210%2Fer.2002-0029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=15180951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVeltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=426-457&issue=3&author=A.+J.+Van%0Ader+Lelyauthor=M.+Tsch%C3%B6pauthor=M.+L.+Heimanauthor=E.+Ghigo&title=Biological%2C+physiological%2C+pathophysiological+and+pharmacological+aspects+of+ghrelin&doi=10.1210%2Fer.2002-0029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin</span></div><div class="casAuthors">van der Lely, Aart J.; Tschop, Matthias; Heiman, Mark L.; Ghigo, Ezio</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">426-457</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Ghrelin is a peptide predominantly produced by the stomach.  Ghrelin displays strong GH-releasing activity.  This activity is mediated by the activation of the so-called GH secretagogue receptor type 1a.  This receptor had been shown to be specific for a family of synthetic, peptidyl and nonpeptidyl GH secretagogues.  Apart from a potent GH-releasing action, ghrelin has other activities including stimulation of lactotroph and corticotroph function, influence on the pituitary gonadal axis, stimulation of appetite, control of energy balance, influence on sleep and behavior, control of gastric motility and acid secretion, and influence on pancreatic exocrine and endocrine function as well as on glucose metab.  Cardiovascular actions and modulation of proliferation of neoplastic cells, as well as of the immune system, are other actions of ghrelin.  Therefore, we consider ghrelin a gastrointestinal peptide contributing to the regulation of diverse functions of the gut-brain axis.  So, there is indeed a possibility that ghrelin analogs, acting as either agonists or antagonists, might have clin. impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW0mquUT4pvrVg90H21EOLACvtfcHk0lgKi6VcCRaEpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVeltLo%253D&md5=7e7338e11cd64c0cc3f7d4aa6ace75e1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1210%2Fer.2002-0029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2002-0029%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BLely%26aufirst%3DA.%2BJ.%26aulast%3DTsch%25C3%25B6p%26aufirst%3DM.%26aulast%3DHeiman%26aufirst%3DM.%2BL.%26aulast%3DGhigo%26aufirst%3DE.%26atitle%3DBiological%252C%2520physiological%252C%2520pathophysiological%2520and%2520pharmacological%2520aspects%2520of%2520ghrelin%26jtitle%3DEndocr.%2520Rev.%26date%3D2004%26volume%3D25%26issue%3D3%26spage%3D426%26epage%3D457%26doi%3D10.1210%2Fer.2002-0029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagaya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uematsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyatake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span> <span> </span><span class="NLM_article-title">Treatment of cachexia with ghrelin in patients with COPD</span>. <i>Chest</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1187</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1378/chest.128.3.1187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1378%2Fchest.128.3.1187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=16162705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2005&pages=1187-1193&issue=3&author=N.+Nagayaauthor=T.+Itohauthor=S.+Murakamiauthor=H.+Oyaauthor=M.+Uematsuauthor=K.+Miyatakeauthor=K.+Kangawa&title=Treatment+of+cachexia+with+ghrelin+in+patients+with+COPD&doi=10.1378%2Fchest.128.3.1187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of cachexia with ghrelin in patients with COPD</span></div><div class="casAuthors">Nagaya, Noritoshi; Itoh, Takefumi; Murakami, Shinsuke; Oya, Hideo; Uematsu, Masaaki; Miyatake, Kunio; Kangawa, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Chest</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1187-1193</span>CODEN:
                <span class="NLM_cas:coden">CHETBF</span>;
        ISSN:<span class="NLM_cas:issn">0012-3692</span>.
    
            (<span class="NLM_cas:orgname">American College of Chest Physicians</span>)
        </div><div class="casAbstract">Study objectives: Ghrelin is a novel growth hormone (GH)-releasing peptide that also induces a pos. energy balance by decreasing fat utility and stimulating feeding through GH-independent mechanisms.  We investigated whether ghrelin improves cachexia and functional capacity in patients with COPD.  Methods: This is an open-label pilot study.  Human ghrelin (2 μg/kg bid) was IV administered to seven cachectic patients with COPD for 3 wk.  Food intake, body compn., muscle strength, exercise capacity, pulmonary function, and sympathetic nerve activity were examd. before and after ghrelin therapy.  Results: A single administration of ghrelin markedly increased serum GH (21-fold).  Three-week treatment with ghrelin resulted in a significant increase in mean (± SEM) body wt. (49.3 ± 3.6 to 50.3 ± 3.8 kg; p < 0.05).  Food intake was significantly increased during ghrelin therapy.  Ghrelin increased lean body mass and peripheral and respiratory muscle strength.  Ghrelin significantly increased Karnofsky performance status score and the distance walked in 6 min (370 ± 30 to 432 ± 35 m; p < 0.05), although it did not significantly alter pulmonary function.  Ghrelin attenuated the exaggerated sympathetic nerve activity, as indicated by a marked decrease in plasma norepinephrine level (889 ± 123 to 597 ± 116 pg/mL; p < 0.05).  Conclusions: These preliminary results suggest that repeated administration of ghrelin improves body compn., muscle wasting, functional capacity, and sympathetic augmentation in cachectic patients with COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH00rMa5X4DbVg90H21EOLACvtfcHk0lgKi6VcCRaEpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVWjtw%253D%253D&md5=5b4232ebb551a421f3111d0492521bef</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1378%2Fchest.128.3.1187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1378%252Fchest.128.3.1187%26sid%3Dliteratum%253Aachs%26aulast%3DNagaya%26aufirst%3DN.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DS.%26aulast%3DOya%26aufirst%3DH.%26aulast%3DUematsu%26aufirst%3DM.%26aulast%3DMiyatake%26aufirst%3DK.%26aulast%3DKangawa%26aufirst%3DK.%26atitle%3DTreatment%2520of%2520cachexia%2520with%2520ghrelin%2520in%2520patients%2520with%2520COPD%26jtitle%3DChest%26date%3D2005%26volume%3D128%26issue%3D3%26spage%3D1187%26epage%3D1193%26doi%3D10.1378%2Fchest.128.3.1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levinson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertner, J.</span></span> <span> </span><span class="NLM_article-title">Randomized study of the efficacy and safety of SUN11031 (synthetic human ghrelin) in cachexia associated with chronic obstructive pulmonary disease</span>. <i>e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e171</span>– <span class="NLM_lpage">e175</span>, <span class="refDoi"> DOI: 10.1016/j.clnme.2012.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2Fj.clnme.2012.07.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e171-e175&author=B.+G.+Levinsonauthor=J.+Gertner&title=Randomized+study+of+the+efficacy+and+safety+of+SUN11031+%28synthetic+human+ghrelin%29+in+cachexia+associated+with+chronic+obstructive+pulmonary+disease&doi=10.1016%2Fj.clnme.2012.07.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.clnme.2012.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clnme.2012.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DLevinson%26aufirst%3DB.%2BG.%26aulast%3DGertner%26aufirst%3DJ.%26atitle%3DRandomized%2520study%2520of%2520the%2520efficacy%2520and%2520safety%2520of%2520SUN11031%2520%2528synthetic%2520human%2520ghrelin%2529%2520in%2520cachexia%2520associated%2520with%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3De-SPEN%252C%2520the%2520European%2520e-Journal%2520of%2520Clinical%2520Nutrition%2520and%2520Metabolism%26date%3D2012%26volume%3D7%26spage%3De171%26epage%3De175%26doi%3D10.1016%2Fj.clnme.2012.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagaya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uematsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Date, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yutani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span> <span> </span><span class="NLM_article-title">Elevated circulating level of ghrelin in cachexia associated with chronic heart failure. Relationships between ghrelin and anabolic/catabolic factors</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">2034</span>– <span class="NLM_lpage">2038</span>, <span class="refDoi"> DOI: 10.1161/hc4201.097836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1161%2Fhc4201.097836" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=2034-2038&author=N.+Nagayaauthor=M.+Uematsuauthor=M.+Kojimaauthor=Y.+Dateauthor=M.+Nakazatoauthor=H.+Okumuraauthor=H.+Hosodaauthor=W.+Shimizuauthor=M.+Yamagishiauthor=H.+Oyaauthor=H.+Kohauthor=C.+Yutaniauthor=K.+Kangawa&title=Elevated+circulating+level+of+ghrelin+in+cachexia+associated+with+chronic+heart+failure.+Relationships+between+ghrelin+and+anabolic%2Fcatabolic+factors&doi=10.1161%2Fhc4201.097836"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1161%2Fhc4201.097836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252Fhc4201.097836%26sid%3Dliteratum%253Aachs%26aulast%3DNagaya%26aufirst%3DN.%26aulast%3DUematsu%26aufirst%3DM.%26aulast%3DKojima%26aufirst%3DM.%26aulast%3DDate%26aufirst%3DY.%26aulast%3DNakazato%26aufirst%3DM.%26aulast%3DOkumura%26aufirst%3DH.%26aulast%3DHosoda%26aufirst%3DH.%26aulast%3DShimizu%26aufirst%3DW.%26aulast%3DYamagishi%26aufirst%3DM.%26aulast%3DOya%26aufirst%3DH.%26aulast%3DKoh%26aufirst%3DH.%26aulast%3DYutani%26aufirst%3DC.%26aulast%3DKangawa%26aufirst%3DK.%26atitle%3DElevated%2520circulating%2520level%2520of%2520ghrelin%2520in%2520cachexia%2520associated%2520with%2520chronic%2520heart%2520failure.%2520Relationships%2520between%2520ghrelin%2520and%2520anabolic%252Fcatabolic%2520factors%26jtitle%3DCirculation%26date%3D2001%26volume%3D104%26spage%3D2034%26epage%3D2038%26doi%3D10.1161%2Fhc4201.097836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akamizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irako, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teramukai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokode, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics, safety and endocrine and appetite effects of ghrelin administration in young healthy subjects</span>. <i>Eur. J. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>150</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">455</span>, <span class="refDoi"> DOI: 10.1530/eje.0.1500447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1530%2Feje.0.1500447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=15080773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFCjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2004&pages=447-455&issue=4&author=T.+Akamizuauthor=K.+Takayaauthor=T.+Irakoauthor=H.+Hosodaauthor=S.+Teramukaiauthor=A.+Matsuyamaauthor=H.+Tadaauthor=K.+Miuraauthor=A.+Shimizuauthor=M.+Fukushimaauthor=M.+Yokodeauthor=K.+Tanakaauthor=K.+Kangawa&title=Pharmacokinetics%2C+safety+and+endocrine+and+appetite+effects+of+ghrelin+administration+in+young+healthy+subjects&doi=10.1530%2Feje.0.1500447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects</span></div><div class="casAuthors">Akamizu, Takashi; Takaya, Kazuhiko; Irako, Taiga; Hosoda, Hiroshi; Teramukai, Satoshi; Matsuyama, Akiko; Tada, Harue; Miura, Kazumi; Shimizu, Akira; Fukushima, Masanori; Yokode, Masayuki; Tanaka, Koichi; Kangawa, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">447-455</span>CODEN:
                <span class="NLM_cas:coden">EJOEEP</span>;
        ISSN:<span class="NLM_cas:issn">0804-4643</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">It has been demonstrated that ghrelin plays a major role in the regulation of GH secretion and food intake.  These actions make ghrelin a strong candidate for the treatment of GH deficiency, anorexia and cachexia.  However, only preliminary studies have been performed to assess ghrelin administration in humans.  In this study, the authors have conducted a double-blind, randomized, placebo-controlled trial to investigate the pharmacokinetics, safety, and endocrine and appetite effects of ghrelin in young healthy volunteers.  Eighteen male volunteers were randomly assigned into three groups of six subjects: low- and high-dose ghrelin groups, who received i.v. injections of 1 and 5 μg/kg ghrelin (acylated form) resp., and a placebo group who were injected with mannitol instead of ghrelin.  Acylated ghrelin disappeared more rapidly from plasma than total ghrelin, with elimination half life (t1/2) of 9-13 and 27-31 min resp.  The no. of subjects that experienced adverse effects did not significantly differ among the three groups, and all adverse effects were transient and well tolerated.  Both the low and high doses of ghrelin strongly stimulated GH release (peak plasma concn. (Cmax,0-90 min); 124.2±63.9 and 153.2±52.2 ng/mL for 1 and 5 μg/kg ghrelin resp.).  Slight alterations of blood glucose and insulin levels after the injection were obsd.  Although not statistically significant, ghrelin administration tended to increase hunger sensation in a dose-dependent manner.  These results suggest that ghrelin is safe, and that clin. trials may be started to assess the usefulness of ghrelin for the treatment of disorders related to GH secretion and appetite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDz8K2EJAB7LVg90H21EOLACvtfcHk0ljU01BRwzRmtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFCjt78%253D&md5=f996384f5d1006b4c305079224d8404d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1530%2Feje.0.1500447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252Feje.0.1500447%26sid%3Dliteratum%253Aachs%26aulast%3DAkamizu%26aufirst%3DT.%26aulast%3DTakaya%26aufirst%3DK.%26aulast%3DIrako%26aufirst%3DT.%26aulast%3DHosoda%26aufirst%3DH.%26aulast%3DTeramukai%26aufirst%3DS.%26aulast%3DMatsuyama%26aufirst%3DA.%26aulast%3DTada%26aufirst%3DH.%26aulast%3DMiura%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DA.%26aulast%3DFukushima%26aufirst%3DM.%26aulast%3DYokode%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKangawa%26aufirst%3DK.%26atitle%3DPharmacokinetics%252C%2520safety%2520and%2520endocrine%2520and%2520appetite%2520effects%2520of%2520ghrelin%2520administration%2520in%2520young%2520healthy%2520subjects%26jtitle%3DEur.%2520J.%2520Endocrinol.%26date%3D2004%26volume%3D150%26issue%3D4%26spage%3D447%26epage%3D455%26doi%3D10.1530%2Feje.0.1500447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefker, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toler, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadcock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Brino, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNinno, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidsey-Frink, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hada, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inthavongsay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangano, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirie, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tess, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawistoski, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva-Jardine, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and biological characterization of Capromorelin analogues with extended half-lives</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3279</span>– <span class="NLM_lpage">3282</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00734-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2FS0960-894X%2802%2900734-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3279-3282&author=P.+A.+Carpinoauthor=B.+A.+Lefkerauthor=S.+M.+Tolerauthor=L.+C.+Panauthor=J.+R.+Hadcockauthor=M.+C.+Murrayauthor=E.+R.+Cookauthor=J.+N.+Di+Brinoauthor=S.+L.+DeNinnoauthor=K.+L.+Chidsey-Frinkauthor=W.+A.+Hadaauthor=J.+Inthavongsayauthor=S.+K.+Lewisauthor=F.+M.+Manganoauthor=M.+A.+Mullinsauthor=D.+F.+Nickersonauthor=O.+Ngauthor=C.+M.+Pirieauthor=J.+A.+Raganauthor=C.+R.+Roseauthor=D.+A.+Tessauthor=A.+S.+Wrightauthor=L.+Yuauthor=M.+P.+Zawistoskiauthor=J.+C.+Pettersenauthor=P.+A.+DaSilva-Jardineauthor=T.+C.+Wilsonauthor=D.+D.+Thompson&title=Discovery+and+biological+characterization+of+Capromorelin+analogues+with+extended+half-lives&doi=10.1016%2FS0960-894X%2802%2900734-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900734-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900734-5%26sid%3Dliteratum%253Aachs%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DToler%26aufirst%3DS.%2BM.%26aulast%3DPan%26aufirst%3DL.%2BC.%26aulast%3DHadcock%26aufirst%3DJ.%2BR.%26aulast%3DMurray%26aufirst%3DM.%2BC.%26aulast%3DCook%26aufirst%3DE.%2BR.%26aulast%3DDi%2BBrino%26aufirst%3DJ.%2BN.%26aulast%3DDeNinno%26aufirst%3DS.%2BL.%26aulast%3DChidsey-Frink%26aufirst%3DK.%2BL.%26aulast%3DHada%26aufirst%3DW.%2BA.%26aulast%3DInthavongsay%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DS.%2BK.%26aulast%3DMangano%26aufirst%3DF.%2BM.%26aulast%3DMullins%26aufirst%3DM.%2BA.%26aulast%3DNickerson%26aufirst%3DD.%2BF.%26aulast%3DNg%26aufirst%3DO.%26aulast%3DPirie%26aufirst%3DC.%2BM.%26aulast%3DRagan%26aufirst%3DJ.%2BA.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DZawistoski%26aufirst%3DM.%2BP.%26aulast%3DPettersen%26aufirst%3DJ.%2BC.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%2BA.%26aulast%3DWilson%26aufirst%3DT.%2BC.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520and%2520biological%2520characterization%2520of%2520Capromorelin%2520analogues%2520with%2520extended%2520half-lives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3279%26epage%3D3282%26doi%3D10.1016%2FS0960-894X%2802%2900734-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tata, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. W.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleim, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patchett, A. A.</span></span> <span> </span><span class="NLM_article-title">Highly potent growth hormone secretagogues</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3657</span>– <span class="NLM_lpage">3659</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.04.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2Fj.bmcl.2007.04.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3657-3659&author=Z.+Luauthor=J.+R.+Tataauthor=K.+Chengauthor=L.+Weiauthor=W.+W.-S.+Chanauthor=B.+Butlerauthor=K.+D.+Schleimauthor=T.+M.+Jacksauthor=G.+Hickeyauthor=A.+A.+Patchett&title=Highly+potent+growth+hormone+secretagogues&doi=10.1016%2Fj.bmcl.2007.04.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.04.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.04.050%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DW.%2BW.-S.%26aulast%3DButler%26aufirst%3DB.%26aulast%3DSchleim%26aufirst%3DK.%2BD.%26aulast%3DJacks%26aufirst%3DT.%2BM.%26aulast%3DHickey%26aufirst%3DG.%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26atitle%3DHighly%2520potent%2520growth%2520hormone%2520secretagogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3657%26epage%3D3659%26doi%3D10.1016%2Fj.bmcl.2007.04.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefker, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toler, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadcock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiBrino, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campeta, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNinno, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidsey-Frink, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hada, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inthavongsay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangano, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirie, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tess, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawistoski, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva-Jardine, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D. D.</span></span> <span> </span><span class="NLM_article-title">Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs): Discovery of Capromorelin</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(02)00433-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2FS0968-0896%2802%2900433-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=581-590&author=P.+A.+Carpinoauthor=B.+A.+Lefkerauthor=S.+M.+Tolerauthor=L.+C.+Panauthor=J.+R.+Hadcockauthor=E.+R.+Cookauthor=J.+N.+DiBrinoauthor=A.+M.+Campetaauthor=S.+L.+DeNinnoauthor=K.+L.+Chidsey-Frinkauthor=W.+A.+Hadaauthor=J.+Inthavongsayauthor=F.+M.+Manganoauthor=M.+A.+Mullinsauthor=D.+F.+Nickersonauthor=O.+Ngauthor=C.+M.+Pirieauthor=J.+A.+Raganauthor=C.+R.+Roseauthor=D.+A.+Tessauthor=A.+S.+Wrightauthor=L.+Yuauthor=M.+P.+Zawistoskiauthor=P.+A.+DaSilva-Jardineauthor=T.+C.+Wilsonauthor=D.+D.+Thompson&title=Pyrazolinone-piperidine+dipeptide+growth+hormone+secretagogues+%28GHSs%29%3A+Discovery+of+Capromorelin&doi=10.1016%2FS0968-0896%2802%2900433-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900433-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900433-9%26sid%3Dliteratum%253Aachs%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DToler%26aufirst%3DS.%2BM.%26aulast%3DPan%26aufirst%3DL.%2BC.%26aulast%3DHadcock%26aufirst%3DJ.%2BR.%26aulast%3DCook%26aufirst%3DE.%2BR.%26aulast%3DDiBrino%26aufirst%3DJ.%2BN.%26aulast%3DCampeta%26aufirst%3DA.%2BM.%26aulast%3DDeNinno%26aufirst%3DS.%2BL.%26aulast%3DChidsey-Frink%26aufirst%3DK.%2BL.%26aulast%3DHada%26aufirst%3DW.%2BA.%26aulast%3DInthavongsay%26aufirst%3DJ.%26aulast%3DMangano%26aufirst%3DF.%2BM.%26aulast%3DMullins%26aufirst%3DM.%2BA.%26aulast%3DNickerson%26aufirst%3DD.%2BF.%26aulast%3DNg%26aufirst%3DO.%26aulast%3DPirie%26aufirst%3DC.%2BM.%26aulast%3DRagan%26aufirst%3DJ.%2BA.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DZawistoski%26aufirst%3DM.%2BP.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%2BA.%26aulast%3DWilson%26aufirst%3DT.%2BC.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DPyrazolinone-piperidine%2520dipeptide%2520growth%2520hormone%2520secretagogues%2520%2528GHSs%2529%253A%2520Discovery%2520of%2520Capromorelin%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D581%26epage%3D590%26doi%3D10.1016%2FS0968-0896%2802%2900433-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrie, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landschulz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyles, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvatori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ettinger, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morey, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merriam, G. R.</span></span> <span> </span><span class="NLM_article-title">Effects of an oral growth hormone secretagogue in older adults</span>. <i>J. Clin. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1198</span>– <span class="NLM_lpage">1206</span>, <span class="refDoi"> DOI: 10.1210/jc.2008-0632</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1210%2Fjc.2008-0632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=19174493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksFaitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2009&pages=1198-1206&issue=4&author=H.+K.+Whiteauthor=C.+D.+Petrieauthor=W.+Landschulzauthor=D.+MacLeanauthor=A.+Taylorauthor=K.+Lylesauthor=J.+Y.+Weiauthor=A.+R.+Hoffmanauthor=R.+Salvatoriauthor=M.+P.+Ettingerauthor=M.+C.+Moreyauthor=M.+R.+Blackmanauthor=G.+R.+Merriam&title=Effects+of+an+oral+growth+hormone+secretagogue+in+older+adults&doi=10.1210%2Fjc.2008-0632"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of an oral growth hormone secretagogue in older adults</span></div><div class="casAuthors">White, Heidi K.; Petrie, Charles D.; Landschulz, William; MacLean, David; Taylor, Ann; Lyles, Kenneth; Wei, Jeanne Y.; Hoffman, Andrew R.; Salvatori, Roberto; Ettinger, Mark P.; Morey, Miriam C.; Blackman, Marc R.; Merriam, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1198-1206</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">GH secretion declines with age, possibly contributing to reduced muscle mass, strength, and function.  GH secretagogues (GHS) may increase muscle mass and phys. performance.  We conducted a randomized, double-masked, placebo-controlled, multicenter study to investigate the hormonal, body compn., and phys. performance effects and the safety of the orally active GHS capromorelin in older adults with mild functional limitation.  A total of 395 men and women aged 65-84 yr were randomized for an intended 2 yr of treatment to 4 dosing groups (10 mg 3 times/wk, 3 mg twice a day, 10 mg each night, and 10 mg twice a day) or placebo.  Although the study was terminated early according to predetd. treatment effect criteria, 315 subjects completed 6 mo of treatment, and 284 completed 12 mo.  A sustained dose-related rise in IGF-I concns. occurred in all active treatment groups.  Each capromorelin dose prompted a rise in peak nocturnal GH, which was greatest with the least frequent dosing.  At 6 mo, body wt. increased 1.4 kg in subjects receiving capromorelin and decreased 0.2 kg in those receiving placebo (P = 0.006).  Lean body mass increased 1.4 vs. 0.3 kg (P = 0.001), and tandem walk improved by 0.9 s (P = 0.02) in the pooled treatment vs. placebo groups.  By 12 mo, stair climb also improved (P = 0.04).  Adverse events included fatigue, insomnia, and small increases in fasting glucose, glycosylated Hb, and indexes of insulin resistance.  In healthy older adults at risk for functional decline, administration of the oral GHS capromorelin may improve body compn. and phys. function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqczWQ76h4JqLVg90H21EOLACvtfcHk0liK67hn9pCQ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksFaitLw%253D&md5=388a1c72bcd27165ea3eb0901b90f1d1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1210%2Fjc.2008-0632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2008-0632%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DH.%2BK.%26aulast%3DPetrie%26aufirst%3DC.%2BD.%26aulast%3DLandschulz%26aufirst%3DW.%26aulast%3DMacLean%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DLyles%26aufirst%3DK.%26aulast%3DWei%26aufirst%3DJ.%2BY.%26aulast%3DHoffman%26aufirst%3DA.%2BR.%26aulast%3DSalvatori%26aufirst%3DR.%26aulast%3DEttinger%26aufirst%3DM.%2BP.%26aulast%3DMorey%26aufirst%3DM.%2BC.%26aulast%3DBlackman%26aufirst%3DM.%2BR.%26aulast%3DMerriam%26aufirst%3DG.%2BR.%26atitle%3DEffects%2520of%2520an%2520oral%2520growth%2520hormone%2520secretagogue%2520in%2520older%2520adults%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2009%26volume%3D94%26issue%3D4%26spage%3D1198%26epage%3D1206%26doi%3D10.1210%2Fjc.2008-0632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patchett, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nargund, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tata, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barakat, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, D. B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. W.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pong, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaung, L.-Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frazier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, S.-H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. G.</span></span> <span> </span><span class="NLM_article-title">Design and biological activity of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">7001</span>– <span class="NLM_lpage">7005</span>, <span class="refDoi"> DOI: 10.1073/pnas.92.15.7001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1073%2Fpnas.92.15.7001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=7001-7005&author=A.+A.+Patchettauthor=R.+P.+Nargundauthor=J.+R.+Tataauthor=M.-H.+Chenauthor=K.+J.+Barakatauthor=D.+B.+R.+Johnstonauthor=K.+Chengauthor=W.+W.-S.+Chanauthor=B.+Butlerauthor=G.+Hickeyauthor=T.+Jacksauthor=K.+Schleimauthor=S.-S.+Pongauthor=L.-Y.+P.+Chaungauthor=H.+Y.+Chenauthor=E.+Frazierauthor=K.+H.+Leungauthor=S.-H.+L.+Chiuauthor=R.+G.+Smith&title=Design+and+biological+activity+of+L-163%2C191+%28MK-0677%29%3A+a+potent%2C+orally+active+growth+hormone+secretagogue&doi=10.1073%2Fpnas.92.15.7001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.15.7001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.15.7001%26sid%3Dliteratum%253Aachs%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DM.-H.%26aulast%3DBarakat%26aufirst%3DK.%2BJ.%26aulast%3DJohnston%26aufirst%3DD.%2BB.%2BR.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DW.%2BW.-S.%26aulast%3DButler%26aufirst%3DB.%26aulast%3DHickey%26aufirst%3DG.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DSchleim%26aufirst%3DK.%26aulast%3DPong%26aufirst%3DS.-S.%26aulast%3DChaung%26aufirst%3DL.-Y.%2BP.%26aulast%3DChen%26aufirst%3DH.%2BY.%26aulast%3DFrazier%26aufirst%3DE.%26aulast%3DLeung%26aufirst%3DK.%2BH.%26aulast%3DChiu%26aufirst%3DS.-H.%2BL.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26atitle%3DDesign%2520and%2520biological%2520activity%2520of%2520L-163%252C191%2520%2528MK-0677%2529%253A%2520a%2520potent%252C%2520orally%2520active%2520growth%2520hormone%2520secretagogue%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D7001%26epage%3D7005%26doi%3D10.1073%2Fpnas.92.15.7001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nass, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzoli, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveri, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrie, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrell, F. E.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clasey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymsfield, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorner, M. O.</span></span> <span> </span><span class="NLM_article-title">Effects of an oral ghrelin mimetic on body composition and clinical outcome in healthy older adults: a randomized, controlled trial</span>. <i>Ann. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>149</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">611</span>, <span class="refDoi"> DOI: 10.7326/0003-4819-149-9-200811040-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.7326%2F0003-4819-149-9-200811040-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=18981485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A280%3ADC%252BD1cjhsVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2008&pages=601-611&issue=9&author=R.+Nassauthor=S.+S.+Pezzoliauthor=M.+C.+Oliveriauthor=J.+T.+Patrieauthor=F.+E.+Harrellauthor=J.+L.+Claseyauthor=S.+B.+Heymsfieldauthor=M.+A.+Bachauthor=M.+L.+Vanceauthor=M.+O.+Thorner&title=Effects+of+an+oral+ghrelin+mimetic+on+body+composition+and+clinical+outcome+in+healthy+older+adults%3A+a+randomized%2C+controlled+trial&doi=10.7326%2F0003-4819-149-9-200811040-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial</span></div><div class="casAuthors">Nass Ralf; Pezzoli Suzan S; Oliveri Mary Clancy; Patrie James T; Harrell Frank E Jr; Clasey Jody L; Heymsfield Steven B; Bach Mark A; Vance Mary Lee; Thorner Michael O</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">601-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Growth hormone secretion and muscle mass decline from midpuberty throughout life, culminating in sarcopenia, frailty, decreased function, and loss of independence.  The decline of growth hormone in the development of sarcopenia is one of many factors, and its etiologic role needs to be demonstrated.  OBJECTIVE:  To determine whether MK-677, an oral ghrelin mimetic, increases growth hormone secretion into the young-adult range without serious adverse effects, prevents the decline of fat-free mass, and decreases abdominal visceral fat in healthy older adults.  DESIGN:  2-year, double-blind, randomized, placebo-controlled, modified-crossover clinical trial.  SETTING:  General clinical research center study performed at a university hospital.  PARTICIPANTS:  65 healthy adults (men, women receiving hormone replacement therapy, and women not receiving hormone replacement therapy) ranging from 60 to 81 years of age.  INTERVENTION:  Oral administration of MK-677, 25 mg, or placebo once daily.  MEASUREMENTS:  Growth hormone and insulin-like growth factor I levels.  Fat-free mass and abdominal visceral fat were the primary end points after 1 year of treatment.  Other end points were body weight, fat mass, insulin sensitivity, lipid and cortisol levels, bone mineral density, limb lean and fat mass, isokinetic strength, function, and quality of life.  All end points were assessed at baseline and every 6 months.  RESULTS:  Daily administration of MK-677 significantly increased growth hormone and insulin-like growth factor I levels to those of healthy young adults without serious adverse effects.  Mean fat-free mass decreased in the placebo group but increased in the MK-677 group (change, -0.5 kg [95% CI, -1.1 to 0.2 kg] vs. 1.1 kg [CI, 0.7 to 1.5 kg], respectively; P < 0.001), as did body cell mass, as reflected by intracellular water (change, -1.0 kg [CI, -2.1 to 0.2 kg] vs. 0.8 kg [CI, -0.1 to 1.6 kg], respectively; P = 0.021).  No significant differences were observed in abdominal visceral fat or total fat mass; however, the average increase in limb fat was greater in the MK-677 group than the placebo group (1.1 kg vs. 0.24 kg; P = 0.001).  Body weight increased 0.8 kg (CI, -0.3 to 1.8 kg) in the placebo group and 2.7 kg (CI, 2.0 to 3.5 kg) in the MK-677 group (P = 0.003).  Fasting blood glucose level increased an average of 0.3 mmol/L (5 mg/dL) in the MK-677 group (P = 0.015), and insulin sensitivity decreased.  The most frequent side effects were an increase in appetite that subsided in a few months and transient, mild lower-extremity edema and muscle pain.  Low-density lipoprotein cholesterol levels decreased in the MK-677 group relative to baseline values (change, -0.14 mmol/L [CI, -0.27 to -0.01 mmol/L]; -5.4 mg/dL [CI, -10.4 to -0.4 mg/dL]; P = 0.026); no differences between groups were observed in total or high-density lipoprotein cholesterol levels.  Cortisol levels increased 47 nmol/L (CI, 28 to 71 nmol/L (1.7 microg/dL [CI, 1.0 to 2.6 microg/dL]) in MK-677 recipients (P = 0.020).  Changes in bone mineral density consistent with increased bone remodeling occurred in MK-677 recipients.  Increased fat-free mass did not result in changes in strength or function.  Two-year exploratory analyses confirmed the 1-year results.  LIMITATION:  Study power (duration and participant number) was insufficient to evaluate functional end points in healthy elderly persons.  CONCLUSION:  Over 12 months, the ghrelin mimetic MK-677 enhanced pulsatile growth hormone secretion, significantly increased fat-free mass, and was generally well tolerated.  Long-term functional and, ultimately, pharmacoeconomic, studies in elderly persons are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAHfxTSIWuaP6AExegM5LLfW6udTcc2eY7ZG7CIJ7C-Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjhsVKmsw%253D%253D&md5=9224c8e5ea5e35a36d3cfb5d17d65673</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-149-9-200811040-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-149-9-200811040-00003%26sid%3Dliteratum%253Aachs%26aulast%3DNass%26aufirst%3DR.%26aulast%3DPezzoli%26aufirst%3DS.%2BS.%26aulast%3DOliveri%26aufirst%3DM.%2BC.%26aulast%3DPatrie%26aufirst%3DJ.%2BT.%26aulast%3DHarrell%26aufirst%3DF.%2BE.%26aulast%3DClasey%26aufirst%3DJ.%2BL.%26aulast%3DHeymsfield%26aufirst%3DS.%2BB.%26aulast%3DBach%26aufirst%3DM.%2BA.%26aulast%3DVance%26aufirst%3DM.%2BL.%26aulast%3DThorner%26aufirst%3DM.%2BO.%26atitle%3DEffects%2520of%2520an%2520oral%2520ghrelin%2520mimetic%2520on%2520body%2520composition%2520and%2520clinical%2520outcome%2520in%2520healthy%2520older%2520adults%253A%2520a%2520randomized%252C%2520controlled%2520trial%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2008%26volume%3D149%26issue%3D9%26spage%3D601%26epage%3D611%26doi%3D10.7326%2F0003-4819-149-9-200811040-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, J. M.</span></span> <span> </span><span class="NLM_article-title">Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1245</span>– <span class="NLM_lpage">1253</span>, <span class="refDoi"> DOI: 10.1517/14656566.2015.1041500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1517%2F14656566.2015.1041500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=25945893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFGmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=1245-1253&issue=8&author=H.+Zhangauthor=J.+M.+Garcia&title=Anamorelin+hydrochloride+for+the+treatment+of+cancer-anorexia-cachexia+in+NSCLC&doi=10.1517%2F14656566.2015.1041500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC</span></div><div class="casAuthors">Zhang, Hongjie; Garcia, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1245-1253</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction:Cancer anorexia-cachexia syndrome (CACS) is assocd. with increased morbidity and mortality.  Anamorelin is a novel, orally active ghrelin receptor agonist in clin. development for the treatment of CACS in NSCLC.  The aim of this review is to summarize preclin. and clin. studies evaluating anamorelin as a potential promising treatment for CACS in NSCLC.  Areas covered: Pharmacodynamics, pharmacokinetics and metab., clin. efficacy, safety and tolerability of anamorelin for the treatment of CACS in NSCLC were reviewed.  Anamorelin administration may lead to increases in food intake, body wt. and lean body mass, and a stimulatory effect on growth hormone secretion in NSCLC patients.  Anamorelin is well tolerated with no dose-limiting toxicities identified to date.  Expert opinion:Targeting ghrelin receptors presents the advantage of potentially addressing multiple mechanisms of CACS simultaneously including appetite, muscle protein balance, adipose tissue metab., energy expenditure and inflammation.  Clin. data suggest that anamorelin is well tolerated and it effectively increases appetite, body wt. and lean mass in patients with advanced NSCLC.  Long-term safety remains unknown at this time.  The potential synergistic effects of anamorelin with nutritional support or exercise as well as its efficacy/safety in other tumor types are also unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYCRzru9R_kLVg90H21EOLACvtfcHk0liJIdXIUbT_uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFGmurs%253D&md5=11e0d44287432275d49e23156733f902</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1517%2F14656566.2015.1041500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2015.1041500%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGarcia%26aufirst%3DJ.%2BM.%26atitle%3DAnamorelin%2520hydrochloride%2520for%2520the%2520treatment%2520of%2520cancer-anorexia-cachexia%2520in%2520NSCLC%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2015%26volume%3D16%26issue%3D8%26spage%3D1245%26epage%3D1253%26doi%3D10.1517%2F14656566.2015.1041500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Currow, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skipworth, R. J.</span></span> <span> </span><span class="NLM_article-title">The emerging role of Anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia</span>. <i>Future Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">1767</span>– <span class="NLM_lpage">1783</span>, <span class="refDoi"> DOI: 10.2217/fon-2017-0141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.2217%2Ffon-2017-0141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=28621564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2gs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=1767-1783&issue=20&author=D.+C.+Currowauthor=R.+J.+Skipworth&title=The+emerging+role+of+Anamorelin+hydrochloride+in+the+management+of+patients+with+cancer+anorexia-cachexia&doi=10.2217%2Ffon-2017-0141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia</span></div><div class="casAuthors">Currow, David C.; Skipworth, Richard J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1767-1783</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1744-8301</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Cancer cachexia affects many patients with advanced cancer.  This multifactorial syndrome, which involves loss of muscle mass and body wt., profoundly affects patients' phys. functioning and quality of life.  Pharmacol. interventions that target wt. loss and also improve patient-reported measures are required.  Anamorelin hydrochloride is an oral ghrelin receptor agonist for the treatment of cancer anorexia-cachexia that stimulates release of growth hormone and insulin-like growth factor 1, and improves food intake and body wt.  Phase II and III trials have demonstrated that anamorelin increases body muscle and fat compn., and improves patient-reported appetite and quality of life.  Anamorelin shows promise as an anabolic agent with benefits maintained over time, without the virilizing side effects of other anabolic medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpituGHKd04WbVg90H21EOLACvtfcHk0liJIdXIUbT_uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2gs7vI&md5=4c91a30c7ae28fdec00986f0b5522cd9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2217%2Ffon-2017-0141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon-2017-0141%26sid%3Dliteratum%253Aachs%26aulast%3DCurrow%26aufirst%3DD.%2BC.%26aulast%3DSkipworth%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520emerging%2520role%2520of%2520Anamorelin%2520hydrochloride%2520in%2520the%2520management%2520of%2520patients%2520with%2520cancer%2520anorexia-cachexia%26jtitle%3DFuture%2520Oncol.%26date%3D2017%26volume%3D13%26issue%3D20%26spage%3D1767%26epage%3D1783%26doi%3D10.2217%2Ffon-2017-0141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoveyda, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vézina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benakli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaubien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Louis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinault, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaseshan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchemin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhérer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, G. L.</span></span> <span> </span><span class="NLM_article-title">Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): development of Ulimorelin (TZP-101) from hit to clinic</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">8305</span>– <span class="NLM_lpage">8320</span>, <span class="refDoi"> DOI: 10.1021/jm2007062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2007062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8305-8320&issue=24&author=H.+R.+Hoveydaauthor=E.+Marsaultauthor=R.+Gagnonauthor=A.+P.+Mathieuauthor=M.+V%C3%A9zinaauthor=A.+Landryauthor=Z.+Wangauthor=K.+Benakliauthor=S.+Beaubienauthor=M.+Saint-Louisauthor=M.+Brassardauthor=J.-F.+Pinaultauthor=L.+Ouelletauthor=S.+Bhatauthor=M.+Ramaseshanauthor=X.+Pengauthor=L.+Foucherauthor=S.+Beaucheminauthor=P.+Bh%C3%A9rerauthor=D.+F.+Veberauthor=M.+L.+Petersonauthor=G.+L.+Fraser&title=Optimization+of+the+potency+and+pharmacokinetic+properties+of+a+macrocyclic+ghrelin+receptor+agonist+%28Part+I%29%3A+development+of+Ulimorelin+%28TZP-101%29+from+hit+to+clinic&doi=10.1021%2Fjm2007062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm2007062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007062%26sid%3Dliteratum%253Aachs%26aulast%3DHoveyda%26aufirst%3DH.%2BR.%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DGagnon%26aufirst%3DR.%26aulast%3DMathieu%26aufirst%3DA.%2BP.%26aulast%3DV%25C3%25A9zina%26aufirst%3DM.%26aulast%3DLandry%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBenakli%26aufirst%3DK.%26aulast%3DBeaubien%26aufirst%3DS.%26aulast%3DSaint-Louis%26aufirst%3DM.%26aulast%3DBrassard%26aufirst%3DM.%26aulast%3DPinault%26aufirst%3DJ.-F.%26aulast%3DOuellet%26aufirst%3DL.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DRamaseshan%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DFoucher%26aufirst%3DL.%26aulast%3DBeauchemin%26aufirst%3DS.%26aulast%3DBh%25C3%25A9rer%26aufirst%3DP.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DFraser%26aufirst%3DG.%2BL.%26atitle%3DOptimization%2520of%2520the%2520potency%2520and%2520pharmacokinetic%2520properties%2520of%2520a%2520macrocyclic%2520ghrelin%2520receptor%2520agonist%2520%2528Part%2520I%2529%253A%2520development%2520of%2520Ulimorelin%2520%2528TZP-101%2529%2520from%2520hit%2520to%2520clinic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D24%26spage%3D8305%26epage%3D8320%26doi%3D10.1021%2Fjm2007062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moukhametzianov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehmé, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schertler, G. F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. G.</span></span> <span> </span><span class="NLM_article-title">The structural basis for agonist and partial agonist action on a β1-adrenergic receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>469</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1038/nature09746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1038%2Fnature09746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=21228877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFelsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2011&pages=241-244&author=T.+Warneauthor=R.+Moukhametzianovauthor=J.+G.+Bakerauthor=R.+Nehm%C3%A9author=P.+C.+Edwardsauthor=A.+G.+W.+Leslieauthor=G.+F.+X.+Schertlerauthor=C.+G.+Tate&title=The+structural+basis+for+agonist+and+partial+agonist+action+on+a+%CE%B21-adrenergic+receptor&doi=10.1038%2Fnature09746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The structural basis for agonist and partial agonist action on a β1-adrenergic receptor</span></div><div class="casAuthors">Warne, Tony; Moukhametzianov, Rouslan; Baker, Jillian G.; Nehme, Rony; Edwards, Patricia C.; Leslie, Andrew G. W.; Schertler, Gebhard F. X.; Tate, Christopher G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">469</span>
        (<span class="NLM_cas:issue">7329</span>),
    <span class="NLM_cas:pages">241-244</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Adrenergic receptors (βARs) are G-protein-coupled receptors (GPCRs) that activate intracellular G proteins upon binding catecholamine agonist ligands such as adrenaline and noradrenaline.  Synthetic ligands have been developed that either activate or inhibit βARs for the treatment of asthma, hypertension or cardiac dysfunction.  These ligands are classified as either full agonists, partial agonists or antagonists, depending on whether the cellular response is similar to that of the native ligand, reduced or inhibited, resp.  However, the structural basis for these different ligand efficacies is unknown.  Here we present four crystal structures of the thermostabilized turkey (Meleagris gallopavo) β1-adrenergic receptor (β1AR-m23) bound to the full agonists carmoterol and isoprenaline and the partial agonists salbutamol and dobutamine.  In each case, agonist binding induces a 1 Å contraction of the catecholamine-binding pocket relative to the antagonist bound receptor.  Full agonists can form hydrogen bonds with two conserved serine residues in transmembrane helix 5 (Ser5.42 and Ser5.46), but partial agonists only interact with Ser5.42 (superscripts refer to Ballesteros-Weinstein numbering).  The structures provide an understanding of the pharmacol. differences between different ligand classes, illuminating how GPCRs function and providing a solid foundation for the structure-based design of novel ligands with predictable efficacies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2EWXHDM88tLVg90H21EOLACvtfcHk0lgZ93eaXg2Qzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFelsw%253D%253D&md5=aa7fa20ff770ea13d97f0cf39311a1ea</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature09746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09746%26sid%3Dliteratum%253Aachs%26aulast%3DWarne%26aufirst%3DT.%26aulast%3DMoukhametzianov%26aufirst%3DR.%26aulast%3DBaker%26aufirst%3DJ.%2BG.%26aulast%3DNehm%25C3%25A9%26aufirst%3DR.%26aulast%3DEdwards%26aufirst%3DP.%2BC.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DSchertler%26aufirst%3DG.%2BF.%2BX.%26aulast%3DTate%26aufirst%3DC.%2BG.%26atitle%3DThe%2520structural%2520basis%2520for%2520agonist%2520and%2520partial%2520agonist%2520action%2520on%2520a%2520%25CE%25B21-adrenergic%2520receptor%26jtitle%3DNature%26date%3D2011%26volume%3D469%26spage%3D241%26epage%3D244%26doi%3D10.1038%2Fnature09746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dosa, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, E. A.</span></span> <span> </span><span class="NLM_article-title">Tactical approaches to interconverting GPCR agonists and antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">810</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00982</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFamsr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=810-840&author=P.+I.+Dosaauthor=E.+A.+Amin&title=Tactical+approaches+to+interconverting+GPCR+agonists+and+antagonists&doi=10.1021%2Facs.jmedchem.5b00982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Tactical Approaches to Interconverting GPCR Agonists and Antagonists</span></div><div class="casAuthors">Dosa, Peter I.; Amin, Elizabeth Ambrose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">810-840</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are many reported examples of small structural modifications to GPCR-targeted ligands leading to major changes in their functional activity, converting agonists into antagonists or vice versa.  These shifts in functional activity are often accompanied by negligible changes in binding affinity.  The current perspective focuses on outlining and analyzing various approaches that have been used to interconvert GPCR agonists, partial agonists, and antagonists in order to achieve the intended functional activity at a GPCR of therapeutic interest.  An improved understanding of specific structural modifications that are likely to alter the functional activity of a GPCR ligand may be of use to researchers designing GPCR-targeted drugs and/or probe compds., specifically in cases where a particular ligand exhibits good potency but not the preferred functional activity at the GPCR of choice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohWg2-DQHq3LVg90H21EOLACvtfcHk0lhoGT2944P2RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFamsr7P&md5=99ffc0b892eb9c10aaf5d52a7d5dd8bc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00982%26sid%3Dliteratum%253Aachs%26aulast%3DDosa%26aufirst%3DP.%2BI.%26aulast%3DAmin%26aufirst%3DE.%2BA.%26atitle%3DTactical%2520approaches%2520to%2520interconverting%2520GPCR%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D810%26epage%3D840%26doi%3D10.1021%2Facs.jmedchem.5b00982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, S. N. L.</span>; <span class="NLM_string-name">Simpson, I.</span></span> <span> </span><span class="NLM_article-title">Indolamide Derivatives which Possess Glycogen Phosphorylase Inhibitory Activity</span>. <span class="NLM_patent">WO 2005/020985</span>, March 10, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=S.+N.+L.+Bennett&author=I.+Simpson&title=Indolamide+Derivatives+which+Possess+Glycogen+Phosphorylase+Inhibitory+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DS.%2BN.%2BL.%26atitle%3DIndolamide%2520Derivatives%2520which%2520Possess%2520Glycogen%2520Phosphorylase%2520Inhibitory%2520Activity%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagamine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura-Akimaru, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taiji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, H.</span></span> <span> </span><span class="NLM_article-title">Pharmacological profile of a new orally active growth hormone secretagogue, SM-130686</span>. <i>J. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1677/joe.0.1710481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1677%2Fjoe.0.1710481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=11739014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2001&pages=481-489&issue=3&author=J.+Nagamineauthor=R.+Nagataauthor=H.+Sekiauthor=N.+Nomura-Akimaruauthor=Y.+Uekiauthor=K.+Kumagaiauthor=M.+Taijiauthor=H.+Noguchi&title=Pharmacological+profile+of+a+new+orally+active+growth+hormone+secretagogue%2C+SM-130686&doi=10.1677%2Fjoe.0.1710481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of a new orally active growth hormone secretagogue, SM-130686</span></div><div class="casAuthors">Nagamine, J.; Nagata, R.; Seki, H.; Nomura-Akimaru, N.; Ueki, Y.; Kumagai, K.; Taiji, M.; Noguchi, H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">481-489</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">SM-130686, an oxindole deriv., is a novel orally active GH secretagogue (GHS) which is structurally distinct from previously reported GHSs such as MK-677, NN 703 and hexarelin.  SM-130686 stimulates GH release from cultured rat pituitary cells in a dose-dependent manner.  Half-max. stimulation was obsd. at a concn. of 6.3 nM.  SM-130686-induced GH release was inhibited by a GHS antagonist, but not by a GH-releasing hormone antagonist.  SM-130686 dose-dependently inhibited the binding of radiolabeled ligand, 35S-MK-677, to human GHS receptor 1a (IC50 = 1.2 nM).  This indicates that SM-130686 stimulates GH release through the GHS receptor.  The effect of a single oral administration of SM-130686 on GH release in pentobarbital-anesthetized rats was studied.  After treatment with 10 mg/kg SM-130686, plasma GH concns. measured by RIA significantly increased, reaching a peak at 20-45 min, and remained above baseline during the exptl. period (60 min).  The anabolic effect of repetitive SM-130686 administration was studied in rats.  Rats received 10 mg/kg SM-130686 orally twice a day and were weighed every day for 9 days.  At day 9 there was a significant increase in both the body wt. and the fat free mass (19.5 and 18.1 g, resp.).  Serum IGF-I concn. was also significantly elevated 6 h after the last dose of SM-130686.  An endogenous GHS ligand for the GHS receptor has recently been identified from stomach ext. and designated as ghrelin.  The GH-releasing activity in vitro relative to ghrelin (100%) was about 52% for SM-130686.  It is likely that SM-130686 is a partial agonist for the GHS receptor.  In summary, we describe here an orally active GHS, SM-130686, which acts through the GHS receptor.  Repetitive administration of SM-130686 to rats, similar to repetitive administration of GH, significantly increased the fat free mass by an amt. almost equal to the gain in body wt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_wdJAHljjT7Vg90H21EOLACvtfcHk0lhoGT2944P2RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVajtQ%253D%253D&md5=2a3a0711183388efaf64060e47b2ee8f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1677%2Fjoe.0.1710481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjoe.0.1710481%26sid%3Dliteratum%253Aachs%26aulast%3DNagamine%26aufirst%3DJ.%26aulast%3DNagata%26aufirst%3DR.%26aulast%3DSeki%26aufirst%3DH.%26aulast%3DNomura-Akimaru%26aufirst%3DN.%26aulast%3DUeki%26aufirst%3DY.%26aulast%3DKumagai%26aufirst%3DK.%26aulast%3DTaiji%26aufirst%3DM.%26aulast%3DNoguchi%26aufirst%3DH.%26atitle%3DPharmacological%2520profile%2520of%2520a%2520new%2520orally%2520active%2520growth%2520hormone%2520secretagogue%252C%2520SM-130686%26jtitle%3DJ.%2520Endocrinol.%26date%3D2001%26volume%3D171%26issue%3D3%26spage%3D481%26epage%3D489%26doi%3D10.1677%2Fjoe.0.1710481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heding, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span> <span> </span><span class="NLM_article-title">Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2400</span>– <span class="NLM_lpage">2411</span>, <span class="refDoi"> DOI: 10.1210/me.2005-0059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1210%2Fme.2005-0059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=15905359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFOjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=2400-2411&author=B.+Holstauthor=E.+Brandtauthor=A.+Bachauthor=A.+Hedingauthor=T.+W.+Schwartz&title=Nonpeptide+and+peptide+growth+hormone+secretagogues+act+both+as+ghrelin+receptor+agonist+and+as+positive+or+negative+allosteric+modulators+of+ghrelin+signaling&doi=10.1210%2Fme.2005-0059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling</span></div><div class="casAuthors">Holst, Birgitte; Brandt, Erik; Bach, Anders; Heding, Anders; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2400-2411</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Two nonpeptide (L692,429 and MK-677) and two peptide [GH-releasing peptide (GHRP)-6 and ghrelin] agonists were compared in binding and in signal transduction assays: calcium mobilization, inositol phosphate turnover, cAMP-responsive element (CRE), and serum-responsive element (SRE) controlled transcription, as well as arrestin mobilization.  MK-677 acted as a simple agonist having an affinity of 6.5 nM and activated all signal transduction systems with similar high potency (0.2-1.4 nM).  L-692,429 also displayed a very similar potency in all signaling assays (25-60 nM) but competed with a 1000-fold lower apparent affinity for ghrelin binding and surprisingly acted as a pos. allosteric receptor modulator by increasing ghrelin's potency 4- to 10-fold.  In contrast, the potency of GHRP-6 varied 600-fold (0.1-61 nM) depending on the signal transduction assay, and it acted as a neg. allosteric modulator of ghrelin signaling.  Unexpectedly, the maximal signaling efficacy for ghrelin was increased above what was obsd. with the hormone itself during coadministration with the nonendogenous agonists.  It is concluded that agonists for the ghrelin receptor vary both in respect of their intrinsic agonist properties and in their ability to modulate ghrelin signaling.  A receptor model is presented wherein ghrelin normally only activates one receptor subunit in a dimer and where the smaller nonendogenous agonists bind in the other subunit to act both as coagonists and as either neutral (MK-677), pos. (L-692,429), or neg. (GHRP-6) modulators of ghrelin function.  It is suggested that an optimal drug candidate could be an agonist that also is a pos. modulator of ghrelin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKuWRqbj3BJbVg90H21EOLACvtfcHk0liXX-PiWHD8mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFOjsbg%253D&md5=f4f0871313e11f00a20c5bcf80a9bf40</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1210%2Fme.2005-0059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2005-0059%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DBrandt%26aufirst%3DE.%26aulast%3DBach%26aufirst%3DA.%26aulast%3DHeding%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DNonpeptide%2520and%2520peptide%2520growth%2520hormone%2520secretagogues%2520act%2520both%2520as%2520ghrelin%2520receptor%2520agonist%2520and%2520as%2520positive%2520or%2520negative%2520allosteric%2520modulators%2520of%2520ghrelin%2520signaling%26jtitle%3DMol.%2520Endocrinol.%26date%3D2005%26volume%3D19%26spage%3D2400%26epage%3D2411%26doi%3D10.1210%2Fme.2005-0059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pietra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tazawa-Ogata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuanfeng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duus, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northrup, R.</span></span> <span> </span><span class="NLM_article-title">Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile</span>. <i>J. Cachexia Sarcopenia Muscle</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1007/s13539-014-0159-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1007%2Fs13539-014-0159-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=25267366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A280%3ADC%252BC2M7ls1Omsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=329-337&author=C.+Pietraauthor=Y.+Takedaauthor=N.+Tazawa-Ogataauthor=M.+Minamiauthor=X.+Yuanfengauthor=E.+M.+Duusauthor=R.+Northrup&title=Anamorelin+HCl+%28ONO-7643%29%2C+a+novel+ghrelin+receptor+agonist%2C+for+the+treatment+of+cancer+anorexia-cachexia+syndrome%3A+preclinical+profile&doi=10.1007%2Fs13539-014-0159-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile</span></div><div class="casAuthors">Pietra Claudio; Takeda Yasuhiro; Tazawa-Ogata Naoko; Minami Masashi; Yuanfeng Xia; Duus Elizabeth Manning; Northrup Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cachexia, sarcopenia and muscle</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-37</span>
        ISSN:<span class="NLM_cas:issn">2190-5991</span>.
    </div><div class="casAbstract">BACKGROUND:  Anamorelin HCl (ANAM) is a novel, orally active, ghrelin receptor agonist in clinical development for the treatment of cancer cachexia.  We report in vitro and in vivo studies evaluating the preclinical pharmacologic profile of ANAM.  METHODS:  Fluorescent imaging plate reader and binding assays in HEK293 and baby hamster kidney cells determined the agonist and antagonist activity of ANAM, and its affinity for the ghrelin receptor.  Rat pituitary cells were incubated with ANAM to evaluate its effect on growth hormone (GH) release.  In vivo, rats were treated with ANAM 3, 10, or 30 mg/kg, or control orally, once daily for 6 days to evaluate the effect on food intake (FI) and body weight (BW), and once to assess GH response.  In pigs, single (3.5 mg/kg) or continuous (1 mg/kg/day) ANAM doses were administered to assess GH and insulin-like growth factor (IGF-1) response.  RESULTS:  ANAM showed significant agonist and binding activity on the ghrelin receptor, and stimulated GH release in vitro.  In rats, ANAM significantly and dose-dependently increased FI and BW at all dose levels compared with control, and significantly increased GH levels at 10 or 30 mg/kg doses.  Increases in GH and IGF-1 levels were observed following ANAM administration in pigs.  CONCLUSION:  ANAM is a potent and highly specific ghrelin receptor agonist with significant appetite-enhancing activity, leading to increases in FI and BW, and a stimulatory effect on GH secretion.  These results support the continued investigation of ANAM as a potential treatment of cancer anorexia-cachexia syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_yjJHhZhx0LjnyZkbE8yXfW6udTcc2ea34CMqKBcjd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7ls1Omsg%253D%253D&md5=e983e10a0531528d8af3de46aa83cf9e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs13539-014-0159-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13539-014-0159-5%26sid%3Dliteratum%253Aachs%26aulast%3DPietra%26aufirst%3DC.%26aulast%3DTakeda%26aufirst%3DY.%26aulast%3DTazawa-Ogata%26aufirst%3DN.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DYuanfeng%26aufirst%3DX.%26aulast%3DDuus%26aufirst%3DE.%2BM.%26aulast%3DNorthrup%26aufirst%3DR.%26atitle%3DAnamorelin%2520HCl%2520%2528ONO-7643%2529%252C%2520a%2520novel%2520ghrelin%2520receptor%2520agonist%252C%2520for%2520the%2520treatment%2520of%2520cancer%2520anorexia-cachexia%2520syndrome%253A%2520preclinical%2520profile%26jtitle%3DJ.%2520Cachexia%2520Sarcopenia%2520Muscle%26date%3D2014%26volume%3D5%26spage%3D329%26epage%3D337%26doi%3D10.1007%2Fs13539-014-0159-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefker, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toler, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettleton, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirie, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidsey-Frink, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tess, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva-Jardine, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D. D.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacology of CP-424,391, an orally active pyrazolidinone-piperidine growth hormone secretagogue</span>. <i>Endocr. J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1385/ENDO:14:1:121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1385%2FENDO%3A14%3A1%3A121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2001&pages=121-132&issue=1&author=L.+C.+Panauthor=P.+A.+Carpinoauthor=B.+A.+Lefkerauthor=J.+A.+Raganauthor=S.+M.+Tolerauthor=J.+C.+Pettersenauthor=D.+O.+Nettletonauthor=O.+Ngauthor=C.+M.+Pirieauthor=K.+Chidsey-Frinkauthor=B.+Luauthor=D.+F.+Nickersonauthor=D.+A.+Tessauthor=M.+A.+Mullinsauthor=D.+B.+MacLeanauthor=P.+A.+DaSilva-Jardineauthor=D.+D.+Thompson&title=Preclinical+pharmacology+of+CP-424%2C391%2C+an+orally+active+pyrazolidinone-piperidine+growth+hormone+secretagogue&doi=10.1385%2FENDO%3A14%3A1%3A121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1385%2FENDO%3A14%3A1%3A121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FENDO%253A14%253A1%253A121%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DL.%2BC.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DRagan%26aufirst%3DJ.%2BA.%26aulast%3DToler%26aufirst%3DS.%2BM.%26aulast%3DPettersen%26aufirst%3DJ.%2BC.%26aulast%3DNettleton%26aufirst%3DD.%2BO.%26aulast%3DNg%26aufirst%3DO.%26aulast%3DPirie%26aufirst%3DC.%2BM.%26aulast%3DChidsey-Frink%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DNickerson%26aufirst%3DD.%2BF.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DMullins%26aufirst%3DM.%2BA.%26aulast%3DMacLean%26aufirst%3DD.%2BB.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%2BA.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DPreclinical%2520pharmacology%2520of%2520CP-424%252C391%252C%2520an%2520orally%2520active%2520pyrazolidinone-piperidine%2520growth%2520hormone%2520secretagogue%26jtitle%3DEndocr.%2520J.%26date%3D2001%26volume%3D14%26issue%3D1%26spage%3D121%26epage%3D132%26doi%3D10.1385%2FENDO%3A14%3A1%3A121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witherington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abberley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaiba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, J. G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takle, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadsworth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span> <span> </span><span class="NLM_article-title">Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: lead optimization</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2203</span>– <span class="NLM_lpage">2205</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2Fj.bmcl.2007.12.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2203-2205&author=J.+Witheringtonauthor=L.+Abberleyauthor=M.+A.+Briggsauthor=K.+Collisauthor=D.+K.+Deanauthor=A.+Gaibaauthor=N.+P.+Kingauthor=H.+Krausauthor=N.+Shukerauthor=J.+G.+A.+Steadmanauthor=A.+K.+Takleauthor=G.+Sangerauthor=G.+Wadsworthauthor=S.+Butlerauthor=F.+McKayauthor=A.+Muirauthor=K.+Winbornauthor=T.+D.+Heightman&title=Potent+achiral+agonists+of+the+growth+hormone+secretagogue+%28ghrelin%29+receptor.+Part+2%3A+lead+optimization&doi=10.1016%2Fj.bmcl.2007.12.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DAbberley%26aufirst%3DL.%26aulast%3DBriggs%26aufirst%3DM.%2BA.%26aulast%3DCollis%26aufirst%3DK.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DGaiba%26aufirst%3DA.%26aulast%3DKing%26aufirst%3DN.%2BP.%26aulast%3DKraus%26aufirst%3DH.%26aulast%3DShuker%26aufirst%3DN.%26aulast%3DSteadman%26aufirst%3DJ.%2BG.%2BA.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DSanger%26aufirst%3DG.%26aulast%3DWadsworth%26aufirst%3DG.%26aulast%3DButler%26aufirst%3DS.%26aulast%3DMcKay%26aufirst%3DF.%26aulast%3DMuir%26aufirst%3DA.%26aulast%3DWinborn%26aufirst%3DK.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3DPotent%2520achiral%2520agonists%2520of%2520the%2520growth%2520hormone%2520secretagogue%2520%2528ghrelin%2529%2520receptor.%2520Part%25202%253A%2520lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2203%26epage%3D2205%26doi%3D10.1016%2Fj.bmcl.2007.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patchett, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleim, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. W.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, S.-H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. D.</span></span> <span> </span><span class="NLM_article-title">1-[2(R)-(2-Amino-2-methylpropionylamino)-3-(1<i>H</i>-indol-3-yl)propionyl]-3-benzylpiperidine-3(S)-carboxylic acid ethyl ester (L-163,540): a potent, orally bioavailable, and short-duration growth hormone secretagogue</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2439</span>– <span class="NLM_lpage">2441</span>, <span class="refDoi"> DOI: 10.1021/jm9800191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9800191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2439-2441&author=L.+Yangauthor=G.+Morrielloauthor=A.+A.+Patchettauthor=K.+Leungauthor=T.+Jacksauthor=K.+Chengauthor=K.+D.+Schleimauthor=W.+Feeneyauthor=W.+W.-S.+Chanauthor=S.-H.+L.+Chiuauthor=R.+D.+Smith&title=1-%5B2%28R%29-%282-Amino-2-methylpropionylamino%29-3-%281H-indol-3-yl%29propionyl%5D-3-benzylpiperidine-3%28S%29-carboxylic+acid+ethyl+ester+%28L-163%2C540%29%3A+a+potent%2C+orally+bioavailable%2C+and+short-duration+growth+hormone+secretagogue&doi=10.1021%2Fjm9800191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm9800191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9800191%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DMorriello%26aufirst%3DG.%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DSchleim%26aufirst%3DK.%2BD.%26aulast%3DFeeney%26aufirst%3DW.%26aulast%3DChan%26aufirst%3DW.%2BW.-S.%26aulast%3DChiu%26aufirst%3DS.-H.%2BL.%26aulast%3DSmith%26aufirst%3DR.%2BD.%26atitle%3D1-%255B2%2528R%2529-%25282-Amino-2-methylpropionylamino%2529-3-%25281H-indol-3-yl%2529propionyl%255D-3-benzylpiperidine-3%2528S%2529-carboxylic%2520acid%2520ethyl%2520ester%2520%2528L-163%252C540%2529%253A%2520a%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520short-duration%2520growth%2520hormone%2520secretagogue%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2439%26epage%3D2441%26doi%3D10.1021%2Fjm9800191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witherington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abberley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellenie, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boatman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaiba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, J. G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrew, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takle, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span> <span> </span><span class="NLM_article-title">Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">684</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.12.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2Fj.bmcl.2008.12.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=684-687&issue=3&author=J.+Witheringtonauthor=L.+Abberleyauthor=B.+R.+Bellenieauthor=R.+Boatmanauthor=K.+Collisauthor=D.+K.+Deanauthor=A.+Gaibaauthor=N.+P.+Kingauthor=N.+Shukerauthor=J.+G.+A.+Steadmanauthor=K.+Andrewauthor=A.+K.+Takleauthor=G.+Sangerauthor=S.+Butlerauthor=F.+McKayauthor=A.+Muirauthor=K.+Winbornauthor=R.+W.+Wardauthor=T.+D.+Heightman&title=Aryl+sulphonyl+amides+as+potent+agonists+of+the+growth+hormone+secretagogue+%28ghrelin%29+receptor&doi=10.1016%2Fj.bmcl.2008.12.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.12.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.12.042%26sid%3Dliteratum%253Aachs%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DAbberley%26aufirst%3DL.%26aulast%3DBellenie%26aufirst%3DB.%2BR.%26aulast%3DBoatman%26aufirst%3DR.%26aulast%3DCollis%26aufirst%3DK.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DGaiba%26aufirst%3DA.%26aulast%3DKing%26aufirst%3DN.%2BP.%26aulast%3DShuker%26aufirst%3DN.%26aulast%3DSteadman%26aufirst%3DJ.%2BG.%2BA.%26aulast%3DAndrew%26aufirst%3DK.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DSanger%26aufirst%3DG.%26aulast%3DButler%26aufirst%3DS.%26aulast%3DMcKay%26aufirst%3DF.%26aulast%3DMuir%26aufirst%3DA.%26aulast%3DWinborn%26aufirst%3DK.%26aulast%3DWard%26aufirst%3DR.%2BW.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3DAryl%2520sulphonyl%2520amides%2520as%2520potent%2520agonists%2520of%2520the%2520growth%2520hormone%2520secretagogue%2520%2528ghrelin%2529%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D3%26spage%3D684%26epage%3D687%26doi%3D10.1016%2Fj.bmcl.2008.12.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smondyrev, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. N.</span></span> <span> </span><span class="NLM_article-title">PHASE: A novel approach to pharmacophore modeling and 3D database searching</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2006.00384.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1111%2Fj.1747-0285.2006.00384.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=16784462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVeqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=370-372&author=S.+L.+Dixonauthor=A.+M.+Smondyrevauthor=S.+N.+Rao&title=PHASE%3A+A+novel+approach+to+pharmacophore+modeling+and+3D+database+searching&doi=10.1111%2Fj.1747-0285.2006.00384.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Novel approach to pharmacophore modeling and 3D database searching</span></div><div class="casAuthors">Dixon, Steven L.; Smondyrev, Alexander M.; Rao, Shashidhar N.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">370-372</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Pharmacophore modeling and 3D database searching are now recognized as integral components of lead discovery and lead optimization, and the continuing need for improved pharmacophore-based tools has driven the development of PHASE.  PHASE pharmacophore and 3D QSAR models provide a means for rationalizing structure-activity data, predicting the activity of new compds., and efficiently extg. actives from a prototypical database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo50KpRHTGgAbVg90H21EOLACvtfcHk0ljTKSkDLH9Qbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVeqsbg%253D&md5=30d06fe99776e203eed35b0f774bbe64</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2006.00384.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2006.00384.x%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BL.%26aulast%3DSmondyrev%26aufirst%3DA.%2BM.%26aulast%3DRao%26aufirst%3DS.%2BN.%26atitle%3DPHASE%253A%2520A%2520novel%2520approach%2520to%2520pharmacophore%2520modeling%2520and%25203D%2520database%2520searching%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D370%26epage%3D372%26doi%3D10.1111%2Fj.1747-0285.2006.00384.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimurer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halkjaer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullberg, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span> <span> </span><span class="NLM_article-title">Overlapping binding site for endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1124/mol.108.049189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1124%2Fmol.108.049189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=18923064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVOltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2009&pages=44-59&author=B.+Holstauthor=T.+M.+Frimurerauthor=J.+Mokrosinskiauthor=T.+Halkjaerauthor=K.+B.+Cullbergauthor=C.+R.+Underwoodauthor=T.+W.+Schwartz&title=Overlapping+binding+site+for+endogenous+agonist%2C+small-molecule+agonists%2C+and+ago-allosteric+modulators+on+the+ghrelin+receptor&doi=10.1124%2Fmol.108.049189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor</span></div><div class="casAuthors">Holst, Birgitte; Frimurer, Thomas M.; Mokrosinski, Jacek; Halkjaer, Tine; Cullberg, Karina B.; Underwood, Christina R.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-59</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A library of robust ghrelin receptor mutants with single substitutions at 22 positions in the main ligand-binding pocket was employed to map binding sites for six different agonists: two peptides (the 28-amino-acid octanoylated endogenous ligand ghrelin and the hexapeptide growth hormone secretagogue GHRP-6) plus four nonpeptide agonists-the original benzolactam L-692,429, the spiroindoline sulfonamide MK-677, and two novel oxindole derivs., SM-130686 and SM-157740.  The strongest mutational effect with respect to decrease in potency for stimulation of inositol phosphate turnover was for all six agonists the GluIII:09-to-Gln substitution in the extracellular segment of TM-III.  Likewise, all six agonists were affected by substitutions of PheVI:16, ArgVI:20, and PheVI:23 on the opposing face of transmembrane domain (TM) VI.  Each of the agonists was also affected selectively by specific mutations.  The mutational map of the ability of L-692,429 and GHRP-6 to act as allosteric modulators by increasing ghrelin's maximal efficacy overlapped with the common mutational map for agonism but it was not identical with the map for the agonist property of these small-mol. ligands.  In mol. models, built over the inactive conformation of rhodopsin, low energy conformations of the nonpeptide agonists could be docked to satisfy many of their mutational hits.  It is concluded that although each of the ligands in addn. exploits other parts of the receptor, a large, common binding site for both small-mol. agonists-including ago-allosteric modulators-and the endogenous agonist is found on the opposing faces of TM-III and -VI of the ghrelin receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7vPmuuW-QabVg90H21EOLACvtfcHk0lh9eqb-SMDqlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVOltw%253D%253D&md5=565858dd8c6657fda2938e10ab30fed1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.049189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.049189%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DMokrosinski%26aufirst%3DJ.%26aulast%3DHalkjaer%26aufirst%3DT.%26aulast%3DCullberg%26aufirst%3DK.%2BB.%26aulast%3DUnderwood%26aufirst%3DC.%2BR.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DOverlapping%2520binding%2520site%2520for%2520endogenous%2520agonist%252C%2520small-molecule%2520agonists%252C%2520and%2520ago-allosteric%2520modulators%2520on%2520the%2520ghrelin%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2009%26volume%3D75%26spage%3D44%26epage%3D59%26doi%3D10.1124%2Fmol.108.049189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nygaard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimurer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span> <span> </span><span class="NLM_article-title">Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">15799</span>– <span class="NLM_lpage">15811</span>, <span class="refDoi"> DOI: 10.1074/jbc.M609796200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1074%2Fjbc.M609796200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=17371869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=15799-15811&author=B.+Holstauthor=J.+Mokrosinskiauthor=M.+Langauthor=E.+Brandtauthor=R.+Nygaardauthor=T.+M.+Frimurerauthor=A.+G.+Beck-Sickingerauthor=T.+W.+Schwartz&title=Identification+of+an+efficacy+switch+region+in+the+ghrelin+receptor+responsible+for+interchange+between+agonism+and+inverse+agonism&doi=10.1074%2Fjbc.M609796200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an Efficacy Switch Region in the Ghrelin Receptor Responsible for Interchange between Agonism and Inverse Agonism</span></div><div class="casAuthors">Holst, Birgitte; Mokrosinski, Jacek; Lang, Manja; Brandt, Erik; Nygaard, Rie; Frimurer, Thomas M.; Beck-Sickinger, Annette G.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">15799-15811</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The carboxyamidated wFwLL peptide was used as a core ligand to probe the structural basis for agonism vs. inverse agonism in the constitutively active ghrelin receptor.  In the ligand, an efficacy switch could be built at the N terminus, as exemplified by AwFwLL, which functioned as a high potency agonist, whereas KwFwLL was an equally high potency inverse agonist.  The wFw-contg. peptides, agonists as well as inverse agonists, were affected by receptor mutations covering the whole main ligand-binding pocket with key interaction sites being an arom. cluster in transmembrane (TM)-VI and -VII and residues on the opposing face of TM-III.  Gain-of-function in respect of either increased agonist or inverse agonist potency or swap between high potency versions of these properties was obtained by substitutions at a no. of positions covering a broad area of the binding pocket on TM-III, -IV, and -V.  However, in particular, space-generating substitutions at position III:04 shifted the efficacy of the ligands from inverse agonism toward agonism, whereas similar substitutions at position III: 08, one helical turn below, shifted the efficacy from agonism toward inverse agonism.  It is suggested that the relative position of the ligand in the binding pocket between this "efficacy shift region" on TM-III and the opposing arom. cluster on TM-VI and TM-VII leads either to agonism, i.e. in a superficial binding mode, or it leads to inverse agonism, i.e. in a more profound binding mode.  This relationship between different binding modes and opposite efficacy is in accordance with the Global Toggle Switch model for 7TM receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJqfgDA6O7ubVg90H21EOLACvtfcHk0lh9eqb-SMDqlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7g%253D&md5=9d994028f084be1fcd9a6b58a9547785</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609796200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609796200%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DMokrosinski%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DBrandt%26aufirst%3DE.%26aulast%3DNygaard%26aufirst%3DR.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DIdentification%2520of%2520an%2520efficacy%2520switch%2520region%2520in%2520the%2520ghrelin%2520receptor%2520responsible%2520for%2520interchange%2520between%2520agonism%2520and%2520inverse%2520agonism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D15799%26epage%3D15811%26doi%3D10.1074%2Fjbc.M609796200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charron, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowkes, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyt, L. G.</span></span> <span> </span><span class="NLM_article-title">Bridging computational modeling with amino acid replacements to investigate GHS-R1a-peptidomimetic recognition</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">822</span>– <span class="NLM_lpage">833</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.07.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2Fj.ejmech.2016.07.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=27541265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2016&pages=822-833&author=J.+Houauthor=C.+L.+Charronauthor=M.+M.+Fowkesauthor=L.+G.+Luyt&title=Bridging+computational+modeling+with+amino+acid+replacements+to+investigate+GHS-R1a-peptidomimetic+recognition&doi=10.1016%2Fj.ejmech.2016.07.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Bridging computational modeling with amino acid replacements to investigate GHS-R1a-peptidomimetic recognition</span></div><div class="casAuthors">Hou, Jinqiang; Charron, Carlie L.; Fowkes, Milan M.; Luyt, Leonard G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">822-833</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The ghrelin receptor, also referred to as the growth hormone secretagogue receptor 1a (GHS-R1a), is a G protein-coupled receptor (GPCR) primarily expressed in the brain and pituitary.  The wide spectrum of biol. functions of GHS-R1a has rendered it a target for therapeutic drugs and for mol. imaging agents, for a variety of diseases.  An improved understanding of the binding mechanism of a ligand to GHS-R1a would provide guidance on ligand design.  This study investigates the binding of G-7039, a peptidomimetic agonist, to the GHS-R1a.  A series of computational studies including homol. modeling, mol. docking, mol. dynamics (MD) simulations, and binding free energy calcns. were carried out in conjunction with amino acid replacements on G-7039.  The results suggest that the first three residues on the N-terminal segment of the peptidomimetic are bound to three hydrophobic sub-pockets in the receptor binding site, with the driving force for binding mainly from hydrophobic interactions.  It has been reported that a charge-charge interaction between the pos. charged terminal amine of the agonist and Glu124 on the receptor serves as an anchor point for binding.  However, our studies suggest that this interaction is not strong enough to anchor a ligand to the ghrelin receptor in the absence of hydrophobic interactions.  The resulting computational model provides insight into structure activity relationship anal. for the ghrelin receptor and will assist in future ligand design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos6ZSlrS_AL7Vg90H21EOLACvtfcHk0lg3BGBNP3J7cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7jM&md5=f96e7229ff7b1416f8039adae7bfb7a8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.07.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.07.078%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DCharron%26aufirst%3DC.%2BL.%26aulast%3DFowkes%26aufirst%3DM.%2BM.%26aulast%3DLuyt%26aufirst%3DL.%2BG.%26atitle%3DBridging%2520computational%2520modeling%2520with%2520amino%2520acid%2520replacements%2520to%2520investigate%2520GHS-R1a-peptidomimetic%2520recognition%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D123%26spage%3D822%26epage%3D833%26doi%3D10.1016%2Fj.ejmech.2016.07.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoull, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowker, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, R. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dossetter, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ertan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcombe, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pointon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D.</span></span> <span> </span><span class="NLM_article-title">Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6128</span>– <span class="NLM_lpage">6140</span>, <span class="refDoi"> DOI: 10.1021/jm500610n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500610n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6128-6140&author=W.+McCoullauthor=P.+Bartonauthor=A.+J.+H.+Brownauthor=S.+S.+Bowkerauthor=J.+Cameronauthor=D.+S.+Clarkeauthor=R.+D.+M.+Daviesauthor=A.+G.+Dossetterauthor=A.+Ertanauthor=M.+Fenwickauthor=C.+Greenauthor=J.+L.+Holmesauthor=N.+Martinauthor=D.+Mastersauthor=J.+E.+Mooreauthor=N.+J.+Newcombeauthor=C.+Newtonauthor=H.+Pointonauthor=G.+R.+Robbauthor=C.+Sheldonauthor=S.+Stokesauthor=D.+Morgan&title=Identification%2C+optimization%2C+and+pharmacology+of+acylurea+GHS-R1a+inverse+agonists&doi=10.1021%2Fjm500610n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm500610n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500610n%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DBowker%26aufirst%3DS.%2BS.%26aulast%3DCameron%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DD.%2BS.%26aulast%3DDavies%26aufirst%3DR.%2BD.%2BM.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DErtan%26aufirst%3DA.%26aulast%3DFenwick%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DHolmes%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DMasters%26aufirst%3DD.%26aulast%3DMoore%26aufirst%3DJ.%2BE.%26aulast%3DNewcombe%26aufirst%3DN.%2BJ.%26aulast%3DNewton%26aufirst%3DC.%26aulast%3DPointon%26aufirst%3DH.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DSheldon%26aufirst%3DC.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DMorgan%26aufirst%3DD.%26atitle%3DIdentification%252C%2520optimization%252C%2520and%2520pharmacology%2520of%2520acylurea%2520GHS-R1a%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6128%26epage%3D6140%26doi%3D10.1021%2Fjm500610n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of an agonist-bound human A2a adenosine receptor</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>332</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1126/science.1202793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1126%2Fscience.1202793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=21393508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFWjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2011&pages=322-327&author=F.+Xuauthor=H.+Wuauthor=V.+Katritchauthor=G.+W.+Hanauthor=K.+A.+Jacobsonauthor=Z.+G.+Gaoauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+an+agonist-bound+human+A2a+adenosine+receptor&doi=10.1126%2Fscience.1202793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of an Agonist-Bound Human A2A Adenosine Receptor</span></div><div class="casAuthors">Xu, Fei; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Jacobson, Kenneth A.; Gao, Zhan-Guo; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">6027</span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Activation of G protein-coupled receptors upon agonist binding is a crit. step in the signaling cascade for this family of cell surface proteins.  We report the crystal structure of the A2A adenosine receptor (A2AAR) bound to an agonist UK-432097 at 2.7 angstrom resoln.  Relative to inactive, antagonist-bound A2AAR, the agonist-bound structure displays an outward tilt and rotation of the cytoplasmic half of helix VI, a movement of helix V, and an axial shift of helix III, resembling the changes assocd. with the active-state opsin structure.  Addnl., a seesaw movement of helix VII and a shift of extracellular loop 3 are likely specific to A2AAR and its ligand.  The results define the mol. UK-432097 as a "conformationally selective agonist" capable of receptor stabilization in a specific active-state configuration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMkD1ni9m9GrVg90H21EOLACvtfcHk0liJT7mEF4ULQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFWjt7s%253D&md5=b1e074f38f45c95d4cc3b40378b24923</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1126%2Fscience.1202793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1202793%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520an%2520agonist-bound%2520human%2520A2a%2520adenosine%2520receptor%26jtitle%3DScience%26date%3D2011%26volume%3D332%26spage%3D322%26epage%3D327%26doi%3D10.1126%2Fscience.1202793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: a force field providing broad coverage of drug-like small molecules and proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+W.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+a+force+field+providing+broad+coverage+of+drug-like+small+molecules+and+proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0liJT7mEF4ULQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BW.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520a%2520force%2520field%2520providing%2520broad%2520coverage%2520of%2520drug-like%2520small%2520molecules%2520and%2520proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peterlin
Masic, L. P.</span></span> <span> </span><span class="NLM_article-title">Role of cyclic tertiary amine bioactivation to reactive iminium species: structure toxicity relationship</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.2174/138920011794520044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.2174%2F138920011794520044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=21222587" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=35-50&issue=1&author=L.+P.+Peterlin%0AMasic&title=Role+of+cyclic+tertiary+amine+bioactivation+to+reactive+iminium+species%3A+structure+toxicity+relationship&doi=10.2174%2F138920011794520044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F138920011794520044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920011794520044%26sid%3Dliteratum%253Aachs%26aulast%3DPeterlin%2BMasic%26aufirst%3DL.%2BP.%26atitle%3DRole%2520of%2520cyclic%2520tertiary%2520amine%2520bioactivation%2520to%2520reactive%2520iminium%2520species%253A%2520structure%2520toxicity%2520relationship%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2011%26volume%3D12%26issue%3D1%26spage%3D35%26epage%3D50%26doi%3D10.2174%2F138920011794520044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doss, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngui, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva Elipe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dininno, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stearns, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span> <span> </span><span class="NLM_article-title">In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolites</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1021/tx0496789</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx0496789" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=675-685&issue=4&author=Z.+Zhangauthor=Q.+Chenauthor=Y.+Liauthor=G.+A.+Dossauthor=B.+J.+Deanauthor=J.+S.+Nguiauthor=M.+Silva+Elipeauthor=S.+Kimauthor=J.+Y.+Wuauthor=F.+Dininnoauthor=M.+L.+Hammondauthor=R.+A.+Stearnsauthor=D.+C.+Evansauthor=T.+A.+Baillieauthor=W.+Tang&title=In+vitro+bioactivation+of+dihydrobenzoxathiin+selective+estrogen+receptor+modulators+by+cytochrome+P450+3A4+in+human+liver+microsomes%3A+formation+of+reactive+iminium+and+quinone+type+metabolites&doi=10.1021%2Ftx0496789"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Ftx0496789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx0496789%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DDoss%26aufirst%3DG.%2BA.%26aulast%3DDean%26aufirst%3DB.%2BJ.%26aulast%3DNgui%26aufirst%3DJ.%2BS.%26aulast%3DSilva%2BElipe%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DJ.%2BY.%26aulast%3DDininno%26aufirst%3DF.%26aulast%3DHammond%26aufirst%3DM.%2BL.%26aulast%3DStearns%26aufirst%3DR.%2BA.%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DIn%2520vitro%2520bioactivation%2520of%2520dihydrobenzoxathiin%2520selective%2520estrogen%2520receptor%2520modulators%2520by%2520cytochrome%2520P450%25203A4%2520in%2520human%2520liver%2520microsomes%253A%2520formation%2520of%2520reactive%2520iminium%2520and%2520quinone%2520type%2520metabolites%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2005%26volume%3D18%26issue%3D4%26spage%3D675%26epage%3D685%26doi%3D10.1021%2Ftx0496789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boobis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laverty, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naisbitt, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll-Griffith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routledge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedie, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">Managing the challenge of chemically reactive metabolites in drug development</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1038/nrd3408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1038%2Fnrd3408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=21455238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=292-306&issue=4&author=B.+K.+Parkauthor=A.+Boobisauthor=S.+Clarkeauthor=C.+E.+Goldringauthor=D.+Jonesauthor=J.+G.+Kennaauthor=C.+Lambertauthor=H.+G.+Lavertyauthor=D.+J.+Naisbittauthor=S.+Nelsonauthor=D.+A.+Nicoll-Griffithauthor=R.+S.+Obachauthor=P.+Routledgeauthor=D.+A.+Smithauthor=D.+J.+Tweedieauthor=N.+Vermeulenauthor=D.+P.+Williamsauthor=I.+D.+Wilsonauthor=T.+A.+Baillie&title=Managing+the+challenge+of+chemically+reactive+metabolites+in+drug+development&doi=10.1038%2Fnrd3408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Managing the challenge of chemically reactive metabolites in drug development</span></div><div class="casAuthors">Park, B. Kevin; Boobis, Alan; Clarke, Stephen; Goldring, Chris E. P.; Jones, David; Kenna, J. Gerry; Lambert, Craig; Laverty, Hugh G.; Naisbitt, Dean J.; Nelson, Sidney; Nicoll-Griffith, Deborah A.; Obach, R. Scott; Routledge, Philip; Smith, Dennis A.; Tweedie, Donald J.; Vermeulen, Nico; Williams, Dominic P.; Wilson, Ian D.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">292-306</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The normal metab. of drugs can generate metabolites that have intrinsic chem. reactivity towards cellular mols., and therefore have the potential to alter biol. function and initiate serious adverse drug reactions.  Here, we present an assessment of the current approaches used for the evaluation of chem. reactive metabolites.  We also describe how these approaches are being used within the pharmaceutical industry to assess and minimize the potential of drug candidates to cause toxicity.  At early stages of drug discovery, iteration between medicinal chem. and drug metab. can eliminate perceived reactive metabolite-mediated chem. liabilities without compromising pharmacol. activity or the need for extensive safety evaluation beyond std. practices.  In the future, reactive metabolite evaluation may also be useful during clin. development for improving clin. risk assessment and risk management.  Currently, there remains a huge gap in our understanding of the basic mechanisms that underlie chem. stress-mediated adverse reactions in humans.  This Review summarizes our views on this complex topic, and includes insights into practices considered by the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBv41vr7ZlNLVg90H21EOLACvtfcHk0lhcwwKwvZDCFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGnu78%253D&md5=8f6865f17bbe50b51aa4282379e82a08</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrd3408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3408%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DBoobis%26aufirst%3DA.%26aulast%3DClarke%26aufirst%3DS.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26aulast%3DLambert%26aufirst%3DC.%26aulast%3DLaverty%26aufirst%3DH.%2BG.%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRoutledge%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26aulast%3DVermeulen%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DWilson%26aufirst%3DI.%2BD.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DManaging%2520the%2520challenge%2520of%2520chemically%2520reactive%2520metabolites%2520in%2520drug%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D4%26spage%3D292%26epage%3D306%26doi%3D10.1038%2Fnrd3408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darwish, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attwa, M. W.</span></span> <span> </span><span class="NLM_article-title">LC-MS/MS reveals the formation of aldehydes and iminium reactive intermediates in foretinib metabolism: phase I metabolic profiling</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">36279</span>– <span class="NLM_lpage">36287</span>, <span class="refDoi"> DOI: 10.1039/C7RA06341E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1039%2FC7RA06341E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Sgt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=36279-36287&author=A.+Kadiauthor=S.+M.+Amerauthor=H.+W.+Darwishauthor=M.+W.+Attwa&title=LC-MS%2FMS+reveals+the+formation+of+aldehydes+and+iminium+reactive+intermediates+in+foretinib+metabolism%3A+phase+I+metabolic+profiling&doi=10.1039%2FC7RA06341E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">LC-MS/MS reveals the formation of aldehydes and iminium reactive intermediates in foretinib metabolism: phase I metabolic profiling</span></div><div class="casAuthors">Kadi, Adnan A.; Amer, Sawsan M.; Darwish, Hany W.; Attwa, Mohamed W.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">58</span>),
    <span class="NLM_cas:pages">36279-36287</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Foretinib (GSK1363089) is an inhibitor of multiple receptor tyrosine kinases including MET and VEGFR, with the potential for treatment of solid tumors.  In this study, we investigated the in vitro metabolic pathways for foretinib in rat liver microsomes using LC-MS/MS.  Methoxylamine and potassium cyanide were used as trapping agents for aldehyde and iminium reactive intermediates, resp., of foretinib to form a stable complex that can be identified by LC-MS/MS.  Six foretinib phase I metabolites were characterized.  The phase I metabolic pathways were oxidn., defluorination, redn. and hydroxylation.  Addnl., four potential reactive metabolites, two aldehydes and two iminium ions, were found and the bioactivation pathways were proposed.  Reporting the in vitro and reactive metabolites of foretinib is very crucial in the development stage.  A literature review showed that no previous articles have provided an in vitro metab. study of foretinib or detailed structural identification of the formed reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpUjox-Bi8rrVg90H21EOLACvtfcHk0lhcwwKwvZDCFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Sgt7nL&md5=c70b6176eabae9f6d6c10f82ddebd518</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1039%2FC7RA06341E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7RA06341E%26sid%3Dliteratum%253Aachs%26aulast%3DKadi%26aufirst%3DA.%26aulast%3DAmer%26aufirst%3DS.%2BM.%26aulast%3DDarwish%26aufirst%3DH.%2BW.%26aulast%3DAttwa%26aufirst%3DM.%2BW.%26atitle%3DLC-MS%252FMS%2520reveals%2520the%2520formation%2520of%2520aldehydes%2520and%2520iminium%2520reactive%2520intermediates%2520in%2520foretinib%2520metabolism%253A%2520phase%2520I%2520metabolic%2520profiling%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D36279%26epage%3D36287%26doi%3D10.1039%2FC7RA06341E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammarlund-Udenaes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridén, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syvänen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span> <span> </span><span class="NLM_article-title">On the rate and extent of drug delivery to the brain</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1737</span>– <span class="NLM_lpage">1750</span>, <span class="refDoi"> DOI: 10.1007/s11095-007-9502-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1007%2Fs11095-007-9502-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=18058202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Whsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=1737-1750&issue=8&author=M.+Hammarlund-Udenaesauthor=M.+Frid%C3%A9nauthor=S.+Syv%C3%A4nenauthor=A.+Gupta&title=On+the+rate+and+extent+of+drug+delivery+to+the+brain&doi=10.1007%2Fs11095-007-9502-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">On The Rate and Extent of Drug Delivery to the Brain</span></div><div class="casAuthors">Hammarlund-Udenaes, Margareta; Friden, Markus; Syvaenen, Stina; Gupta, Anubha</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1737-1750</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  To define and differentiate relevant aspects of blood-brain barrier transport and distribution in order to aid research methodol. in brain drug delivery.  Pharmacokinetic parameters relative to the rate and extent of brain drug delivery are described and illustrated with relevant data, with special emphasis on the unbound, pharmacol. active drug mol.  Drug delivery to the brain can be comprehensively described using three parameters: K p,uu (concn. ratio of unbound drug in brain to blood), CLin (permeability clearance into the brain), and V u,brain (intra-brain distribution).  The permeability of the blood-brain barrier is less relevant to drug action within the CNS than the extent of drug delivery, as most drugs are administered on a continuous (repeated) basis.  K p,uu can differ between CNS-active drugs by a factor of up to 150-fold.  This range is much smaller than that for log BB ratios (K p), which can differ by up to at least 2000-fold, or for BBB permeabilities, which span an even larger range (up to at least 20,000-fold difference).  Methods that measure the three parameters K p,uu, CLin, and V u,brain can give clin. valuable ests. of brain drug delivery in early drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkysWU99T_hbVg90H21EOLACvtfcHk0lj8ZCNtbADqDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Whsb8%253D&md5=20f106a980c4949b78ead8c00cb5db41</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs11095-007-9502-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-007-9502-2%26sid%3Dliteratum%253Aachs%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26aulast%3DFrid%25C3%25A9n%26aufirst%3DM.%26aulast%3DSyv%25C3%25A4nen%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DA.%26atitle%3DOn%2520the%2520rate%2520and%2520extent%2520of%2520drug%2520delivery%2520to%2520the%2520brain%26jtitle%3DPharm.%2520Res.%26date%3D2008%26volume%3D25%26issue%3D8%26spage%3D1737%26epage%3D1750%26doi%3D10.1007%2Fs11095-007-9502-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredlund, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winiwarter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgendorf, C.</span></span> <span> </span><span class="NLM_article-title">In vitro intrinsic permeability: a transporter-independent measure of Caco-2 cell permeability in drug design and development</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1601</span>– <span class="NLM_lpage">1609</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.6b01059</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.6b01059" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC2sXks1GgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=1601-1609&issue=5&author=L.+Fredlundauthor=S.+Winiwarterauthor=C.+Hilgendorf&title=In+vitro+intrinsic+permeability%3A+a+transporter-independent+measure+of+Caco-2+cell+permeability+in+drug+design+and+development&doi=10.1021%2Facs.molpharmaceut.6b01059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development</span></div><div class="casAuthors">Fredlund, Linda; Winiwarter, Susanne; Hilgendorf, Constanze</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1601-1609</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In vitro permeability data have a central place in absorption risk assessments in drug discovery and development.  For compds. where active efflux impacts permeability in vitro, the inherent passive membrane permeability ("intrinsic permeability") gives a concn.-independent measure of the compd.'s permeability.  This work describes the validation of an in vitro intrinsic permeability assay and application of the data in a predictive in silico model.  Apparent intrinsic permeability (Papp) across Caco-2 cell monolayers is detd. in the presence of an optimized cocktail of chem. inhibitors toward the three major efflux transporters ABCB1, ABCC2, and ABCG2.  The intrinsic Papp value gives an est. of passive permeability, which is independent of transporter expression levels and not limited by soly. or cell toxicity.  An in silico model has been established to predict the Caco-2 intrinsic permeability and shown to consistently identify highly permeable compds.  The new intrinsic permeability assay is useful for early absorption ests. and suitable for absorption risk assessment in DMPK and pharmaceutical development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzz4IoZ6pXJbVg90H21EOLACvtfcHk0lj8ZCNtbADqDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXks1GgsLw%253D&md5=2e3af857e97f2ce5ce9743294c50d3b9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.6b01059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.6b01059%26sid%3Dliteratum%253Aachs%26aulast%3DFredlund%26aufirst%3DL.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DHilgendorf%26aufirst%3DC.%26atitle%3DIn%2520vitro%2520intrinsic%2520permeability%253A%2520a%2520transporter-independent%2520measure%2520of%2520Caco-2%2520cell%2520permeability%2520in%2520drug%2520design%2520and%2520development%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2017%26volume%3D14%26issue%3D5%26spage%3D1601%26epage%3D1609%26doi%3D10.1021%2Facs.molpharmaceut.6b01059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hermansson, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drmota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, N.</span></span> <span> </span><span class="NLM_article-title">Adenosine is not a direct GHSR agonist-artificial cross-talk between GHSR and adenosine receptor pathways</span>. <i>Acta Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1111/j.1365-201X.2007.01691.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1111%2Fj.1365-201X.2007.01691.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=17428235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVaqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2007&pages=77-86&author=N.+O.+Hermanssonauthor=D.+G.+Morganauthor=T.+Drmotaauthor=N.+Larsson&title=Adenosine+is+not+a+direct+GHSR+agonist-artificial+cross-talk+between+GHSR+and+adenosine+receptor+pathways&doi=10.1111%2Fj.1365-201X.2007.01691.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine is not a direct GHSR agonist - artificial cross-talk between GHSR and adenosine receptor pathways</span></div><div class="casAuthors">Hermansson, N.-O.; Morgan, D. G. A.; Drmota, T.; Larsson, N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Physiologica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-86</span>CODEN:
                <span class="NLM_cas:coden">APCHC4</span>;
        ISSN:<span class="NLM_cas:issn">1748-1708</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aim: To assess if adenosine is a direct growth hormone secretagogue receptor (GHSR) agonist by investigating the mechanism behind adenosine induced calcium release in human embryonic kidney 293s (HEK) cells expressing GHSR.  Methods: Calcium mobilization, cAMP (cAMP) and IP3 expts. were performed using HEK cells stably expressing GHSR and/or adenosine A2B receptor (A2BR).  Results: Adenosine has been widely reported as a GHSR agonist.  In our hands, adenosine and forskolin stimulated calcium release from IP3 controlled stores in HEK-GHSR cells but not in non-transfected HEK cells.  This release was not accompanied by increased IP3 levels.  The calcium release was both cholera toxin and U73122 sensitive, indicating the involvement of both Gαs/adenylyl cyclase and Gαq/11/phospholipase C pathways.  Importantly, the GHSR inverse agonist [D-Arg1 D-Phe5 D-Trp7,9 Leu11]-Substance P (SP-analog) blocked the adenosine stimulated calcium release, demonstrating that GHSR is involved.  Assessment of the GHSR-dependent calcium release using adenosine receptor agonists and antagonists resulted in a rank order of potencies resembling the profile of A2BR.  A2BR over-expression in HEK-GHSR cells enhanced potency and efficacy of the adenosine induced calcium release without increasing IP3 prodn.  Moreover, A2BR over-expression in HEK cells potentiated NECA-induced cAMP prodn.  However, GHSR expression had no effect on intracellular cAMP prodn.  Conclusion: In HEK-GHSR cells adenosine activates endogenously expressed A2BR resulting in calcium mobilization.  We hypothesize that the responsible mechanism is cAMP-dependent sensitization of IP3 receptors for the high basal level of IP3 caused by GHSR constitutive activity.  Altogether, our results demonstrate that adenosine is not a direct GHSR agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4xsD9OHtxHLVg90H21EOLACvtfcHk0ljMdQDcnchrZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVaqtbs%253D&md5=70f0cb61ba1421cb2d30c51ef4044a43</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-201X.2007.01691.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-201X.2007.01691.x%26sid%3Dliteratum%253Aachs%26aulast%3DHermansson%26aufirst%3DN.%2BO.%26aulast%3DMorgan%26aufirst%3DD.%2BG.%26aulast%3DDrmota%26aufirst%3DT.%26aulast%3DLarsson%26aufirst%3DN.%26atitle%3DAdenosine%2520is%2520not%2520a%2520direct%2520GHSR%2520agonist-artificial%2520cross-talk%2520between%2520GHSR%2520and%2520adenosine%2520receptor%2520pathways%26jtitle%3DActa%2520Physiol.%26date%3D2007%26volume%3D190%26spage%3D77%26epage%3D86%26doi%3D10.1111%2Fj.1365-201X.2007.01691.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trinquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourrier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansanay, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durroux, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhaire, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernout, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrétien, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapleur, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, G.</span></span> <span> </span><span class="NLM_article-title">D-myo-Inositol 1-phosphate as a surrogate of d-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2006.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2Fj.ab.2006.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=16965760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyktrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2006&pages=126-135&author=E.+Trinquetauthor=M.+Finkauthor=H.+Bazinauthor=F.+Grilletauthor=F.+Maurinauthor=E.+Bourrierauthor=H.+Ansanayauthor=C.+Leroyauthor=A.+Michaudauthor=T.+Durrouxauthor=D.+Maurelauthor=F.+Malhaireauthor=C.+Goudetauthor=J.+P.+Pinauthor=M.+Navalauthor=O.+Hernoutauthor=F.+Chr%C3%A9tienauthor=Y.+Chapleurauthor=G.+Mathis&title=D-myo-Inositol+1-phosphate+as+a+surrogate+of+d-myo-inositol+1%2C4%2C5-tris+phosphate+to+monitor+G+protein-coupled+receptor+activation&doi=10.1016%2Fj.ab.2006.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">D-myo-Inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation</span></div><div class="casAuthors">Trinquet, Eric; Fink, Michel; Bazin, Herve; Grillet, Florence; Maurin, Fabrice; Bourrier, Emmanuel; Ansanay, Herve; Leroy, Cedric; Michaud, Audrey; Durroux, Thierry; Maurel, Damien; Malhaire, Fanny; Goudet, Cyril; Pin, Jean-Philippe; Naval, Magali; Hernout, Olivier; Chretien, Francoise; Chapleur, Yves; Mathis, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-135</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phospholipase C β (PLC-β)-coupled G protein-coupled receptor (GPCR) activities traditionally are assessed by measuring Ca2+ triggered by D-myo-inositol 1,4,5-trisphosphate (IP3), a PLC-β hydrolysis product, or by measuring the prodn. of inositol phosphate using cumbersome radioactive assays.  A specific detection of IP3 prodn. was also established using IP3 binding proteins.  The short lifetime of IP3 makes this detection very challenging in measuring GPCR responses.  Indeed, this IP3 rapidly enters the metabolic inositol phosphate cascade.  It has been known for decades that lithium chloride (LiCl) leads to D-myo-inositol 1-phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase, the final enzyme of the IP3 metabolic cascade.  We show here that IP1 can be used as a surrogate of IP3 to monitor GPCR activation.  We developed a novel homogeneous time-resolved fluorescence (HTRF) assay that correlates perfectly with existing methods and is easily amenable to high-throughput screening.  The IP-One assay was validated on various GPCR models.  It has the advantage over the traditional Ca2+ assay of allowing the measurement of inverse agonist activity as well as the anal. of PLC-β activity in any nontransfected primary cultures.  Finally, the high assay specificity for D-myo-inositol 1 monophosphate (IP1(1)) opens new possibilities in developing selective assays to study the functional roles of the various isoforms of inositol phosphates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRFlTq9szK1LVg90H21EOLACvtfcHk0ljMdQDcnchrZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyktrfJ&md5=fce292860fb4d99a590a9118772d9f58</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2006.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2006.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DFink%26aufirst%3DM.%26aulast%3DBazin%26aufirst%3DH.%26aulast%3DGrillet%26aufirst%3DF.%26aulast%3DMaurin%26aufirst%3DF.%26aulast%3DBourrier%26aufirst%3DE.%26aulast%3DAnsanay%26aufirst%3DH.%26aulast%3DLeroy%26aufirst%3DC.%26aulast%3DMichaud%26aufirst%3DA.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMaurel%26aufirst%3DD.%26aulast%3DMalhaire%26aufirst%3DF.%26aulast%3DGoudet%26aufirst%3DC.%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DNaval%26aufirst%3DM.%26aulast%3DHernout%26aufirst%3DO.%26aulast%3DChr%25C3%25A9tien%26aufirst%3DF.%26aulast%3DChapleur%26aufirst%3DY.%26aulast%3DMathis%26aufirst%3DG.%26atitle%3DD-myo-Inositol%25201-phosphate%2520as%2520a%2520surrogate%2520of%2520d-myo-inositol%25201%252C4%252C5-tris%2520phosphate%2520to%2520monitor%2520G%2520protein-coupled%2520receptor%2520activation%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D358%26spage%3D126%26epage%3D135%26doi%3D10.1016%2Fj.ab.2006.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergsdorf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropp-Goerkis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaehler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ketscher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boemer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parczyk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span> <span> </span><span class="NLM_article-title">A one-day, dispense-only IP-one HTRF assay for high-throughput screening of Gαq protein-coupled receptors: towards cells as reagents</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1089/adt.2007.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1089%2Fadt.2007.108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=39-53&author=C.+Bergsdorfauthor=C.+Kropp-Goerkisauthor=I.+Kaehlerauthor=L.+Ketscherauthor=U.+Boemerauthor=K.+Parczykauthor=B.+Bader&title=A+one-day%2C+dispense-only+IP-one+HTRF+assay+for+high-throughput+screening+of+G%CE%B1q+protein-coupled+receptors%3A+towards+cells+as+reagents&doi=10.1089%2Fadt.2007.108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1089%2Fadt.2007.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2007.108%26sid%3Dliteratum%253Aachs%26aulast%3DBergsdorf%26aufirst%3DC.%26aulast%3DKropp-Goerkis%26aufirst%3DC.%26aulast%3DKaehler%26aufirst%3DI.%26aulast%3DKetscher%26aufirst%3DL.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DParczyk%26aufirst%3DK.%26aulast%3DBader%26aufirst%3DB.%26atitle%3DA%2520one-day%252C%2520dispense-only%2520IP-one%2520HTRF%2520assay%2520for%2520high-throughput%2520screening%2520of%2520G%25CE%25B1q%2520protein-coupled%2520receptors%253A%2520towards%2520cells%2520as%2520reagents%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2008%26volume%3D6%26spage%3D39%26epage%3D53%26doi%3D10.1089%2Fadt.2007.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Andrew N. Dinh, Sean M. Maddox, Sagar D. Vaidya, Mirza A. Saputra, Christopher J. Nalbandian, <span class="NLM_string-name hlFld-ContribAuthor">Jeffrey L. Gustafson</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-Controlled Regioselective Chlorination of Phenols and Anilines through a Lewis Basic Selenoether Catalyst. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (21)
                                     , 13895-13905. <a href="https://doi.org/10.1021/acs.joc.0c01917" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01917%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCatalyst-Controlled%252BRegioselective%252BChlorination%252Bof%252BPhenols%252Band%252BAnilines%252Bthrough%252Ba%252BLewis%252BBasic%252BSelenoether%252BCatalyst%26aulast%3DDinh%26aufirst%3DAndrew%2BN.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14082020%26date%3D12102020%26volume%3D85%26issue%3D21%26spage%3D13895%26epage%3D13905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Martin Cooper, Antonio Llinas, Peter Hansen, Moya Caffrey, Asim Ray, Stina Sjödin, Igor Shamovsky, Hiroki Wada, Tina Jellesmark Jensen, Ulf Sivars, Leif Hultin, Ulf Andersson, Sara Lundqvist, Karin Gedda, Lisa Jinton, Nina Krutrök, Richard Lewis, Paul Jansson, <span class="NLM_string-name hlFld-ContribAuthor">Cristina Gardelli</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9705-9730. <a href="https://doi.org/10.1021/acs.jmedchem.0c00828" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00828</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00828%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BOptimization%252Bof%252BPyrrolidine%252BDerivatives%252Bas%252BHighly%252BPotent%252BGhrelin%252BReceptor%252BFull%252BAgonists%26aulast%3DCooper%26aufirst%3DMartin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15052020%26date%3D27082020%26date%3D12082020%26volume%3D63%26issue%3D17%26spage%3D9705%26epage%3D9730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bharatkumar Chaudhary, Prashant Auti, Suchita Dattatray Shinde, Prasanna Anjaneyulu Yakkala, Deepesh Giri, <span class="NLM_string-name hlFld-ContribAuthor">Satyasheel Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Rh(III)-Catalyzed [3 + 2] Annulation via C–H Activation: Direct Access to Trifluoromethyl-Substituted Indenamines and Aminoindanes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (8)
                                     , 2763-2767. <a href="https://doi.org/10.1021/acs.orglett.9b00720" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b00720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b00720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b00720%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRh%252528III%252529-Catalyzed%252B%25255B3%252B%25252B%252B2%25255D%252BAnnulation%252Bvia%252BC%2525E2%252580%252593H%252BActivation%25253A%252BDirect%252BAccess%252Bto%252BTrifluoromethyl-Substituted%252BIndenamines%252Band%252BAminoindanes%26aulast%3DChaudhary%26aufirst%3DBharatkumar%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D01042019%26volume%3D21%26issue%3D8%26spage%3D2763%26epage%3D2767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balaji Sundara  Sekar</span>, <span class="hlFld-ContribAuthor ">Jiwei  Mao</span>, <span class="hlFld-ContribAuthor ">Benedict Ryan  Lukito</span>, <span class="hlFld-ContribAuthor ">Zilong  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Bioproduction of Enantiopure (
              R
              )‐ and (
              S
              )‐2‐Phenylglycinols from Styrenes and Renewable Feedstocks. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (7)
                                     , 1892-1903. <a href="https://doi.org/10.1002/adsc.202001322" title="DOI URL">https://doi.org/10.1002/adsc.202001322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202001322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202001322%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DBioproduction%252Bof%252BEnantiopure%252B%252528%252BR%252B%252529%2525E2%252580%252590%252Band%252B%252528%252BS%252B%252529%2525E2%252580%2525902%2525E2%252580%252590Phenylglycinols%252Bfrom%252BStyrenes%252Band%252BRenewable%252BFeedstocks%26aulast%3DSekar%26aufirst%3DBalaji%2BSundara%26date%3D2021%26date%3D2020%26volume%3D363%26issue%3D7%26spage%3D1892%26epage%3D1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bharatkumar  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Neeraj  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Nehanaz  Saiyed</span>, <span class="hlFld-ContribAuthor ">Meenakshi  Chaurasia</span>, <span class="hlFld-ContribAuthor ">Surbhi  Desai</span>, <span class="hlFld-ContribAuthor ">Sagar  Potkule</span>, <span class="hlFld-ContribAuthor ">Satyasheel  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">β
              ‐Trifluoromethyl
              α
              ,
              β
              ‐unsaturated Ketones: Efficient Building Blocks for Diverse Trifluoromethylated Molecules. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (22)
                                     , 4794-4819. <a href="https://doi.org/10.1002/adsc.202001018" title="DOI URL">https://doi.org/10.1002/adsc.202001018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202001018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202001018%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3D%2525CE%2525B2%252B%2525E2%252580%252590Trifluoromethyl%252B%2525CE%2525B1%252B%25252C%252B%2525CE%2525B2%252B%2525E2%252580%252590unsaturated%252BKetones%25253A%252BEfficient%252BBuilding%252BBlocks%252Bfor%252BDiverse%252BTrifluoromethylated%252BMolecules%26aulast%3DChaudhary%26aufirst%3DBharatkumar%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D22%26spage%3D4794%26epage%3D4819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bharatkumar  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Neeraj  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Satyasheel  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium(
              iii
              )-catalyzed synthesis of 3-trifluoromethylindanones from
              N
              -methoxybenzamides
              via
              C–H activation and Claisen/retro-Claisen reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (12)
                                     , 1512-1519. <a href="https://doi.org/10.1039/D0QO00330A" title="DOI URL">https://doi.org/10.1039/D0QO00330A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00330A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00330A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DRhodium%252528%252Biii%252B%252529-catalyzed%252Bsynthesis%252Bof%252B3-trifluoromethylindanones%252Bfrom%252BN%252B-methoxybenzamides%252Bvia%252BC%2525E2%252580%252593H%252Bactivation%252Band%252BClaisen%25252Fretro-Claisen%252Breaction%26aulast%3DChaudhary%26aufirst%3DBharatkumar%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D12%26spage%3D1512%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. A.  Selivanova</span>, <span class="hlFld-ContribAuthor ">E. V.  Tretyakov</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorinated benzimidazoles for medicinal chemistry and new materials. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2020,</strong> <em>69 </em>
                                    (5)
                                     , 838-858. <a href="https://doi.org/10.1007/s11172-020-2842-3" title="DOI URL">https://doi.org/10.1007/s11172-020-2842-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-020-2842-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-020-2842-3%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DFluorinated%252Bbenzimidazoles%252Bfor%252Bmedicinal%252Bchemistry%252Band%252Bnew%252Bmaterials%26aulast%3DSelivanova%26aufirst%3DG.%2BA.%26date%3D2020%26date%3D2020%26volume%3D69%26issue%3D5%26spage%3D838%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshihiro  Shiomi</span>, <span class="hlFld-ContribAuthor ">Makoto  Yoshimura</span>, <span class="hlFld-ContribAuthor ">Yuko  Hori</span>, <span class="hlFld-ContribAuthor ">Yuta  Ohira</span>, <span class="hlFld-ContribAuthor ">Kenji  Nagahama</span>, <span class="hlFld-ContribAuthor ">Tomoko  Ozaki</span>, <span class="hlFld-ContribAuthor ">Mineo  Takei</span>, <span class="hlFld-ContribAuthor ">Takao  Tanaka</span>, <span class="hlFld-ContribAuthor ">Tomohide  Uno</span>. </span><span class="cited-content_cbyCitation_article-title">Z-505, an Oral Ghrelin Receptor Agonist, Attenuates Anorexia After Total Gastrectomy in Rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Surgical Research</span><span> <strong>2020,</strong> <em>246 </em>, 527-534. <a href="https://doi.org/10.1016/j.jss.2019.09.035" title="DOI URL">https://doi.org/10.1016/j.jss.2019.09.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jss.2019.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jss.2019.09.035%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Surgical%2520Research%26atitle%3DZ-505%25252C%252Ban%252BOral%252BGhrelin%252BReceptor%252BAgonist%25252C%252BAttenuates%252BAnorexia%252BAfter%252BTotal%252BGastrectomy%252Bin%252BRats%26aulast%3DShiomi%26aufirst%3DYoshihiro%26date%3D2020%26volume%3D246%26spage%3D527%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana L.R.  Silva</span>, <span class="hlFld-ContribAuthor ">Paula M.V.  Gama</span>, <span class="hlFld-ContribAuthor ">Maria D.M.C.  Ribeiro da Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Influence of the functional groups −NH
              2
              , −OCH
              3
              , and −OH on the thermochemistry of indanes. </span><span class="cited-content_cbyCitation_journal-name">Canadian Journal of Chemistry</span><span> <strong>2019,</strong> <em>97 </em>
                                    (11)
                                     , 788-794. <a href="https://doi.org/10.1139/cjc-2019-0257" title="DOI URL">https://doi.org/10.1139/cjc-2019-0257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1139/cjc-2019-0257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1139%2Fcjc-2019-0257%26sid%3Dliteratum%253Aachs%26jtitle%3DCanadian%2520Journal%2520of%2520Chemistry%26atitle%3DInfluence%252Bof%252Bthe%252Bfunctional%252Bgroups%252B%2525E2%252588%252592NH%252B2%252B%25252C%252B%2525E2%252588%252592OCH%252B3%252B%25252C%252Band%252B%2525E2%252588%252592OH%252Bon%252Bthe%252Bthermochemistry%252Bof%252Bindanes%26aulast%3DSilva%26aufirst%3DAna%2BL.R.%26date%3D2019%26volume%3D97%26issue%3D11%26spage%3D788%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ze-Nan  Feng</span>, <span class="hlFld-ContribAuthor ">Jin-Yun  Luo</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Guang-Fen  Du</span>, <span class="hlFld-ContribAuthor ">Lin  He</span>. </span><span class="cited-content_cbyCitation_article-title">N-Heterocyclic carbene-catalyzed diastereoselective synthesis of sulfenylated indanes
              via
              sulfa-Michael–Michael (aldol) cascade reactions. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (19)
                                     , 4700-4704. <a href="https://doi.org/10.1039/C9OB00210C" title="DOI URL">https://doi.org/10.1039/C9OB00210C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00210C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00210C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DN-Heterocyclic%252Bcarbene-catalyzed%252Bdiastereoselective%252Bsynthesis%252Bof%252Bsulfenylated%252Bindanes%252Bvia%252Bsulfa-Michael%2525E2%252580%252593Michael%252B%252528aldol%252529%252Bcascade%252Breactions%26aulast%3DFeng%26aufirst%3DZe-Nan%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D19%26spage%3D4700%26epage%3D4704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Initial leads in the indane series <b>1</b>–<b>3</b> and optimized compound <b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Indane Diamino Derivatives <b>4</b>, <b>6</b>, <b>8</b>–<b>21</b>, and <b>51</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt, o/n; (b) MsCl, Et<sub>3</sub>N, DCM, 0° to rt, 3 h; (c) NaN<sub>3</sub>, dry DMF, 90 °C, o/n. (d) H<sub>2</sub>, 10% Pd/C, o/n; (e) RCOOH or 5-methyl-1<i>H</i>-indole-2-carboxylic acid, DIPEA, HOBT, DCM, EDCI, rt; (f) TBDMSOTf, DCM, 6 h, rt; (g) R<sub>1</sub>COOH, HATU, Et<sub>3</sub>N, DMF.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>23</b> (as Representative of the Synthesis of Compounds <b>22</b>–<b>33</b> and <b>35</b>–<b>38</b>) and <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TBDMSOTf, DCM, 6 h, rt; (b) HCHO, MeOH, NaBH<sub>3</sub>CN; (c) Ac<sub>2</sub>O.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of β-Amino Acids Derivatives <b>39</b>–<b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NH<sub>4</sub>OAc, MeOH, 50°; (b) TFA, NaBH<sub>4</sub>, THF; (c) Boc<sub>2</sub>O; (d) MeONa, H<sub>2</sub>O, MeOH; (e) HPLC; (f) N<sub>1</sub>,N<sub>1</sub>-dimethylethane-1,2-diamine or NH<sub>2</sub>R, HATU, Et<sub>3</sub>N, DMF-DCM; (g) HCl, dioxane; (h) chiral HPLC; (i) R<sub>1</sub>COOH, HATU, Et<sub>3</sub>N, DMF-DCM.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Intermediates <b>65a</b> and <b>65b</b> for the Elucidation of the Absolute Configuration of the Indane Compounds <b>39</b>–<b>40</b> through VCD<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chiral HPLC; (b) NHMe<sub>2</sub>, DIPEA, HATU, PyBOP, dry DMF; (c) HCl 4 M in dioxane.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compounds <b>4</b>–<b>7</b> made to assess the desired stereochemistry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Conformation of <b>2</b> mapped into the pharmacophore model. Color spheres illustrate the optimal locations of the three points pharmacophore features: <b>A</b> (basic, red), <b>B</b> (aromatic, amber), and <b>C</b> (H-bond acceptor, green). Only polar hydrogens are illustrated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. SAR around the aminopyridine moiety of compound <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Interactions of compound <b>8</b> with the homology model of ghrelin receptor as structural drivers for full agonism. The binding mode of <b>8</b> was obtained by energy minimization of the complex using the OPLS3 force field.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Residues of human ghrelin receptor within the homology model that interact with compounds <b>8</b> and <b>23</b>. Ionic, polar, charge-reinforced H-bonding, and hydrophobic interactions are shown in red, amber, purple, and green, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Morpholine diamide <b>23</b> and reverse amide <b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Increase in IGF-1 plasma levels (mean ± SEM) from baseline after oral administration of 8 mg/kg of <b>39</b>, 4 mg/kg of <b>22</b>, and 30 μg/kg (iv) of ghrelin, four dogs per group. All compounds caused a significant (<i>p</i> < 0.05) increase in IGF-1 compared to vehicle, 4 and 7 h after administration. <b>39</b> caused a significant IGF-1 increase 24 h after administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/medium/jm-2018-00322e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0009.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Plasma concentration from baseline after oral administration of compound <b>39</b>, 8 mg/kg, and <b>22</b>, 4 mg/kg, <i>n</i> = 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00322/20180719/images/large/jm-2018-00322e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00322&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37624" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37624" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsubara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span> <span> </span><span class="NLM_article-title">Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1016/S0196-9781(01)00633-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2FS0196-9781%2801%2900633-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=11836003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVKrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=531-536&author=I.+Sakataauthor=K.+Nakamuraauthor=M.+Yamazakiauthor=M.+Matsubaraauthor=Y.+Hayashiauthor=K.+Kangawaauthor=T.+Sakai&title=Ghrelin-producing+cells+exist+as+two+types+of+cells%2C+closed-+and+opened-type+cells%2C+in+the+rat+gastrointestinal+tract&doi=10.1016%2FS0196-9781%2801%2900633-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract</span></div><div class="casAuthors">Sakata, Ichiro; Nakamura, Kazuaki; Yamazaki, Mami; Matsubara, Maki; Hayashi, Yuijiro; Kangawa, Kenji; Sakai, Takafumi</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">531-536</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Ghrelin was recently isolated from the rat stomach as an endogenous ligand for the growth-hormone secretagogue receptor (GHS-R) and is known to exist in the gastrointestinal tract and hypothalamus.  In this study, the authors investigated in detail the distribution and morphol. characteristics of ghrelin-contg. cells (ghrelin cells) in the gastrointestinal tract by immunohistochem. and in situ hybridization.  Ghrelin cells were found to be localized in the mucous membrane of the stomach, duodenum, ileum, cecum and colon but not in myenteric plexus, and they can be classified into open- and closed-type cells.  The greatest no. of ghrelin cells was found in the stomach, and it was found that the no. of the opened-type cells gradually increased in the direction from stomach to the lower gastrointestinal tract.  These results suggest that the two types of ghrelin cells may be distinctly regulated and play different physiol. roles in various regions of the gastrointestinal tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPPBfgaJT_67Vg90H21EOLACvtfcHk0lgQON2Uuc27NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVKrsb8%253D&md5=1624e2c509d4cc8f7711834a18c09877</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2801%2900633-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252801%252900633-7%26sid%3Dliteratum%253Aachs%26aulast%3DSakata%26aufirst%3DI.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DMatsubara%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKangawa%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DT.%26atitle%3DGhrelin-producing%2520cells%2520exist%2520as%2520two%2520types%2520of%2520cells%252C%2520closed-%2520and%2520opened-type%2520cells%252C%2520in%2520the%2520rat%2520gastrointestinal%2520tract%26jtitle%3DPeptides%26date%3D2002%26volume%3D23%26spage%3D531%26epage%3D536%26doi%3D10.1016%2FS0196-9781%2801%2900633-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
der Lely, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschöp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, E.</span></span> <span> </span><span class="NLM_article-title">Biological, physiological, pathophysiological and pharmacological aspects of ghrelin</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">426</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1210/er.2002-0029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1210%2Fer.2002-0029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=15180951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVeltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=426-457&issue=3&author=A.+J.+Van%0Ader+Lelyauthor=M.+Tsch%C3%B6pauthor=M.+L.+Heimanauthor=E.+Ghigo&title=Biological%2C+physiological%2C+pathophysiological+and+pharmacological+aspects+of+ghrelin&doi=10.1210%2Fer.2002-0029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin</span></div><div class="casAuthors">van der Lely, Aart J.; Tschop, Matthias; Heiman, Mark L.; Ghigo, Ezio</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">426-457</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Ghrelin is a peptide predominantly produced by the stomach.  Ghrelin displays strong GH-releasing activity.  This activity is mediated by the activation of the so-called GH secretagogue receptor type 1a.  This receptor had been shown to be specific for a family of synthetic, peptidyl and nonpeptidyl GH secretagogues.  Apart from a potent GH-releasing action, ghrelin has other activities including stimulation of lactotroph and corticotroph function, influence on the pituitary gonadal axis, stimulation of appetite, control of energy balance, influence on sleep and behavior, control of gastric motility and acid secretion, and influence on pancreatic exocrine and endocrine function as well as on glucose metab.  Cardiovascular actions and modulation of proliferation of neoplastic cells, as well as of the immune system, are other actions of ghrelin.  Therefore, we consider ghrelin a gastrointestinal peptide contributing to the regulation of diverse functions of the gut-brain axis.  So, there is indeed a possibility that ghrelin analogs, acting as either agonists or antagonists, might have clin. impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW0mquUT4pvrVg90H21EOLACvtfcHk0lijKq5UOTrelg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVeltLo%253D&md5=7e7338e11cd64c0cc3f7d4aa6ace75e1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1210%2Fer.2002-0029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2002-0029%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BLely%26aufirst%3DA.%2BJ.%26aulast%3DTsch%25C3%25B6p%26aufirst%3DM.%26aulast%3DHeiman%26aufirst%3DM.%2BL.%26aulast%3DGhigo%26aufirst%3DE.%26atitle%3DBiological%252C%2520physiological%252C%2520pathophysiological%2520and%2520pharmacological%2520aspects%2520of%2520ghrelin%26jtitle%3DEndocr.%2520Rev.%26date%3D2004%26volume%3D25%26issue%3D3%26spage%3D426%26epage%3D457%26doi%3D10.1210%2Fer.2002-0029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagaya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uematsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyatake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span> <span> </span><span class="NLM_article-title">Treatment of cachexia with ghrelin in patients with COPD</span>. <i>Chest</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1187</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1378/chest.128.3.1187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1378%2Fchest.128.3.1187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=16162705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2005&pages=1187-1193&issue=3&author=N.+Nagayaauthor=T.+Itohauthor=S.+Murakamiauthor=H.+Oyaauthor=M.+Uematsuauthor=K.+Miyatakeauthor=K.+Kangawa&title=Treatment+of+cachexia+with+ghrelin+in+patients+with+COPD&doi=10.1378%2Fchest.128.3.1187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of cachexia with ghrelin in patients with COPD</span></div><div class="casAuthors">Nagaya, Noritoshi; Itoh, Takefumi; Murakami, Shinsuke; Oya, Hideo; Uematsu, Masaaki; Miyatake, Kunio; Kangawa, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Chest</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1187-1193</span>CODEN:
                <span class="NLM_cas:coden">CHETBF</span>;
        ISSN:<span class="NLM_cas:issn">0012-3692</span>.
    
            (<span class="NLM_cas:orgname">American College of Chest Physicians</span>)
        </div><div class="casAbstract">Study objectives: Ghrelin is a novel growth hormone (GH)-releasing peptide that also induces a pos. energy balance by decreasing fat utility and stimulating feeding through GH-independent mechanisms.  We investigated whether ghrelin improves cachexia and functional capacity in patients with COPD.  Methods: This is an open-label pilot study.  Human ghrelin (2 μg/kg bid) was IV administered to seven cachectic patients with COPD for 3 wk.  Food intake, body compn., muscle strength, exercise capacity, pulmonary function, and sympathetic nerve activity were examd. before and after ghrelin therapy.  Results: A single administration of ghrelin markedly increased serum GH (21-fold).  Three-week treatment with ghrelin resulted in a significant increase in mean (± SEM) body wt. (49.3 ± 3.6 to 50.3 ± 3.8 kg; p < 0.05).  Food intake was significantly increased during ghrelin therapy.  Ghrelin increased lean body mass and peripheral and respiratory muscle strength.  Ghrelin significantly increased Karnofsky performance status score and the distance walked in 6 min (370 ± 30 to 432 ± 35 m; p < 0.05), although it did not significantly alter pulmonary function.  Ghrelin attenuated the exaggerated sympathetic nerve activity, as indicated by a marked decrease in plasma norepinephrine level (889 ± 123 to 597 ± 116 pg/mL; p < 0.05).  Conclusions: These preliminary results suggest that repeated administration of ghrelin improves body compn., muscle wasting, functional capacity, and sympathetic augmentation in cachectic patients with COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH00rMa5X4DbVg90H21EOLACvtfcHk0lijKq5UOTrelg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVWjtw%253D%253D&md5=5b4232ebb551a421f3111d0492521bef</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1378%2Fchest.128.3.1187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1378%252Fchest.128.3.1187%26sid%3Dliteratum%253Aachs%26aulast%3DNagaya%26aufirst%3DN.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DS.%26aulast%3DOya%26aufirst%3DH.%26aulast%3DUematsu%26aufirst%3DM.%26aulast%3DMiyatake%26aufirst%3DK.%26aulast%3DKangawa%26aufirst%3DK.%26atitle%3DTreatment%2520of%2520cachexia%2520with%2520ghrelin%2520in%2520patients%2520with%2520COPD%26jtitle%3DChest%26date%3D2005%26volume%3D128%26issue%3D3%26spage%3D1187%26epage%3D1193%26doi%3D10.1378%2Fchest.128.3.1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levinson, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertner, J.</span></span> <span> </span><span class="NLM_article-title">Randomized study of the efficacy and safety of SUN11031 (synthetic human ghrelin) in cachexia associated with chronic obstructive pulmonary disease</span>. <i>e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e171</span>– <span class="NLM_lpage">e175</span>, <span class="refDoi"> DOI: 10.1016/j.clnme.2012.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2Fj.clnme.2012.07.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e171-e175&author=B.+G.+Levinsonauthor=J.+Gertner&title=Randomized+study+of+the+efficacy+and+safety+of+SUN11031+%28synthetic+human+ghrelin%29+in+cachexia+associated+with+chronic+obstructive+pulmonary+disease&doi=10.1016%2Fj.clnme.2012.07.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.clnme.2012.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clnme.2012.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DLevinson%26aufirst%3DB.%2BG.%26aulast%3DGertner%26aufirst%3DJ.%26atitle%3DRandomized%2520study%2520of%2520the%2520efficacy%2520and%2520safety%2520of%2520SUN11031%2520%2528synthetic%2520human%2520ghrelin%2529%2520in%2520cachexia%2520associated%2520with%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3De-SPEN%252C%2520the%2520European%2520e-Journal%2520of%2520Clinical%2520Nutrition%2520and%2520Metabolism%26date%3D2012%26volume%3D7%26spage%3De171%26epage%3De175%26doi%3D10.1016%2Fj.clnme.2012.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagaya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uematsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Date, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yutani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span> <span> </span><span class="NLM_article-title">Elevated circulating level of ghrelin in cachexia associated with chronic heart failure. Relationships between ghrelin and anabolic/catabolic factors</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">2034</span>– <span class="NLM_lpage">2038</span>, <span class="refDoi"> DOI: 10.1161/hc4201.097836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1161%2Fhc4201.097836" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=2034-2038&author=N.+Nagayaauthor=M.+Uematsuauthor=M.+Kojimaauthor=Y.+Dateauthor=M.+Nakazatoauthor=H.+Okumuraauthor=H.+Hosodaauthor=W.+Shimizuauthor=M.+Yamagishiauthor=H.+Oyaauthor=H.+Kohauthor=C.+Yutaniauthor=K.+Kangawa&title=Elevated+circulating+level+of+ghrelin+in+cachexia+associated+with+chronic+heart+failure.+Relationships+between+ghrelin+and+anabolic%2Fcatabolic+factors&doi=10.1161%2Fhc4201.097836"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1161%2Fhc4201.097836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252Fhc4201.097836%26sid%3Dliteratum%253Aachs%26aulast%3DNagaya%26aufirst%3DN.%26aulast%3DUematsu%26aufirst%3DM.%26aulast%3DKojima%26aufirst%3DM.%26aulast%3DDate%26aufirst%3DY.%26aulast%3DNakazato%26aufirst%3DM.%26aulast%3DOkumura%26aufirst%3DH.%26aulast%3DHosoda%26aufirst%3DH.%26aulast%3DShimizu%26aufirst%3DW.%26aulast%3DYamagishi%26aufirst%3DM.%26aulast%3DOya%26aufirst%3DH.%26aulast%3DKoh%26aufirst%3DH.%26aulast%3DYutani%26aufirst%3DC.%26aulast%3DKangawa%26aufirst%3DK.%26atitle%3DElevated%2520circulating%2520level%2520of%2520ghrelin%2520in%2520cachexia%2520associated%2520with%2520chronic%2520heart%2520failure.%2520Relationships%2520between%2520ghrelin%2520and%2520anabolic%252Fcatabolic%2520factors%26jtitle%3DCirculation%26date%3D2001%26volume%3D104%26spage%3D2034%26epage%3D2038%26doi%3D10.1161%2Fhc4201.097836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akamizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irako, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teramukai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokode, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics, safety and endocrine and appetite effects of ghrelin administration in young healthy subjects</span>. <i>Eur. J. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>150</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">455</span>, <span class="refDoi"> DOI: 10.1530/eje.0.1500447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1530%2Feje.0.1500447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=15080773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFCjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2004&pages=447-455&issue=4&author=T.+Akamizuauthor=K.+Takayaauthor=T.+Irakoauthor=H.+Hosodaauthor=S.+Teramukaiauthor=A.+Matsuyamaauthor=H.+Tadaauthor=K.+Miuraauthor=A.+Shimizuauthor=M.+Fukushimaauthor=M.+Yokodeauthor=K.+Tanakaauthor=K.+Kangawa&title=Pharmacokinetics%2C+safety+and+endocrine+and+appetite+effects+of+ghrelin+administration+in+young+healthy+subjects&doi=10.1530%2Feje.0.1500447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects</span></div><div class="casAuthors">Akamizu, Takashi; Takaya, Kazuhiko; Irako, Taiga; Hosoda, Hiroshi; Teramukai, Satoshi; Matsuyama, Akiko; Tada, Harue; Miura, Kazumi; Shimizu, Akira; Fukushima, Masanori; Yokode, Masayuki; Tanaka, Koichi; Kangawa, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">447-455</span>CODEN:
                <span class="NLM_cas:coden">EJOEEP</span>;
        ISSN:<span class="NLM_cas:issn">0804-4643</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">It has been demonstrated that ghrelin plays a major role in the regulation of GH secretion and food intake.  These actions make ghrelin a strong candidate for the treatment of GH deficiency, anorexia and cachexia.  However, only preliminary studies have been performed to assess ghrelin administration in humans.  In this study, the authors have conducted a double-blind, randomized, placebo-controlled trial to investigate the pharmacokinetics, safety, and endocrine and appetite effects of ghrelin in young healthy volunteers.  Eighteen male volunteers were randomly assigned into three groups of six subjects: low- and high-dose ghrelin groups, who received i.v. injections of 1 and 5 μg/kg ghrelin (acylated form) resp., and a placebo group who were injected with mannitol instead of ghrelin.  Acylated ghrelin disappeared more rapidly from plasma than total ghrelin, with elimination half life (t1/2) of 9-13 and 27-31 min resp.  The no. of subjects that experienced adverse effects did not significantly differ among the three groups, and all adverse effects were transient and well tolerated.  Both the low and high doses of ghrelin strongly stimulated GH release (peak plasma concn. (Cmax,0-90 min); 124.2±63.9 and 153.2±52.2 ng/mL for 1 and 5 μg/kg ghrelin resp.).  Slight alterations of blood glucose and insulin levels after the injection were obsd.  Although not statistically significant, ghrelin administration tended to increase hunger sensation in a dose-dependent manner.  These results suggest that ghrelin is safe, and that clin. trials may be started to assess the usefulness of ghrelin for the treatment of disorders related to GH secretion and appetite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDz8K2EJAB7LVg90H21EOLACvtfcHk0lggQtGQclHjsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFCjt78%253D&md5=f996384f5d1006b4c305079224d8404d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1530%2Feje.0.1500447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252Feje.0.1500447%26sid%3Dliteratum%253Aachs%26aulast%3DAkamizu%26aufirst%3DT.%26aulast%3DTakaya%26aufirst%3DK.%26aulast%3DIrako%26aufirst%3DT.%26aulast%3DHosoda%26aufirst%3DH.%26aulast%3DTeramukai%26aufirst%3DS.%26aulast%3DMatsuyama%26aufirst%3DA.%26aulast%3DTada%26aufirst%3DH.%26aulast%3DMiura%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DA.%26aulast%3DFukushima%26aufirst%3DM.%26aulast%3DYokode%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKangawa%26aufirst%3DK.%26atitle%3DPharmacokinetics%252C%2520safety%2520and%2520endocrine%2520and%2520appetite%2520effects%2520of%2520ghrelin%2520administration%2520in%2520young%2520healthy%2520subjects%26jtitle%3DEur.%2520J.%2520Endocrinol.%26date%3D2004%26volume%3D150%26issue%3D4%26spage%3D447%26epage%3D455%26doi%3D10.1530%2Feje.0.1500447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefker, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toler, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadcock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Brino, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNinno, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidsey-Frink, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hada, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inthavongsay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangano, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirie, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tess, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawistoski, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva-Jardine, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and biological characterization of Capromorelin analogues with extended half-lives</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3279</span>– <span class="NLM_lpage">3282</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00734-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2FS0960-894X%2802%2900734-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3279-3282&author=P.+A.+Carpinoauthor=B.+A.+Lefkerauthor=S.+M.+Tolerauthor=L.+C.+Panauthor=J.+R.+Hadcockauthor=M.+C.+Murrayauthor=E.+R.+Cookauthor=J.+N.+Di+Brinoauthor=S.+L.+DeNinnoauthor=K.+L.+Chidsey-Frinkauthor=W.+A.+Hadaauthor=J.+Inthavongsayauthor=S.+K.+Lewisauthor=F.+M.+Manganoauthor=M.+A.+Mullinsauthor=D.+F.+Nickersonauthor=O.+Ngauthor=C.+M.+Pirieauthor=J.+A.+Raganauthor=C.+R.+Roseauthor=D.+A.+Tessauthor=A.+S.+Wrightauthor=L.+Yuauthor=M.+P.+Zawistoskiauthor=J.+C.+Pettersenauthor=P.+A.+DaSilva-Jardineauthor=T.+C.+Wilsonauthor=D.+D.+Thompson&title=Discovery+and+biological+characterization+of+Capromorelin+analogues+with+extended+half-lives&doi=10.1016%2FS0960-894X%2802%2900734-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900734-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900734-5%26sid%3Dliteratum%253Aachs%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DToler%26aufirst%3DS.%2BM.%26aulast%3DPan%26aufirst%3DL.%2BC.%26aulast%3DHadcock%26aufirst%3DJ.%2BR.%26aulast%3DMurray%26aufirst%3DM.%2BC.%26aulast%3DCook%26aufirst%3DE.%2BR.%26aulast%3DDi%2BBrino%26aufirst%3DJ.%2BN.%26aulast%3DDeNinno%26aufirst%3DS.%2BL.%26aulast%3DChidsey-Frink%26aufirst%3DK.%2BL.%26aulast%3DHada%26aufirst%3DW.%2BA.%26aulast%3DInthavongsay%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DS.%2BK.%26aulast%3DMangano%26aufirst%3DF.%2BM.%26aulast%3DMullins%26aufirst%3DM.%2BA.%26aulast%3DNickerson%26aufirst%3DD.%2BF.%26aulast%3DNg%26aufirst%3DO.%26aulast%3DPirie%26aufirst%3DC.%2BM.%26aulast%3DRagan%26aufirst%3DJ.%2BA.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DZawistoski%26aufirst%3DM.%2BP.%26aulast%3DPettersen%26aufirst%3DJ.%2BC.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%2BA.%26aulast%3DWilson%26aufirst%3DT.%2BC.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520and%2520biological%2520characterization%2520of%2520Capromorelin%2520analogues%2520with%2520extended%2520half-lives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3279%26epage%3D3282%26doi%3D10.1016%2FS0960-894X%2802%2900734-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tata, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. W.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleim, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patchett, A. A.</span></span> <span> </span><span class="NLM_article-title">Highly potent growth hormone secretagogues</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3657</span>– <span class="NLM_lpage">3659</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.04.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2Fj.bmcl.2007.04.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3657-3659&author=Z.+Luauthor=J.+R.+Tataauthor=K.+Chengauthor=L.+Weiauthor=W.+W.-S.+Chanauthor=B.+Butlerauthor=K.+D.+Schleimauthor=T.+M.+Jacksauthor=G.+Hickeyauthor=A.+A.+Patchett&title=Highly+potent+growth+hormone+secretagogues&doi=10.1016%2Fj.bmcl.2007.04.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.04.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.04.050%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DW.%2BW.-S.%26aulast%3DButler%26aufirst%3DB.%26aulast%3DSchleim%26aufirst%3DK.%2BD.%26aulast%3DJacks%26aufirst%3DT.%2BM.%26aulast%3DHickey%26aufirst%3DG.%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26atitle%3DHighly%2520potent%2520growth%2520hormone%2520secretagogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3657%26epage%3D3659%26doi%3D10.1016%2Fj.bmcl.2007.04.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefker, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toler, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadcock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiBrino, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campeta, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNinno, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidsey-Frink, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hada, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inthavongsay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangano, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirie, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tess, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawistoski, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva-Jardine, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D. D.</span></span> <span> </span><span class="NLM_article-title">Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs): Discovery of Capromorelin</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(02)00433-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2FS0968-0896%2802%2900433-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=581-590&author=P.+A.+Carpinoauthor=B.+A.+Lefkerauthor=S.+M.+Tolerauthor=L.+C.+Panauthor=J.+R.+Hadcockauthor=E.+R.+Cookauthor=J.+N.+DiBrinoauthor=A.+M.+Campetaauthor=S.+L.+DeNinnoauthor=K.+L.+Chidsey-Frinkauthor=W.+A.+Hadaauthor=J.+Inthavongsayauthor=F.+M.+Manganoauthor=M.+A.+Mullinsauthor=D.+F.+Nickersonauthor=O.+Ngauthor=C.+M.+Pirieauthor=J.+A.+Raganauthor=C.+R.+Roseauthor=D.+A.+Tessauthor=A.+S.+Wrightauthor=L.+Yuauthor=M.+P.+Zawistoskiauthor=P.+A.+DaSilva-Jardineauthor=T.+C.+Wilsonauthor=D.+D.+Thompson&title=Pyrazolinone-piperidine+dipeptide+growth+hormone+secretagogues+%28GHSs%29%3A+Discovery+of+Capromorelin&doi=10.1016%2FS0968-0896%2802%2900433-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900433-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900433-9%26sid%3Dliteratum%253Aachs%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DToler%26aufirst%3DS.%2BM.%26aulast%3DPan%26aufirst%3DL.%2BC.%26aulast%3DHadcock%26aufirst%3DJ.%2BR.%26aulast%3DCook%26aufirst%3DE.%2BR.%26aulast%3DDiBrino%26aufirst%3DJ.%2BN.%26aulast%3DCampeta%26aufirst%3DA.%2BM.%26aulast%3DDeNinno%26aufirst%3DS.%2BL.%26aulast%3DChidsey-Frink%26aufirst%3DK.%2BL.%26aulast%3DHada%26aufirst%3DW.%2BA.%26aulast%3DInthavongsay%26aufirst%3DJ.%26aulast%3DMangano%26aufirst%3DF.%2BM.%26aulast%3DMullins%26aufirst%3DM.%2BA.%26aulast%3DNickerson%26aufirst%3DD.%2BF.%26aulast%3DNg%26aufirst%3DO.%26aulast%3DPirie%26aufirst%3DC.%2BM.%26aulast%3DRagan%26aufirst%3DJ.%2BA.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DZawistoski%26aufirst%3DM.%2BP.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%2BA.%26aulast%3DWilson%26aufirst%3DT.%2BC.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DPyrazolinone-piperidine%2520dipeptide%2520growth%2520hormone%2520secretagogues%2520%2528GHSs%2529%253A%2520Discovery%2520of%2520Capromorelin%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D581%26epage%3D590%26doi%3D10.1016%2FS0968-0896%2802%2900433-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrie, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landschulz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyles, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvatori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ettinger, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morey, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merriam, G. R.</span></span> <span> </span><span class="NLM_article-title">Effects of an oral growth hormone secretagogue in older adults</span>. <i>J. Clin. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1198</span>– <span class="NLM_lpage">1206</span>, <span class="refDoi"> DOI: 10.1210/jc.2008-0632</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1210%2Fjc.2008-0632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=19174493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksFaitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2009&pages=1198-1206&issue=4&author=H.+K.+Whiteauthor=C.+D.+Petrieauthor=W.+Landschulzauthor=D.+MacLeanauthor=A.+Taylorauthor=K.+Lylesauthor=J.+Y.+Weiauthor=A.+R.+Hoffmanauthor=R.+Salvatoriauthor=M.+P.+Ettingerauthor=M.+C.+Moreyauthor=M.+R.+Blackmanauthor=G.+R.+Merriam&title=Effects+of+an+oral+growth+hormone+secretagogue+in+older+adults&doi=10.1210%2Fjc.2008-0632"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of an oral growth hormone secretagogue in older adults</span></div><div class="casAuthors">White, Heidi K.; Petrie, Charles D.; Landschulz, William; MacLean, David; Taylor, Ann; Lyles, Kenneth; Wei, Jeanne Y.; Hoffman, Andrew R.; Salvatori, Roberto; Ettinger, Mark P.; Morey, Miriam C.; Blackman, Marc R.; Merriam, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1198-1206</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">GH secretion declines with age, possibly contributing to reduced muscle mass, strength, and function.  GH secretagogues (GHS) may increase muscle mass and phys. performance.  We conducted a randomized, double-masked, placebo-controlled, multicenter study to investigate the hormonal, body compn., and phys. performance effects and the safety of the orally active GHS capromorelin in older adults with mild functional limitation.  A total of 395 men and women aged 65-84 yr were randomized for an intended 2 yr of treatment to 4 dosing groups (10 mg 3 times/wk, 3 mg twice a day, 10 mg each night, and 10 mg twice a day) or placebo.  Although the study was terminated early according to predetd. treatment effect criteria, 315 subjects completed 6 mo of treatment, and 284 completed 12 mo.  A sustained dose-related rise in IGF-I concns. occurred in all active treatment groups.  Each capromorelin dose prompted a rise in peak nocturnal GH, which was greatest with the least frequent dosing.  At 6 mo, body wt. increased 1.4 kg in subjects receiving capromorelin and decreased 0.2 kg in those receiving placebo (P = 0.006).  Lean body mass increased 1.4 vs. 0.3 kg (P = 0.001), and tandem walk improved by 0.9 s (P = 0.02) in the pooled treatment vs. placebo groups.  By 12 mo, stair climb also improved (P = 0.04).  Adverse events included fatigue, insomnia, and small increases in fasting glucose, glycosylated Hb, and indexes of insulin resistance.  In healthy older adults at risk for functional decline, administration of the oral GHS capromorelin may improve body compn. and phys. function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqczWQ76h4JqLVg90H21EOLACvtfcHk0lg4K1z1CPuOUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksFaitLw%253D&md5=388a1c72bcd27165ea3eb0901b90f1d1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1210%2Fjc.2008-0632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2008-0632%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DH.%2BK.%26aulast%3DPetrie%26aufirst%3DC.%2BD.%26aulast%3DLandschulz%26aufirst%3DW.%26aulast%3DMacLean%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DLyles%26aufirst%3DK.%26aulast%3DWei%26aufirst%3DJ.%2BY.%26aulast%3DHoffman%26aufirst%3DA.%2BR.%26aulast%3DSalvatori%26aufirst%3DR.%26aulast%3DEttinger%26aufirst%3DM.%2BP.%26aulast%3DMorey%26aufirst%3DM.%2BC.%26aulast%3DBlackman%26aufirst%3DM.%2BR.%26aulast%3DMerriam%26aufirst%3DG.%2BR.%26atitle%3DEffects%2520of%2520an%2520oral%2520growth%2520hormone%2520secretagogue%2520in%2520older%2520adults%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2009%26volume%3D94%26issue%3D4%26spage%3D1198%26epage%3D1206%26doi%3D10.1210%2Fjc.2008-0632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patchett, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nargund, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tata, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barakat, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, D. B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. W.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pong, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaung, L.-Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frazier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, S.-H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. G.</span></span> <span> </span><span class="NLM_article-title">Design and biological activity of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">7001</span>– <span class="NLM_lpage">7005</span>, <span class="refDoi"> DOI: 10.1073/pnas.92.15.7001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1073%2Fpnas.92.15.7001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=7001-7005&author=A.+A.+Patchettauthor=R.+P.+Nargundauthor=J.+R.+Tataauthor=M.-H.+Chenauthor=K.+J.+Barakatauthor=D.+B.+R.+Johnstonauthor=K.+Chengauthor=W.+W.-S.+Chanauthor=B.+Butlerauthor=G.+Hickeyauthor=T.+Jacksauthor=K.+Schleimauthor=S.-S.+Pongauthor=L.-Y.+P.+Chaungauthor=H.+Y.+Chenauthor=E.+Frazierauthor=K.+H.+Leungauthor=S.-H.+L.+Chiuauthor=R.+G.+Smith&title=Design+and+biological+activity+of+L-163%2C191+%28MK-0677%29%3A+a+potent%2C+orally+active+growth+hormone+secretagogue&doi=10.1073%2Fpnas.92.15.7001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.15.7001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.15.7001%26sid%3Dliteratum%253Aachs%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DM.-H.%26aulast%3DBarakat%26aufirst%3DK.%2BJ.%26aulast%3DJohnston%26aufirst%3DD.%2BB.%2BR.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DW.%2BW.-S.%26aulast%3DButler%26aufirst%3DB.%26aulast%3DHickey%26aufirst%3DG.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DSchleim%26aufirst%3DK.%26aulast%3DPong%26aufirst%3DS.-S.%26aulast%3DChaung%26aufirst%3DL.-Y.%2BP.%26aulast%3DChen%26aufirst%3DH.%2BY.%26aulast%3DFrazier%26aufirst%3DE.%26aulast%3DLeung%26aufirst%3DK.%2BH.%26aulast%3DChiu%26aufirst%3DS.-H.%2BL.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26atitle%3DDesign%2520and%2520biological%2520activity%2520of%2520L-163%252C191%2520%2528MK-0677%2529%253A%2520a%2520potent%252C%2520orally%2520active%2520growth%2520hormone%2520secretagogue%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D7001%26epage%3D7005%26doi%3D10.1073%2Fpnas.92.15.7001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nass, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzoli, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveri, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrie, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrell, F. E.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clasey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymsfield, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorner, M. O.</span></span> <span> </span><span class="NLM_article-title">Effects of an oral ghrelin mimetic on body composition and clinical outcome in healthy older adults: a randomized, controlled trial</span>. <i>Ann. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>149</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">611</span>, <span class="refDoi"> DOI: 10.7326/0003-4819-149-9-200811040-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.7326%2F0003-4819-149-9-200811040-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=18981485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A280%3ADC%252BD1cjhsVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2008&pages=601-611&issue=9&author=R.+Nassauthor=S.+S.+Pezzoliauthor=M.+C.+Oliveriauthor=J.+T.+Patrieauthor=F.+E.+Harrellauthor=J.+L.+Claseyauthor=S.+B.+Heymsfieldauthor=M.+A.+Bachauthor=M.+L.+Vanceauthor=M.+O.+Thorner&title=Effects+of+an+oral+ghrelin+mimetic+on+body+composition+and+clinical+outcome+in+healthy+older+adults%3A+a+randomized%2C+controlled+trial&doi=10.7326%2F0003-4819-149-9-200811040-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial</span></div><div class="casAuthors">Nass Ralf; Pezzoli Suzan S; Oliveri Mary Clancy; Patrie James T; Harrell Frank E Jr; Clasey Jody L; Heymsfield Steven B; Bach Mark A; Vance Mary Lee; Thorner Michael O</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">601-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Growth hormone secretion and muscle mass decline from midpuberty throughout life, culminating in sarcopenia, frailty, decreased function, and loss of independence.  The decline of growth hormone in the development of sarcopenia is one of many factors, and its etiologic role needs to be demonstrated.  OBJECTIVE:  To determine whether MK-677, an oral ghrelin mimetic, increases growth hormone secretion into the young-adult range without serious adverse effects, prevents the decline of fat-free mass, and decreases abdominal visceral fat in healthy older adults.  DESIGN:  2-year, double-blind, randomized, placebo-controlled, modified-crossover clinical trial.  SETTING:  General clinical research center study performed at a university hospital.  PARTICIPANTS:  65 healthy adults (men, women receiving hormone replacement therapy, and women not receiving hormone replacement therapy) ranging from 60 to 81 years of age.  INTERVENTION:  Oral administration of MK-677, 25 mg, or placebo once daily.  MEASUREMENTS:  Growth hormone and insulin-like growth factor I levels.  Fat-free mass and abdominal visceral fat were the primary end points after 1 year of treatment.  Other end points were body weight, fat mass, insulin sensitivity, lipid and cortisol levels, bone mineral density, limb lean and fat mass, isokinetic strength, function, and quality of life.  All end points were assessed at baseline and every 6 months.  RESULTS:  Daily administration of MK-677 significantly increased growth hormone and insulin-like growth factor I levels to those of healthy young adults without serious adverse effects.  Mean fat-free mass decreased in the placebo group but increased in the MK-677 group (change, -0.5 kg [95% CI, -1.1 to 0.2 kg] vs. 1.1 kg [CI, 0.7 to 1.5 kg], respectively; P < 0.001), as did body cell mass, as reflected by intracellular water (change, -1.0 kg [CI, -2.1 to 0.2 kg] vs. 0.8 kg [CI, -0.1 to 1.6 kg], respectively; P = 0.021).  No significant differences were observed in abdominal visceral fat or total fat mass; however, the average increase in limb fat was greater in the MK-677 group than the placebo group (1.1 kg vs. 0.24 kg; P = 0.001).  Body weight increased 0.8 kg (CI, -0.3 to 1.8 kg) in the placebo group and 2.7 kg (CI, 2.0 to 3.5 kg) in the MK-677 group (P = 0.003).  Fasting blood glucose level increased an average of 0.3 mmol/L (5 mg/dL) in the MK-677 group (P = 0.015), and insulin sensitivity decreased.  The most frequent side effects were an increase in appetite that subsided in a few months and transient, mild lower-extremity edema and muscle pain.  Low-density lipoprotein cholesterol levels decreased in the MK-677 group relative to baseline values (change, -0.14 mmol/L [CI, -0.27 to -0.01 mmol/L]; -5.4 mg/dL [CI, -10.4 to -0.4 mg/dL]; P = 0.026); no differences between groups were observed in total or high-density lipoprotein cholesterol levels.  Cortisol levels increased 47 nmol/L (CI, 28 to 71 nmol/L (1.7 microg/dL [CI, 1.0 to 2.6 microg/dL]) in MK-677 recipients (P = 0.020).  Changes in bone mineral density consistent with increased bone remodeling occurred in MK-677 recipients.  Increased fat-free mass did not result in changes in strength or function.  Two-year exploratory analyses confirmed the 1-year results.  LIMITATION:  Study power (duration and participant number) was insufficient to evaluate functional end points in healthy elderly persons.  CONCLUSION:  Over 12 months, the ghrelin mimetic MK-677 enhanced pulsatile growth hormone secretion, significantly increased fat-free mass, and was generally well tolerated.  Long-term functional and, ultimately, pharmacoeconomic, studies in elderly persons are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAHfxTSIWuaP6AExegM5LLfW6udTcc2eYdc7cS4uNt7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjhsVKmsw%253D%253D&md5=9224c8e5ea5e35a36d3cfb5d17d65673</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-149-9-200811040-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-149-9-200811040-00003%26sid%3Dliteratum%253Aachs%26aulast%3DNass%26aufirst%3DR.%26aulast%3DPezzoli%26aufirst%3DS.%2BS.%26aulast%3DOliveri%26aufirst%3DM.%2BC.%26aulast%3DPatrie%26aufirst%3DJ.%2BT.%26aulast%3DHarrell%26aufirst%3DF.%2BE.%26aulast%3DClasey%26aufirst%3DJ.%2BL.%26aulast%3DHeymsfield%26aufirst%3DS.%2BB.%26aulast%3DBach%26aufirst%3DM.%2BA.%26aulast%3DVance%26aufirst%3DM.%2BL.%26aulast%3DThorner%26aufirst%3DM.%2BO.%26atitle%3DEffects%2520of%2520an%2520oral%2520ghrelin%2520mimetic%2520on%2520body%2520composition%2520and%2520clinical%2520outcome%2520in%2520healthy%2520older%2520adults%253A%2520a%2520randomized%252C%2520controlled%2520trial%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2008%26volume%3D149%26issue%3D9%26spage%3D601%26epage%3D611%26doi%3D10.7326%2F0003-4819-149-9-200811040-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, J. M.</span></span> <span> </span><span class="NLM_article-title">Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1245</span>– <span class="NLM_lpage">1253</span>, <span class="refDoi"> DOI: 10.1517/14656566.2015.1041500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1517%2F14656566.2015.1041500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=25945893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFGmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=1245-1253&issue=8&author=H.+Zhangauthor=J.+M.+Garcia&title=Anamorelin+hydrochloride+for+the+treatment+of+cancer-anorexia-cachexia+in+NSCLC&doi=10.1517%2F14656566.2015.1041500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC</span></div><div class="casAuthors">Zhang, Hongjie; Garcia, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1245-1253</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction:Cancer anorexia-cachexia syndrome (CACS) is assocd. with increased morbidity and mortality.  Anamorelin is a novel, orally active ghrelin receptor agonist in clin. development for the treatment of CACS in NSCLC.  The aim of this review is to summarize preclin. and clin. studies evaluating anamorelin as a potential promising treatment for CACS in NSCLC.  Areas covered: Pharmacodynamics, pharmacokinetics and metab., clin. efficacy, safety and tolerability of anamorelin for the treatment of CACS in NSCLC were reviewed.  Anamorelin administration may lead to increases in food intake, body wt. and lean body mass, and a stimulatory effect on growth hormone secretion in NSCLC patients.  Anamorelin is well tolerated with no dose-limiting toxicities identified to date.  Expert opinion:Targeting ghrelin receptors presents the advantage of potentially addressing multiple mechanisms of CACS simultaneously including appetite, muscle protein balance, adipose tissue metab., energy expenditure and inflammation.  Clin. data suggest that anamorelin is well tolerated and it effectively increases appetite, body wt. and lean mass in patients with advanced NSCLC.  Long-term safety remains unknown at this time.  The potential synergistic effects of anamorelin with nutritional support or exercise as well as its efficacy/safety in other tumor types are also unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYCRzru9R_kLVg90H21EOLACvtfcHk0ljZIdUgrJ249Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFGmurs%253D&md5=11e0d44287432275d49e23156733f902</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1517%2F14656566.2015.1041500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2015.1041500%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGarcia%26aufirst%3DJ.%2BM.%26atitle%3DAnamorelin%2520hydrochloride%2520for%2520the%2520treatment%2520of%2520cancer-anorexia-cachexia%2520in%2520NSCLC%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2015%26volume%3D16%26issue%3D8%26spage%3D1245%26epage%3D1253%26doi%3D10.1517%2F14656566.2015.1041500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Currow, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skipworth, R. J.</span></span> <span> </span><span class="NLM_article-title">The emerging role of Anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia</span>. <i>Future Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">1767</span>– <span class="NLM_lpage">1783</span>, <span class="refDoi"> DOI: 10.2217/fon-2017-0141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.2217%2Ffon-2017-0141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=28621564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2gs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=1767-1783&issue=20&author=D.+C.+Currowauthor=R.+J.+Skipworth&title=The+emerging+role+of+Anamorelin+hydrochloride+in+the+management+of+patients+with+cancer+anorexia-cachexia&doi=10.2217%2Ffon-2017-0141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia</span></div><div class="casAuthors">Currow, David C.; Skipworth, Richard J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1767-1783</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1744-8301</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Cancer cachexia affects many patients with advanced cancer.  This multifactorial syndrome, which involves loss of muscle mass and body wt., profoundly affects patients' phys. functioning and quality of life.  Pharmacol. interventions that target wt. loss and also improve patient-reported measures are required.  Anamorelin hydrochloride is an oral ghrelin receptor agonist for the treatment of cancer anorexia-cachexia that stimulates release of growth hormone and insulin-like growth factor 1, and improves food intake and body wt.  Phase II and III trials have demonstrated that anamorelin increases body muscle and fat compn., and improves patient-reported appetite and quality of life.  Anamorelin shows promise as an anabolic agent with benefits maintained over time, without the virilizing side effects of other anabolic medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpituGHKd04WbVg90H21EOLACvtfcHk0ljZIdUgrJ249Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2gs7vI&md5=4c91a30c7ae28fdec00986f0b5522cd9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2217%2Ffon-2017-0141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon-2017-0141%26sid%3Dliteratum%253Aachs%26aulast%3DCurrow%26aufirst%3DD.%2BC.%26aulast%3DSkipworth%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520emerging%2520role%2520of%2520Anamorelin%2520hydrochloride%2520in%2520the%2520management%2520of%2520patients%2520with%2520cancer%2520anorexia-cachexia%26jtitle%3DFuture%2520Oncol.%26date%3D2017%26volume%3D13%26issue%3D20%26spage%3D1767%26epage%3D1783%26doi%3D10.2217%2Ffon-2017-0141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoveyda, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vézina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benakli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaubien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Louis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinault, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaseshan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchemin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhérer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, G. L.</span></span> <span> </span><span class="NLM_article-title">Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): development of Ulimorelin (TZP-101) from hit to clinic</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">8305</span>– <span class="NLM_lpage">8320</span>, <span class="refDoi"> DOI: 10.1021/jm2007062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2007062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8305-8320&issue=24&author=H.+R.+Hoveydaauthor=E.+Marsaultauthor=R.+Gagnonauthor=A.+P.+Mathieuauthor=M.+V%C3%A9zinaauthor=A.+Landryauthor=Z.+Wangauthor=K.+Benakliauthor=S.+Beaubienauthor=M.+Saint-Louisauthor=M.+Brassardauthor=J.-F.+Pinaultauthor=L.+Ouelletauthor=S.+Bhatauthor=M.+Ramaseshanauthor=X.+Pengauthor=L.+Foucherauthor=S.+Beaucheminauthor=P.+Bh%C3%A9rerauthor=D.+F.+Veberauthor=M.+L.+Petersonauthor=G.+L.+Fraser&title=Optimization+of+the+potency+and+pharmacokinetic+properties+of+a+macrocyclic+ghrelin+receptor+agonist+%28Part+I%29%3A+development+of+Ulimorelin+%28TZP-101%29+from+hit+to+clinic&doi=10.1021%2Fjm2007062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm2007062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007062%26sid%3Dliteratum%253Aachs%26aulast%3DHoveyda%26aufirst%3DH.%2BR.%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DGagnon%26aufirst%3DR.%26aulast%3DMathieu%26aufirst%3DA.%2BP.%26aulast%3DV%25C3%25A9zina%26aufirst%3DM.%26aulast%3DLandry%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBenakli%26aufirst%3DK.%26aulast%3DBeaubien%26aufirst%3DS.%26aulast%3DSaint-Louis%26aufirst%3DM.%26aulast%3DBrassard%26aufirst%3DM.%26aulast%3DPinault%26aufirst%3DJ.-F.%26aulast%3DOuellet%26aufirst%3DL.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DRamaseshan%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DFoucher%26aufirst%3DL.%26aulast%3DBeauchemin%26aufirst%3DS.%26aulast%3DBh%25C3%25A9rer%26aufirst%3DP.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DFraser%26aufirst%3DG.%2BL.%26atitle%3DOptimization%2520of%2520the%2520potency%2520and%2520pharmacokinetic%2520properties%2520of%2520a%2520macrocyclic%2520ghrelin%2520receptor%2520agonist%2520%2528Part%2520I%2529%253A%2520development%2520of%2520Ulimorelin%2520%2528TZP-101%2529%2520from%2520hit%2520to%2520clinic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D24%26spage%3D8305%26epage%3D8320%26doi%3D10.1021%2Fjm2007062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moukhametzianov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehmé, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schertler, G. F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. G.</span></span> <span> </span><span class="NLM_article-title">The structural basis for agonist and partial agonist action on a β1-adrenergic receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>469</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1038/nature09746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1038%2Fnature09746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=21228877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFelsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2011&pages=241-244&author=T.+Warneauthor=R.+Moukhametzianovauthor=J.+G.+Bakerauthor=R.+Nehm%C3%A9author=P.+C.+Edwardsauthor=A.+G.+W.+Leslieauthor=G.+F.+X.+Schertlerauthor=C.+G.+Tate&title=The+structural+basis+for+agonist+and+partial+agonist+action+on+a+%CE%B21-adrenergic+receptor&doi=10.1038%2Fnature09746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The structural basis for agonist and partial agonist action on a β1-adrenergic receptor</span></div><div class="casAuthors">Warne, Tony; Moukhametzianov, Rouslan; Baker, Jillian G.; Nehme, Rony; Edwards, Patricia C.; Leslie, Andrew G. W.; Schertler, Gebhard F. X.; Tate, Christopher G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">469</span>
        (<span class="NLM_cas:issue">7329</span>),
    <span class="NLM_cas:pages">241-244</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Adrenergic receptors (βARs) are G-protein-coupled receptors (GPCRs) that activate intracellular G proteins upon binding catecholamine agonist ligands such as adrenaline and noradrenaline.  Synthetic ligands have been developed that either activate or inhibit βARs for the treatment of asthma, hypertension or cardiac dysfunction.  These ligands are classified as either full agonists, partial agonists or antagonists, depending on whether the cellular response is similar to that of the native ligand, reduced or inhibited, resp.  However, the structural basis for these different ligand efficacies is unknown.  Here we present four crystal structures of the thermostabilized turkey (Meleagris gallopavo) β1-adrenergic receptor (β1AR-m23) bound to the full agonists carmoterol and isoprenaline and the partial agonists salbutamol and dobutamine.  In each case, agonist binding induces a 1 Å contraction of the catecholamine-binding pocket relative to the antagonist bound receptor.  Full agonists can form hydrogen bonds with two conserved serine residues in transmembrane helix 5 (Ser5.42 and Ser5.46), but partial agonists only interact with Ser5.42 (superscripts refer to Ballesteros-Weinstein numbering).  The structures provide an understanding of the pharmacol. differences between different ligand classes, illuminating how GPCRs function and providing a solid foundation for the structure-based design of novel ligands with predictable efficacies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2EWXHDM88tLVg90H21EOLACvtfcHk0ljwk22g1EzDyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFelsw%253D%253D&md5=aa7fa20ff770ea13d97f0cf39311a1ea</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature09746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09746%26sid%3Dliteratum%253Aachs%26aulast%3DWarne%26aufirst%3DT.%26aulast%3DMoukhametzianov%26aufirst%3DR.%26aulast%3DBaker%26aufirst%3DJ.%2BG.%26aulast%3DNehm%25C3%25A9%26aufirst%3DR.%26aulast%3DEdwards%26aufirst%3DP.%2BC.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DSchertler%26aufirst%3DG.%2BF.%2BX.%26aulast%3DTate%26aufirst%3DC.%2BG.%26atitle%3DThe%2520structural%2520basis%2520for%2520agonist%2520and%2520partial%2520agonist%2520action%2520on%2520a%2520%25CE%25B21-adrenergic%2520receptor%26jtitle%3DNature%26date%3D2011%26volume%3D469%26spage%3D241%26epage%3D244%26doi%3D10.1038%2Fnature09746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dosa, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, E. A.</span></span> <span> </span><span class="NLM_article-title">Tactical approaches to interconverting GPCR agonists and antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">810</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00982</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFamsr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=810-840&author=P.+I.+Dosaauthor=E.+A.+Amin&title=Tactical+approaches+to+interconverting+GPCR+agonists+and+antagonists&doi=10.1021%2Facs.jmedchem.5b00982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Tactical Approaches to Interconverting GPCR Agonists and Antagonists</span></div><div class="casAuthors">Dosa, Peter I.; Amin, Elizabeth Ambrose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">810-840</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are many reported examples of small structural modifications to GPCR-targeted ligands leading to major changes in their functional activity, converting agonists into antagonists or vice versa.  These shifts in functional activity are often accompanied by negligible changes in binding affinity.  The current perspective focuses on outlining and analyzing various approaches that have been used to interconvert GPCR agonists, partial agonists, and antagonists in order to achieve the intended functional activity at a GPCR of therapeutic interest.  An improved understanding of specific structural modifications that are likely to alter the functional activity of a GPCR ligand may be of use to researchers designing GPCR-targeted drugs and/or probe compds., specifically in cases where a particular ligand exhibits good potency but not the preferred functional activity at the GPCR of choice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohWg2-DQHq3LVg90H21EOLACvtfcHk0li_IlXQwWPubg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFamsr7P&md5=99ffc0b892eb9c10aaf5d52a7d5dd8bc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00982%26sid%3Dliteratum%253Aachs%26aulast%3DDosa%26aufirst%3DP.%2BI.%26aulast%3DAmin%26aufirst%3DE.%2BA.%26atitle%3DTactical%2520approaches%2520to%2520interconverting%2520GPCR%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D810%26epage%3D840%26doi%3D10.1021%2Facs.jmedchem.5b00982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, S. N. L.</span>; <span class="NLM_string-name">Simpson, I.</span></span> <span> </span><span class="NLM_article-title">Indolamide Derivatives which Possess Glycogen Phosphorylase Inhibitory Activity</span>. <span class="NLM_patent">WO 2005/020985</span>, March 10, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=S.+N.+L.+Bennett&author=I.+Simpson&title=Indolamide+Derivatives+which+Possess+Glycogen+Phosphorylase+Inhibitory+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DS.%2BN.%2BL.%26atitle%3DIndolamide%2520Derivatives%2520which%2520Possess%2520Glycogen%2520Phosphorylase%2520Inhibitory%2520Activity%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagamine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura-Akimaru, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taiji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, H.</span></span> <span> </span><span class="NLM_article-title">Pharmacological profile of a new orally active growth hormone secretagogue, SM-130686</span>. <i>J. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1677/joe.0.1710481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1677%2Fjoe.0.1710481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=11739014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2001&pages=481-489&issue=3&author=J.+Nagamineauthor=R.+Nagataauthor=H.+Sekiauthor=N.+Nomura-Akimaruauthor=Y.+Uekiauthor=K.+Kumagaiauthor=M.+Taijiauthor=H.+Noguchi&title=Pharmacological+profile+of+a+new+orally+active+growth+hormone+secretagogue%2C+SM-130686&doi=10.1677%2Fjoe.0.1710481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of a new orally active growth hormone secretagogue, SM-130686</span></div><div class="casAuthors">Nagamine, J.; Nagata, R.; Seki, H.; Nomura-Akimaru, N.; Ueki, Y.; Kumagai, K.; Taiji, M.; Noguchi, H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">481-489</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">SM-130686, an oxindole deriv., is a novel orally active GH secretagogue (GHS) which is structurally distinct from previously reported GHSs such as MK-677, NN 703 and hexarelin.  SM-130686 stimulates GH release from cultured rat pituitary cells in a dose-dependent manner.  Half-max. stimulation was obsd. at a concn. of 6.3 nM.  SM-130686-induced GH release was inhibited by a GHS antagonist, but not by a GH-releasing hormone antagonist.  SM-130686 dose-dependently inhibited the binding of radiolabeled ligand, 35S-MK-677, to human GHS receptor 1a (IC50 = 1.2 nM).  This indicates that SM-130686 stimulates GH release through the GHS receptor.  The effect of a single oral administration of SM-130686 on GH release in pentobarbital-anesthetized rats was studied.  After treatment with 10 mg/kg SM-130686, plasma GH concns. measured by RIA significantly increased, reaching a peak at 20-45 min, and remained above baseline during the exptl. period (60 min).  The anabolic effect of repetitive SM-130686 administration was studied in rats.  Rats received 10 mg/kg SM-130686 orally twice a day and were weighed every day for 9 days.  At day 9 there was a significant increase in both the body wt. and the fat free mass (19.5 and 18.1 g, resp.).  Serum IGF-I concn. was also significantly elevated 6 h after the last dose of SM-130686.  An endogenous GHS ligand for the GHS receptor has recently been identified from stomach ext. and designated as ghrelin.  The GH-releasing activity in vitro relative to ghrelin (100%) was about 52% for SM-130686.  It is likely that SM-130686 is a partial agonist for the GHS receptor.  In summary, we describe here an orally active GHS, SM-130686, which acts through the GHS receptor.  Repetitive administration of SM-130686 to rats, similar to repetitive administration of GH, significantly increased the fat free mass by an amt. almost equal to the gain in body wt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_wdJAHljjT7Vg90H21EOLACvtfcHk0lhvyBvM_RE-iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVajtQ%253D%253D&md5=2a3a0711183388efaf64060e47b2ee8f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1677%2Fjoe.0.1710481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjoe.0.1710481%26sid%3Dliteratum%253Aachs%26aulast%3DNagamine%26aufirst%3DJ.%26aulast%3DNagata%26aufirst%3DR.%26aulast%3DSeki%26aufirst%3DH.%26aulast%3DNomura-Akimaru%26aufirst%3DN.%26aulast%3DUeki%26aufirst%3DY.%26aulast%3DKumagai%26aufirst%3DK.%26aulast%3DTaiji%26aufirst%3DM.%26aulast%3DNoguchi%26aufirst%3DH.%26atitle%3DPharmacological%2520profile%2520of%2520a%2520new%2520orally%2520active%2520growth%2520hormone%2520secretagogue%252C%2520SM-130686%26jtitle%3DJ.%2520Endocrinol.%26date%3D2001%26volume%3D171%26issue%3D3%26spage%3D481%26epage%3D489%26doi%3D10.1677%2Fjoe.0.1710481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heding, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span> <span> </span><span class="NLM_article-title">Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2400</span>– <span class="NLM_lpage">2411</span>, <span class="refDoi"> DOI: 10.1210/me.2005-0059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1210%2Fme.2005-0059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=15905359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFOjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=2400-2411&author=B.+Holstauthor=E.+Brandtauthor=A.+Bachauthor=A.+Hedingauthor=T.+W.+Schwartz&title=Nonpeptide+and+peptide+growth+hormone+secretagogues+act+both+as+ghrelin+receptor+agonist+and+as+positive+or+negative+allosteric+modulators+of+ghrelin+signaling&doi=10.1210%2Fme.2005-0059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling</span></div><div class="casAuthors">Holst, Birgitte; Brandt, Erik; Bach, Anders; Heding, Anders; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2400-2411</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Two nonpeptide (L692,429 and MK-677) and two peptide [GH-releasing peptide (GHRP)-6 and ghrelin] agonists were compared in binding and in signal transduction assays: calcium mobilization, inositol phosphate turnover, cAMP-responsive element (CRE), and serum-responsive element (SRE) controlled transcription, as well as arrestin mobilization.  MK-677 acted as a simple agonist having an affinity of 6.5 nM and activated all signal transduction systems with similar high potency (0.2-1.4 nM).  L-692,429 also displayed a very similar potency in all signaling assays (25-60 nM) but competed with a 1000-fold lower apparent affinity for ghrelin binding and surprisingly acted as a pos. allosteric receptor modulator by increasing ghrelin's potency 4- to 10-fold.  In contrast, the potency of GHRP-6 varied 600-fold (0.1-61 nM) depending on the signal transduction assay, and it acted as a neg. allosteric modulator of ghrelin signaling.  Unexpectedly, the maximal signaling efficacy for ghrelin was increased above what was obsd. with the hormone itself during coadministration with the nonendogenous agonists.  It is concluded that agonists for the ghrelin receptor vary both in respect of their intrinsic agonist properties and in their ability to modulate ghrelin signaling.  A receptor model is presented wherein ghrelin normally only activates one receptor subunit in a dimer and where the smaller nonendogenous agonists bind in the other subunit to act both as coagonists and as either neutral (MK-677), pos. (L-692,429), or neg. (GHRP-6) modulators of ghrelin function.  It is suggested that an optimal drug candidate could be an agonist that also is a pos. modulator of ghrelin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKuWRqbj3BJbVg90H21EOLACvtfcHk0lhvyBvM_RE-iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFOjsbg%253D&md5=f4f0871313e11f00a20c5bcf80a9bf40</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1210%2Fme.2005-0059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2005-0059%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DBrandt%26aufirst%3DE.%26aulast%3DBach%26aufirst%3DA.%26aulast%3DHeding%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DNonpeptide%2520and%2520peptide%2520growth%2520hormone%2520secretagogues%2520act%2520both%2520as%2520ghrelin%2520receptor%2520agonist%2520and%2520as%2520positive%2520or%2520negative%2520allosteric%2520modulators%2520of%2520ghrelin%2520signaling%26jtitle%3DMol.%2520Endocrinol.%26date%3D2005%26volume%3D19%26spage%3D2400%26epage%3D2411%26doi%3D10.1210%2Fme.2005-0059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pietra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tazawa-Ogata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuanfeng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duus, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northrup, R.</span></span> <span> </span><span class="NLM_article-title">Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile</span>. <i>J. Cachexia Sarcopenia Muscle</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1007/s13539-014-0159-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1007%2Fs13539-014-0159-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=25267366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A280%3ADC%252BC2M7ls1Omsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=329-337&author=C.+Pietraauthor=Y.+Takedaauthor=N.+Tazawa-Ogataauthor=M.+Minamiauthor=X.+Yuanfengauthor=E.+M.+Duusauthor=R.+Northrup&title=Anamorelin+HCl+%28ONO-7643%29%2C+a+novel+ghrelin+receptor+agonist%2C+for+the+treatment+of+cancer+anorexia-cachexia+syndrome%3A+preclinical+profile&doi=10.1007%2Fs13539-014-0159-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile</span></div><div class="casAuthors">Pietra Claudio; Takeda Yasuhiro; Tazawa-Ogata Naoko; Minami Masashi; Yuanfeng Xia; Duus Elizabeth Manning; Northrup Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cachexia, sarcopenia and muscle</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-37</span>
        ISSN:<span class="NLM_cas:issn">2190-5991</span>.
    </div><div class="casAbstract">BACKGROUND:  Anamorelin HCl (ANAM) is a novel, orally active, ghrelin receptor agonist in clinical development for the treatment of cancer cachexia.  We report in vitro and in vivo studies evaluating the preclinical pharmacologic profile of ANAM.  METHODS:  Fluorescent imaging plate reader and binding assays in HEK293 and baby hamster kidney cells determined the agonist and antagonist activity of ANAM, and its affinity for the ghrelin receptor.  Rat pituitary cells were incubated with ANAM to evaluate its effect on growth hormone (GH) release.  In vivo, rats were treated with ANAM 3, 10, or 30 mg/kg, or control orally, once daily for 6 days to evaluate the effect on food intake (FI) and body weight (BW), and once to assess GH response.  In pigs, single (3.5 mg/kg) or continuous (1 mg/kg/day) ANAM doses were administered to assess GH and insulin-like growth factor (IGF-1) response.  RESULTS:  ANAM showed significant agonist and binding activity on the ghrelin receptor, and stimulated GH release in vitro.  In rats, ANAM significantly and dose-dependently increased FI and BW at all dose levels compared with control, and significantly increased GH levels at 10 or 30 mg/kg doses.  Increases in GH and IGF-1 levels were observed following ANAM administration in pigs.  CONCLUSION:  ANAM is a potent and highly specific ghrelin receptor agonist with significant appetite-enhancing activity, leading to increases in FI and BW, and a stimulatory effect on GH secretion.  These results support the continued investigation of ANAM as a potential treatment of cancer anorexia-cachexia syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_yjJHhZhx0LjnyZkbE8yXfW6udTcc2ebffS08u8gnXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7ls1Omsg%253D%253D&md5=e983e10a0531528d8af3de46aa83cf9e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs13539-014-0159-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13539-014-0159-5%26sid%3Dliteratum%253Aachs%26aulast%3DPietra%26aufirst%3DC.%26aulast%3DTakeda%26aufirst%3DY.%26aulast%3DTazawa-Ogata%26aufirst%3DN.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DYuanfeng%26aufirst%3DX.%26aulast%3DDuus%26aufirst%3DE.%2BM.%26aulast%3DNorthrup%26aufirst%3DR.%26atitle%3DAnamorelin%2520HCl%2520%2528ONO-7643%2529%252C%2520a%2520novel%2520ghrelin%2520receptor%2520agonist%252C%2520for%2520the%2520treatment%2520of%2520cancer%2520anorexia-cachexia%2520syndrome%253A%2520preclinical%2520profile%26jtitle%3DJ.%2520Cachexia%2520Sarcopenia%2520Muscle%26date%3D2014%26volume%3D5%26spage%3D329%26epage%3D337%26doi%3D10.1007%2Fs13539-014-0159-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefker, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toler, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettleton, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirie, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidsey-Frink, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tess, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva-Jardine, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D. D.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacology of CP-424,391, an orally active pyrazolidinone-piperidine growth hormone secretagogue</span>. <i>Endocr. J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1385/ENDO:14:1:121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1385%2FENDO%3A14%3A1%3A121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2001&pages=121-132&issue=1&author=L.+C.+Panauthor=P.+A.+Carpinoauthor=B.+A.+Lefkerauthor=J.+A.+Raganauthor=S.+M.+Tolerauthor=J.+C.+Pettersenauthor=D.+O.+Nettletonauthor=O.+Ngauthor=C.+M.+Pirieauthor=K.+Chidsey-Frinkauthor=B.+Luauthor=D.+F.+Nickersonauthor=D.+A.+Tessauthor=M.+A.+Mullinsauthor=D.+B.+MacLeanauthor=P.+A.+DaSilva-Jardineauthor=D.+D.+Thompson&title=Preclinical+pharmacology+of+CP-424%2C391%2C+an+orally+active+pyrazolidinone-piperidine+growth+hormone+secretagogue&doi=10.1385%2FENDO%3A14%3A1%3A121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1385%2FENDO%3A14%3A1%3A121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FENDO%253A14%253A1%253A121%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DL.%2BC.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DRagan%26aufirst%3DJ.%2BA.%26aulast%3DToler%26aufirst%3DS.%2BM.%26aulast%3DPettersen%26aufirst%3DJ.%2BC.%26aulast%3DNettleton%26aufirst%3DD.%2BO.%26aulast%3DNg%26aufirst%3DO.%26aulast%3DPirie%26aufirst%3DC.%2BM.%26aulast%3DChidsey-Frink%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DNickerson%26aufirst%3DD.%2BF.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DMullins%26aufirst%3DM.%2BA.%26aulast%3DMacLean%26aufirst%3DD.%2BB.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%2BA.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DPreclinical%2520pharmacology%2520of%2520CP-424%252C391%252C%2520an%2520orally%2520active%2520pyrazolidinone-piperidine%2520growth%2520hormone%2520secretagogue%26jtitle%3DEndocr.%2520J.%26date%3D2001%26volume%3D14%26issue%3D1%26spage%3D121%26epage%3D132%26doi%3D10.1385%2FENDO%3A14%3A1%3A121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witherington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abberley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaiba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, J. G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takle, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadsworth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span> <span> </span><span class="NLM_article-title">Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: lead optimization</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2203</span>– <span class="NLM_lpage">2205</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2Fj.bmcl.2007.12.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2203-2205&author=J.+Witheringtonauthor=L.+Abberleyauthor=M.+A.+Briggsauthor=K.+Collisauthor=D.+K.+Deanauthor=A.+Gaibaauthor=N.+P.+Kingauthor=H.+Krausauthor=N.+Shukerauthor=J.+G.+A.+Steadmanauthor=A.+K.+Takleauthor=G.+Sangerauthor=G.+Wadsworthauthor=S.+Butlerauthor=F.+McKayauthor=A.+Muirauthor=K.+Winbornauthor=T.+D.+Heightman&title=Potent+achiral+agonists+of+the+growth+hormone+secretagogue+%28ghrelin%29+receptor.+Part+2%3A+lead+optimization&doi=10.1016%2Fj.bmcl.2007.12.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DAbberley%26aufirst%3DL.%26aulast%3DBriggs%26aufirst%3DM.%2BA.%26aulast%3DCollis%26aufirst%3DK.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DGaiba%26aufirst%3DA.%26aulast%3DKing%26aufirst%3DN.%2BP.%26aulast%3DKraus%26aufirst%3DH.%26aulast%3DShuker%26aufirst%3DN.%26aulast%3DSteadman%26aufirst%3DJ.%2BG.%2BA.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DSanger%26aufirst%3DG.%26aulast%3DWadsworth%26aufirst%3DG.%26aulast%3DButler%26aufirst%3DS.%26aulast%3DMcKay%26aufirst%3DF.%26aulast%3DMuir%26aufirst%3DA.%26aulast%3DWinborn%26aufirst%3DK.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3DPotent%2520achiral%2520agonists%2520of%2520the%2520growth%2520hormone%2520secretagogue%2520%2528ghrelin%2529%2520receptor.%2520Part%25202%253A%2520lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2203%26epage%3D2205%26doi%3D10.1016%2Fj.bmcl.2007.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patchett, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleim, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. W.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, S.-H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. D.</span></span> <span> </span><span class="NLM_article-title">1-[2(R)-(2-Amino-2-methylpropionylamino)-3-(1<i>H</i>-indol-3-yl)propionyl]-3-benzylpiperidine-3(S)-carboxylic acid ethyl ester (L-163,540): a potent, orally bioavailable, and short-duration growth hormone secretagogue</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2439</span>– <span class="NLM_lpage">2441</span>, <span class="refDoi"> DOI: 10.1021/jm9800191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9800191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2439-2441&author=L.+Yangauthor=G.+Morrielloauthor=A.+A.+Patchettauthor=K.+Leungauthor=T.+Jacksauthor=K.+Chengauthor=K.+D.+Schleimauthor=W.+Feeneyauthor=W.+W.-S.+Chanauthor=S.-H.+L.+Chiuauthor=R.+D.+Smith&title=1-%5B2%28R%29-%282-Amino-2-methylpropionylamino%29-3-%281H-indol-3-yl%29propionyl%5D-3-benzylpiperidine-3%28S%29-carboxylic+acid+ethyl+ester+%28L-163%2C540%29%3A+a+potent%2C+orally+bioavailable%2C+and+short-duration+growth+hormone+secretagogue&doi=10.1021%2Fjm9800191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm9800191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9800191%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DMorriello%26aufirst%3DG.%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DSchleim%26aufirst%3DK.%2BD.%26aulast%3DFeeney%26aufirst%3DW.%26aulast%3DChan%26aufirst%3DW.%2BW.-S.%26aulast%3DChiu%26aufirst%3DS.-H.%2BL.%26aulast%3DSmith%26aufirst%3DR.%2BD.%26atitle%3D1-%255B2%2528R%2529-%25282-Amino-2-methylpropionylamino%2529-3-%25281H-indol-3-yl%2529propionyl%255D-3-benzylpiperidine-3%2528S%2529-carboxylic%2520acid%2520ethyl%2520ester%2520%2528L-163%252C540%2529%253A%2520a%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520short-duration%2520growth%2520hormone%2520secretagogue%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2439%26epage%3D2441%26doi%3D10.1021%2Fjm9800191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witherington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abberley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellenie, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boatman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaiba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, J. G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrew, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takle, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span> <span> </span><span class="NLM_article-title">Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">684</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.12.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2Fj.bmcl.2008.12.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=684-687&issue=3&author=J.+Witheringtonauthor=L.+Abberleyauthor=B.+R.+Bellenieauthor=R.+Boatmanauthor=K.+Collisauthor=D.+K.+Deanauthor=A.+Gaibaauthor=N.+P.+Kingauthor=N.+Shukerauthor=J.+G.+A.+Steadmanauthor=K.+Andrewauthor=A.+K.+Takleauthor=G.+Sangerauthor=S.+Butlerauthor=F.+McKayauthor=A.+Muirauthor=K.+Winbornauthor=R.+W.+Wardauthor=T.+D.+Heightman&title=Aryl+sulphonyl+amides+as+potent+agonists+of+the+growth+hormone+secretagogue+%28ghrelin%29+receptor&doi=10.1016%2Fj.bmcl.2008.12.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.12.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.12.042%26sid%3Dliteratum%253Aachs%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DAbberley%26aufirst%3DL.%26aulast%3DBellenie%26aufirst%3DB.%2BR.%26aulast%3DBoatman%26aufirst%3DR.%26aulast%3DCollis%26aufirst%3DK.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DGaiba%26aufirst%3DA.%26aulast%3DKing%26aufirst%3DN.%2BP.%26aulast%3DShuker%26aufirst%3DN.%26aulast%3DSteadman%26aufirst%3DJ.%2BG.%2BA.%26aulast%3DAndrew%26aufirst%3DK.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DSanger%26aufirst%3DG.%26aulast%3DButler%26aufirst%3DS.%26aulast%3DMcKay%26aufirst%3DF.%26aulast%3DMuir%26aufirst%3DA.%26aulast%3DWinborn%26aufirst%3DK.%26aulast%3DWard%26aufirst%3DR.%2BW.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3DAryl%2520sulphonyl%2520amides%2520as%2520potent%2520agonists%2520of%2520the%2520growth%2520hormone%2520secretagogue%2520%2528ghrelin%2529%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D3%26spage%3D684%26epage%3D687%26doi%3D10.1016%2Fj.bmcl.2008.12.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smondyrev, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. N.</span></span> <span> </span><span class="NLM_article-title">PHASE: A novel approach to pharmacophore modeling and 3D database searching</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2006.00384.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1111%2Fj.1747-0285.2006.00384.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=16784462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVeqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=370-372&author=S.+L.+Dixonauthor=A.+M.+Smondyrevauthor=S.+N.+Rao&title=PHASE%3A+A+novel+approach+to+pharmacophore+modeling+and+3D+database+searching&doi=10.1111%2Fj.1747-0285.2006.00384.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Novel approach to pharmacophore modeling and 3D database searching</span></div><div class="casAuthors">Dixon, Steven L.; Smondyrev, Alexander M.; Rao, Shashidhar N.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">370-372</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Pharmacophore modeling and 3D database searching are now recognized as integral components of lead discovery and lead optimization, and the continuing need for improved pharmacophore-based tools has driven the development of PHASE.  PHASE pharmacophore and 3D QSAR models provide a means for rationalizing structure-activity data, predicting the activity of new compds., and efficiently extg. actives from a prototypical database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo50KpRHTGgAbVg90H21EOLACvtfcHk0lhQKW73kcyq1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVeqsbg%253D&md5=30d06fe99776e203eed35b0f774bbe64</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2006.00384.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2006.00384.x%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BL.%26aulast%3DSmondyrev%26aufirst%3DA.%2BM.%26aulast%3DRao%26aufirst%3DS.%2BN.%26atitle%3DPHASE%253A%2520A%2520novel%2520approach%2520to%2520pharmacophore%2520modeling%2520and%25203D%2520database%2520searching%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D370%26epage%3D372%26doi%3D10.1111%2Fj.1747-0285.2006.00384.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimurer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halkjaer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullberg, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span> <span> </span><span class="NLM_article-title">Overlapping binding site for endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1124/mol.108.049189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1124%2Fmol.108.049189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=18923064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVOltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2009&pages=44-59&author=B.+Holstauthor=T.+M.+Frimurerauthor=J.+Mokrosinskiauthor=T.+Halkjaerauthor=K.+B.+Cullbergauthor=C.+R.+Underwoodauthor=T.+W.+Schwartz&title=Overlapping+binding+site+for+endogenous+agonist%2C+small-molecule+agonists%2C+and+ago-allosteric+modulators+on+the+ghrelin+receptor&doi=10.1124%2Fmol.108.049189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor</span></div><div class="casAuthors">Holst, Birgitte; Frimurer, Thomas M.; Mokrosinski, Jacek; Halkjaer, Tine; Cullberg, Karina B.; Underwood, Christina R.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-59</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A library of robust ghrelin receptor mutants with single substitutions at 22 positions in the main ligand-binding pocket was employed to map binding sites for six different agonists: two peptides (the 28-amino-acid octanoylated endogenous ligand ghrelin and the hexapeptide growth hormone secretagogue GHRP-6) plus four nonpeptide agonists-the original benzolactam L-692,429, the spiroindoline sulfonamide MK-677, and two novel oxindole derivs., SM-130686 and SM-157740.  The strongest mutational effect with respect to decrease in potency for stimulation of inositol phosphate turnover was for all six agonists the GluIII:09-to-Gln substitution in the extracellular segment of TM-III.  Likewise, all six agonists were affected by substitutions of PheVI:16, ArgVI:20, and PheVI:23 on the opposing face of transmembrane domain (TM) VI.  Each of the agonists was also affected selectively by specific mutations.  The mutational map of the ability of L-692,429 and GHRP-6 to act as allosteric modulators by increasing ghrelin's maximal efficacy overlapped with the common mutational map for agonism but it was not identical with the map for the agonist property of these small-mol. ligands.  In mol. models, built over the inactive conformation of rhodopsin, low energy conformations of the nonpeptide agonists could be docked to satisfy many of their mutational hits.  It is concluded that although each of the ligands in addn. exploits other parts of the receptor, a large, common binding site for both small-mol. agonists-including ago-allosteric modulators-and the endogenous agonist is found on the opposing faces of TM-III and -VI of the ghrelin receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7vPmuuW-QabVg90H21EOLACvtfcHk0lgR1CLykRBqGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVOltw%253D%253D&md5=565858dd8c6657fda2938e10ab30fed1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.049189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.049189%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DMokrosinski%26aufirst%3DJ.%26aulast%3DHalkjaer%26aufirst%3DT.%26aulast%3DCullberg%26aufirst%3DK.%2BB.%26aulast%3DUnderwood%26aufirst%3DC.%2BR.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DOverlapping%2520binding%2520site%2520for%2520endogenous%2520agonist%252C%2520small-molecule%2520agonists%252C%2520and%2520ago-allosteric%2520modulators%2520on%2520the%2520ghrelin%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2009%26volume%3D75%26spage%3D44%26epage%3D59%26doi%3D10.1124%2Fmol.108.049189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nygaard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimurer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span> <span> </span><span class="NLM_article-title">Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">15799</span>– <span class="NLM_lpage">15811</span>, <span class="refDoi"> DOI: 10.1074/jbc.M609796200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1074%2Fjbc.M609796200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=17371869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=15799-15811&author=B.+Holstauthor=J.+Mokrosinskiauthor=M.+Langauthor=E.+Brandtauthor=R.+Nygaardauthor=T.+M.+Frimurerauthor=A.+G.+Beck-Sickingerauthor=T.+W.+Schwartz&title=Identification+of+an+efficacy+switch+region+in+the+ghrelin+receptor+responsible+for+interchange+between+agonism+and+inverse+agonism&doi=10.1074%2Fjbc.M609796200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an Efficacy Switch Region in the Ghrelin Receptor Responsible for Interchange between Agonism and Inverse Agonism</span></div><div class="casAuthors">Holst, Birgitte; Mokrosinski, Jacek; Lang, Manja; Brandt, Erik; Nygaard, Rie; Frimurer, Thomas M.; Beck-Sickinger, Annette G.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">15799-15811</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The carboxyamidated wFwLL peptide was used as a core ligand to probe the structural basis for agonism vs. inverse agonism in the constitutively active ghrelin receptor.  In the ligand, an efficacy switch could be built at the N terminus, as exemplified by AwFwLL, which functioned as a high potency agonist, whereas KwFwLL was an equally high potency inverse agonist.  The wFw-contg. peptides, agonists as well as inverse agonists, were affected by receptor mutations covering the whole main ligand-binding pocket with key interaction sites being an arom. cluster in transmembrane (TM)-VI and -VII and residues on the opposing face of TM-III.  Gain-of-function in respect of either increased agonist or inverse agonist potency or swap between high potency versions of these properties was obtained by substitutions at a no. of positions covering a broad area of the binding pocket on TM-III, -IV, and -V.  However, in particular, space-generating substitutions at position III:04 shifted the efficacy of the ligands from inverse agonism toward agonism, whereas similar substitutions at position III: 08, one helical turn below, shifted the efficacy from agonism toward inverse agonism.  It is suggested that the relative position of the ligand in the binding pocket between this "efficacy shift region" on TM-III and the opposing arom. cluster on TM-VI and TM-VII leads either to agonism, i.e. in a superficial binding mode, or it leads to inverse agonism, i.e. in a more profound binding mode.  This relationship between different binding modes and opposite efficacy is in accordance with the Global Toggle Switch model for 7TM receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJqfgDA6O7ubVg90H21EOLACvtfcHk0li_GT0yvCsN2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7g%253D&md5=9d994028f084be1fcd9a6b58a9547785</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609796200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609796200%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DMokrosinski%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DBrandt%26aufirst%3DE.%26aulast%3DNygaard%26aufirst%3DR.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DIdentification%2520of%2520an%2520efficacy%2520switch%2520region%2520in%2520the%2520ghrelin%2520receptor%2520responsible%2520for%2520interchange%2520between%2520agonism%2520and%2520inverse%2520agonism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D15799%26epage%3D15811%26doi%3D10.1074%2Fjbc.M609796200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charron, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowkes, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyt, L. G.</span></span> <span> </span><span class="NLM_article-title">Bridging computational modeling with amino acid replacements to investigate GHS-R1a-peptidomimetic recognition</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">822</span>– <span class="NLM_lpage">833</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.07.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2Fj.ejmech.2016.07.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=27541265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2016&pages=822-833&author=J.+Houauthor=C.+L.+Charronauthor=M.+M.+Fowkesauthor=L.+G.+Luyt&title=Bridging+computational+modeling+with+amino+acid+replacements+to+investigate+GHS-R1a-peptidomimetic+recognition&doi=10.1016%2Fj.ejmech.2016.07.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Bridging computational modeling with amino acid replacements to investigate GHS-R1a-peptidomimetic recognition</span></div><div class="casAuthors">Hou, Jinqiang; Charron, Carlie L.; Fowkes, Milan M.; Luyt, Leonard G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">822-833</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The ghrelin receptor, also referred to as the growth hormone secretagogue receptor 1a (GHS-R1a), is a G protein-coupled receptor (GPCR) primarily expressed in the brain and pituitary.  The wide spectrum of biol. functions of GHS-R1a has rendered it a target for therapeutic drugs and for mol. imaging agents, for a variety of diseases.  An improved understanding of the binding mechanism of a ligand to GHS-R1a would provide guidance on ligand design.  This study investigates the binding of G-7039, a peptidomimetic agonist, to the GHS-R1a.  A series of computational studies including homol. modeling, mol. docking, mol. dynamics (MD) simulations, and binding free energy calcns. were carried out in conjunction with amino acid replacements on G-7039.  The results suggest that the first three residues on the N-terminal segment of the peptidomimetic are bound to three hydrophobic sub-pockets in the receptor binding site, with the driving force for binding mainly from hydrophobic interactions.  It has been reported that a charge-charge interaction between the pos. charged terminal amine of the agonist and Glu124 on the receptor serves as an anchor point for binding.  However, our studies suggest that this interaction is not strong enough to anchor a ligand to the ghrelin receptor in the absence of hydrophobic interactions.  The resulting computational model provides insight into structure activity relationship anal. for the ghrelin receptor and will assist in future ligand design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos6ZSlrS_AL7Vg90H21EOLACvtfcHk0li_GT0yvCsN2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7jM&md5=f96e7229ff7b1416f8039adae7bfb7a8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.07.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.07.078%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DCharron%26aufirst%3DC.%2BL.%26aulast%3DFowkes%26aufirst%3DM.%2BM.%26aulast%3DLuyt%26aufirst%3DL.%2BG.%26atitle%3DBridging%2520computational%2520modeling%2520with%2520amino%2520acid%2520replacements%2520to%2520investigate%2520GHS-R1a-peptidomimetic%2520recognition%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D123%26spage%3D822%26epage%3D833%26doi%3D10.1016%2Fj.ejmech.2016.07.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoull, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowker, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, R. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dossetter, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ertan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcombe, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pointon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D.</span></span> <span> </span><span class="NLM_article-title">Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6128</span>– <span class="NLM_lpage">6140</span>, <span class="refDoi"> DOI: 10.1021/jm500610n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500610n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6128-6140&author=W.+McCoullauthor=P.+Bartonauthor=A.+J.+H.+Brownauthor=S.+S.+Bowkerauthor=J.+Cameronauthor=D.+S.+Clarkeauthor=R.+D.+M.+Daviesauthor=A.+G.+Dossetterauthor=A.+Ertanauthor=M.+Fenwickauthor=C.+Greenauthor=J.+L.+Holmesauthor=N.+Martinauthor=D.+Mastersauthor=J.+E.+Mooreauthor=N.+J.+Newcombeauthor=C.+Newtonauthor=H.+Pointonauthor=G.+R.+Robbauthor=C.+Sheldonauthor=S.+Stokesauthor=D.+Morgan&title=Identification%2C+optimization%2C+and+pharmacology+of+acylurea+GHS-R1a+inverse+agonists&doi=10.1021%2Fjm500610n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm500610n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500610n%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DBowker%26aufirst%3DS.%2BS.%26aulast%3DCameron%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DD.%2BS.%26aulast%3DDavies%26aufirst%3DR.%2BD.%2BM.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DErtan%26aufirst%3DA.%26aulast%3DFenwick%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DHolmes%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DMasters%26aufirst%3DD.%26aulast%3DMoore%26aufirst%3DJ.%2BE.%26aulast%3DNewcombe%26aufirst%3DN.%2BJ.%26aulast%3DNewton%26aufirst%3DC.%26aulast%3DPointon%26aufirst%3DH.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DSheldon%26aufirst%3DC.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DMorgan%26aufirst%3DD.%26atitle%3DIdentification%252C%2520optimization%252C%2520and%2520pharmacology%2520of%2520acylurea%2520GHS-R1a%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6128%26epage%3D6140%26doi%3D10.1021%2Fjm500610n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of an agonist-bound human A2a adenosine receptor</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>332</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1126/science.1202793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1126%2Fscience.1202793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=21393508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFWjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2011&pages=322-327&author=F.+Xuauthor=H.+Wuauthor=V.+Katritchauthor=G.+W.+Hanauthor=K.+A.+Jacobsonauthor=Z.+G.+Gaoauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+an+agonist-bound+human+A2a+adenosine+receptor&doi=10.1126%2Fscience.1202793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of an Agonist-Bound Human A2A Adenosine Receptor</span></div><div class="casAuthors">Xu, Fei; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Jacobson, Kenneth A.; Gao, Zhan-Guo; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">6027</span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Activation of G protein-coupled receptors upon agonist binding is a crit. step in the signaling cascade for this family of cell surface proteins.  We report the crystal structure of the A2A adenosine receptor (A2AAR) bound to an agonist UK-432097 at 2.7 angstrom resoln.  Relative to inactive, antagonist-bound A2AAR, the agonist-bound structure displays an outward tilt and rotation of the cytoplasmic half of helix VI, a movement of helix V, and an axial shift of helix III, resembling the changes assocd. with the active-state opsin structure.  Addnl., a seesaw movement of helix VII and a shift of extracellular loop 3 are likely specific to A2AAR and its ligand.  The results define the mol. UK-432097 as a "conformationally selective agonist" capable of receptor stabilization in a specific active-state configuration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMkD1ni9m9GrVg90H21EOLACvtfcHk0lhsZDpZsAbL6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFWjt7s%253D&md5=b1e074f38f45c95d4cc3b40378b24923</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1126%2Fscience.1202793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1202793%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520an%2520agonist-bound%2520human%2520A2a%2520adenosine%2520receptor%26jtitle%3DScience%26date%3D2011%26volume%3D332%26spage%3D322%26epage%3D327%26doi%3D10.1126%2Fscience.1202793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: a force field providing broad coverage of drug-like small molecules and proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+W.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+a+force+field+providing+broad+coverage+of+drug-like+small+molecules+and+proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0ljcO_3hZ_1HNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BW.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520a%2520force%2520field%2520providing%2520broad%2520coverage%2520of%2520drug-like%2520small%2520molecules%2520and%2520proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peterlin
Masic, L. P.</span></span> <span> </span><span class="NLM_article-title">Role of cyclic tertiary amine bioactivation to reactive iminium species: structure toxicity relationship</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.2174/138920011794520044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.2174%2F138920011794520044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=21222587" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=35-50&issue=1&author=L.+P.+Peterlin%0AMasic&title=Role+of+cyclic+tertiary+amine+bioactivation+to+reactive+iminium+species%3A+structure+toxicity+relationship&doi=10.2174%2F138920011794520044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F138920011794520044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920011794520044%26sid%3Dliteratum%253Aachs%26aulast%3DPeterlin%2BMasic%26aufirst%3DL.%2BP.%26atitle%3DRole%2520of%2520cyclic%2520tertiary%2520amine%2520bioactivation%2520to%2520reactive%2520iminium%2520species%253A%2520structure%2520toxicity%2520relationship%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2011%26volume%3D12%26issue%3D1%26spage%3D35%26epage%3D50%26doi%3D10.2174%2F138920011794520044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doss, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngui, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva Elipe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dininno, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stearns, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span> <span> </span><span class="NLM_article-title">In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolites</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1021/tx0496789</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx0496789" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=675-685&issue=4&author=Z.+Zhangauthor=Q.+Chenauthor=Y.+Liauthor=G.+A.+Dossauthor=B.+J.+Deanauthor=J.+S.+Nguiauthor=M.+Silva+Elipeauthor=S.+Kimauthor=J.+Y.+Wuauthor=F.+Dininnoauthor=M.+L.+Hammondauthor=R.+A.+Stearnsauthor=D.+C.+Evansauthor=T.+A.+Baillieauthor=W.+Tang&title=In+vitro+bioactivation+of+dihydrobenzoxathiin+selective+estrogen+receptor+modulators+by+cytochrome+P450+3A4+in+human+liver+microsomes%3A+formation+of+reactive+iminium+and+quinone+type+metabolites&doi=10.1021%2Ftx0496789"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Ftx0496789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx0496789%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DDoss%26aufirst%3DG.%2BA.%26aulast%3DDean%26aufirst%3DB.%2BJ.%26aulast%3DNgui%26aufirst%3DJ.%2BS.%26aulast%3DSilva%2BElipe%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DJ.%2BY.%26aulast%3DDininno%26aufirst%3DF.%26aulast%3DHammond%26aufirst%3DM.%2BL.%26aulast%3DStearns%26aufirst%3DR.%2BA.%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DIn%2520vitro%2520bioactivation%2520of%2520dihydrobenzoxathiin%2520selective%2520estrogen%2520receptor%2520modulators%2520by%2520cytochrome%2520P450%25203A4%2520in%2520human%2520liver%2520microsomes%253A%2520formation%2520of%2520reactive%2520iminium%2520and%2520quinone%2520type%2520metabolites%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2005%26volume%3D18%26issue%3D4%26spage%3D675%26epage%3D685%26doi%3D10.1021%2Ftx0496789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boobis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldring, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laverty, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naisbitt, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll-Griffith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routledge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedie, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">Managing the challenge of chemically reactive metabolites in drug development</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1038/nrd3408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1038%2Fnrd3408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=21455238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=292-306&issue=4&author=B.+K.+Parkauthor=A.+Boobisauthor=S.+Clarkeauthor=C.+E.+Goldringauthor=D.+Jonesauthor=J.+G.+Kennaauthor=C.+Lambertauthor=H.+G.+Lavertyauthor=D.+J.+Naisbittauthor=S.+Nelsonauthor=D.+A.+Nicoll-Griffithauthor=R.+S.+Obachauthor=P.+Routledgeauthor=D.+A.+Smithauthor=D.+J.+Tweedieauthor=N.+Vermeulenauthor=D.+P.+Williamsauthor=I.+D.+Wilsonauthor=T.+A.+Baillie&title=Managing+the+challenge+of+chemically+reactive+metabolites+in+drug+development&doi=10.1038%2Fnrd3408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Managing the challenge of chemically reactive metabolites in drug development</span></div><div class="casAuthors">Park, B. Kevin; Boobis, Alan; Clarke, Stephen; Goldring, Chris E. P.; Jones, David; Kenna, J. Gerry; Lambert, Craig; Laverty, Hugh G.; Naisbitt, Dean J.; Nelson, Sidney; Nicoll-Griffith, Deborah A.; Obach, R. Scott; Routledge, Philip; Smith, Dennis A.; Tweedie, Donald J.; Vermeulen, Nico; Williams, Dominic P.; Wilson, Ian D.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">292-306</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The normal metab. of drugs can generate metabolites that have intrinsic chem. reactivity towards cellular mols., and therefore have the potential to alter biol. function and initiate serious adverse drug reactions.  Here, we present an assessment of the current approaches used for the evaluation of chem. reactive metabolites.  We also describe how these approaches are being used within the pharmaceutical industry to assess and minimize the potential of drug candidates to cause toxicity.  At early stages of drug discovery, iteration between medicinal chem. and drug metab. can eliminate perceived reactive metabolite-mediated chem. liabilities without compromising pharmacol. activity or the need for extensive safety evaluation beyond std. practices.  In the future, reactive metabolite evaluation may also be useful during clin. development for improving clin. risk assessment and risk management.  Currently, there remains a huge gap in our understanding of the basic mechanisms that underlie chem. stress-mediated adverse reactions in humans.  This Review summarizes our views on this complex topic, and includes insights into practices considered by the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBv41vr7ZlNLVg90H21EOLACvtfcHk0lghCvIGN07RoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGnu78%253D&md5=8f6865f17bbe50b51aa4282379e82a08</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrd3408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3408%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DBoobis%26aufirst%3DA.%26aulast%3DClarke%26aufirst%3DS.%26aulast%3DGoldring%26aufirst%3DC.%2BE.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26aulast%3DLambert%26aufirst%3DC.%26aulast%3DLaverty%26aufirst%3DH.%2BG.%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DRoutledge%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26aulast%3DVermeulen%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DWilson%26aufirst%3DI.%2BD.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DManaging%2520the%2520challenge%2520of%2520chemically%2520reactive%2520metabolites%2520in%2520drug%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D4%26spage%3D292%26epage%3D306%26doi%3D10.1038%2Fnrd3408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darwish, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attwa, M. W.</span></span> <span> </span><span class="NLM_article-title">LC-MS/MS reveals the formation of aldehydes and iminium reactive intermediates in foretinib metabolism: phase I metabolic profiling</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">36279</span>– <span class="NLM_lpage">36287</span>, <span class="refDoi"> DOI: 10.1039/C7RA06341E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1039%2FC7RA06341E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Sgt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=36279-36287&author=A.+Kadiauthor=S.+M.+Amerauthor=H.+W.+Darwishauthor=M.+W.+Attwa&title=LC-MS%2FMS+reveals+the+formation+of+aldehydes+and+iminium+reactive+intermediates+in+foretinib+metabolism%3A+phase+I+metabolic+profiling&doi=10.1039%2FC7RA06341E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">LC-MS/MS reveals the formation of aldehydes and iminium reactive intermediates in foretinib metabolism: phase I metabolic profiling</span></div><div class="casAuthors">Kadi, Adnan A.; Amer, Sawsan M.; Darwish, Hany W.; Attwa, Mohamed W.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">58</span>),
    <span class="NLM_cas:pages">36279-36287</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Foretinib (GSK1363089) is an inhibitor of multiple receptor tyrosine kinases including MET and VEGFR, with the potential for treatment of solid tumors.  In this study, we investigated the in vitro metabolic pathways for foretinib in rat liver microsomes using LC-MS/MS.  Methoxylamine and potassium cyanide were used as trapping agents for aldehyde and iminium reactive intermediates, resp., of foretinib to form a stable complex that can be identified by LC-MS/MS.  Six foretinib phase I metabolites were characterized.  The phase I metabolic pathways were oxidn., defluorination, redn. and hydroxylation.  Addnl., four potential reactive metabolites, two aldehydes and two iminium ions, were found and the bioactivation pathways were proposed.  Reporting the in vitro and reactive metabolites of foretinib is very crucial in the development stage.  A literature review showed that no previous articles have provided an in vitro metab. study of foretinib or detailed structural identification of the formed reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpUjox-Bi8rrVg90H21EOLACvtfcHk0lg_o9bYP0PZ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Sgt7nL&md5=c70b6176eabae9f6d6c10f82ddebd518</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1039%2FC7RA06341E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7RA06341E%26sid%3Dliteratum%253Aachs%26aulast%3DKadi%26aufirst%3DA.%26aulast%3DAmer%26aufirst%3DS.%2BM.%26aulast%3DDarwish%26aufirst%3DH.%2BW.%26aulast%3DAttwa%26aufirst%3DM.%2BW.%26atitle%3DLC-MS%252FMS%2520reveals%2520the%2520formation%2520of%2520aldehydes%2520and%2520iminium%2520reactive%2520intermediates%2520in%2520foretinib%2520metabolism%253A%2520phase%2520I%2520metabolic%2520profiling%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D36279%26epage%3D36287%26doi%3D10.1039%2FC7RA06341E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammarlund-Udenaes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridén, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syvänen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span> <span> </span><span class="NLM_article-title">On the rate and extent of drug delivery to the brain</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1737</span>– <span class="NLM_lpage">1750</span>, <span class="refDoi"> DOI: 10.1007/s11095-007-9502-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1007%2Fs11095-007-9502-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=18058202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Whsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=1737-1750&issue=8&author=M.+Hammarlund-Udenaesauthor=M.+Frid%C3%A9nauthor=S.+Syv%C3%A4nenauthor=A.+Gupta&title=On+the+rate+and+extent+of+drug+delivery+to+the+brain&doi=10.1007%2Fs11095-007-9502-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">On The Rate and Extent of Drug Delivery to the Brain</span></div><div class="casAuthors">Hammarlund-Udenaes, Margareta; Friden, Markus; Syvaenen, Stina; Gupta, Anubha</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1737-1750</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  To define and differentiate relevant aspects of blood-brain barrier transport and distribution in order to aid research methodol. in brain drug delivery.  Pharmacokinetic parameters relative to the rate and extent of brain drug delivery are described and illustrated with relevant data, with special emphasis on the unbound, pharmacol. active drug mol.  Drug delivery to the brain can be comprehensively described using three parameters: K p,uu (concn. ratio of unbound drug in brain to blood), CLin (permeability clearance into the brain), and V u,brain (intra-brain distribution).  The permeability of the blood-brain barrier is less relevant to drug action within the CNS than the extent of drug delivery, as most drugs are administered on a continuous (repeated) basis.  K p,uu can differ between CNS-active drugs by a factor of up to 150-fold.  This range is much smaller than that for log BB ratios (K p), which can differ by up to at least 2000-fold, or for BBB permeabilities, which span an even larger range (up to at least 20,000-fold difference).  Methods that measure the three parameters K p,uu, CLin, and V u,brain can give clin. valuable ests. of brain drug delivery in early drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkysWU99T_hbVg90H21EOLACvtfcHk0lg_o9bYP0PZ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Whsb8%253D&md5=20f106a980c4949b78ead8c00cb5db41</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs11095-007-9502-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-007-9502-2%26sid%3Dliteratum%253Aachs%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26aulast%3DFrid%25C3%25A9n%26aufirst%3DM.%26aulast%3DSyv%25C3%25A4nen%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DA.%26atitle%3DOn%2520the%2520rate%2520and%2520extent%2520of%2520drug%2520delivery%2520to%2520the%2520brain%26jtitle%3DPharm.%2520Res.%26date%3D2008%26volume%3D25%26issue%3D8%26spage%3D1737%26epage%3D1750%26doi%3D10.1007%2Fs11095-007-9502-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredlund, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winiwarter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgendorf, C.</span></span> <span> </span><span class="NLM_article-title">In vitro intrinsic permeability: a transporter-independent measure of Caco-2 cell permeability in drug design and development</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1601</span>– <span class="NLM_lpage">1609</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.6b01059</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.6b01059" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BC2sXks1GgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=1601-1609&issue=5&author=L.+Fredlundauthor=S.+Winiwarterauthor=C.+Hilgendorf&title=In+vitro+intrinsic+permeability%3A+a+transporter-independent+measure+of+Caco-2+cell+permeability+in+drug+design+and+development&doi=10.1021%2Facs.molpharmaceut.6b01059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development</span></div><div class="casAuthors">Fredlund, Linda; Winiwarter, Susanne; Hilgendorf, Constanze</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1601-1609</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In vitro permeability data have a central place in absorption risk assessments in drug discovery and development.  For compds. where active efflux impacts permeability in vitro, the inherent passive membrane permeability ("intrinsic permeability") gives a concn.-independent measure of the compd.'s permeability.  This work describes the validation of an in vitro intrinsic permeability assay and application of the data in a predictive in silico model.  Apparent intrinsic permeability (Papp) across Caco-2 cell monolayers is detd. in the presence of an optimized cocktail of chem. inhibitors toward the three major efflux transporters ABCB1, ABCC2, and ABCG2.  The intrinsic Papp value gives an est. of passive permeability, which is independent of transporter expression levels and not limited by soly. or cell toxicity.  An in silico model has been established to predict the Caco-2 intrinsic permeability and shown to consistently identify highly permeable compds.  The new intrinsic permeability assay is useful for early absorption ests. and suitable for absorption risk assessment in DMPK and pharmaceutical development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzz4IoZ6pXJbVg90H21EOLACvtfcHk0lg_o9bYP0PZ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXks1GgsLw%253D&md5=2e3af857e97f2ce5ce9743294c50d3b9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.6b01059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.6b01059%26sid%3Dliteratum%253Aachs%26aulast%3DFredlund%26aufirst%3DL.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DHilgendorf%26aufirst%3DC.%26atitle%3DIn%2520vitro%2520intrinsic%2520permeability%253A%2520a%2520transporter-independent%2520measure%2520of%2520Caco-2%2520cell%2520permeability%2520in%2520drug%2520design%2520and%2520development%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2017%26volume%3D14%26issue%3D5%26spage%3D1601%26epage%3D1609%26doi%3D10.1021%2Facs.molpharmaceut.6b01059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hermansson, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drmota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, N.</span></span> <span> </span><span class="NLM_article-title">Adenosine is not a direct GHSR agonist-artificial cross-talk between GHSR and adenosine receptor pathways</span>. <i>Acta Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1111/j.1365-201X.2007.01691.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1111%2Fj.1365-201X.2007.01691.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=17428235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVaqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2007&pages=77-86&author=N.+O.+Hermanssonauthor=D.+G.+Morganauthor=T.+Drmotaauthor=N.+Larsson&title=Adenosine+is+not+a+direct+GHSR+agonist-artificial+cross-talk+between+GHSR+and+adenosine+receptor+pathways&doi=10.1111%2Fj.1365-201X.2007.01691.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine is not a direct GHSR agonist - artificial cross-talk between GHSR and adenosine receptor pathways</span></div><div class="casAuthors">Hermansson, N.-O.; Morgan, D. G. A.; Drmota, T.; Larsson, N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Physiologica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-86</span>CODEN:
                <span class="NLM_cas:coden">APCHC4</span>;
        ISSN:<span class="NLM_cas:issn">1748-1708</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aim: To assess if adenosine is a direct growth hormone secretagogue receptor (GHSR) agonist by investigating the mechanism behind adenosine induced calcium release in human embryonic kidney 293s (HEK) cells expressing GHSR.  Methods: Calcium mobilization, cAMP (cAMP) and IP3 expts. were performed using HEK cells stably expressing GHSR and/or adenosine A2B receptor (A2BR).  Results: Adenosine has been widely reported as a GHSR agonist.  In our hands, adenosine and forskolin stimulated calcium release from IP3 controlled stores in HEK-GHSR cells but not in non-transfected HEK cells.  This release was not accompanied by increased IP3 levels.  The calcium release was both cholera toxin and U73122 sensitive, indicating the involvement of both Gαs/adenylyl cyclase and Gαq/11/phospholipase C pathways.  Importantly, the GHSR inverse agonist [D-Arg1 D-Phe5 D-Trp7,9 Leu11]-Substance P (SP-analog) blocked the adenosine stimulated calcium release, demonstrating that GHSR is involved.  Assessment of the GHSR-dependent calcium release using adenosine receptor agonists and antagonists resulted in a rank order of potencies resembling the profile of A2BR.  A2BR over-expression in HEK-GHSR cells enhanced potency and efficacy of the adenosine induced calcium release without increasing IP3 prodn.  Moreover, A2BR over-expression in HEK cells potentiated NECA-induced cAMP prodn.  However, GHSR expression had no effect on intracellular cAMP prodn.  Conclusion: In HEK-GHSR cells adenosine activates endogenously expressed A2BR resulting in calcium mobilization.  We hypothesize that the responsible mechanism is cAMP-dependent sensitization of IP3 receptors for the high basal level of IP3 caused by GHSR constitutive activity.  Altogether, our results demonstrate that adenosine is not a direct GHSR agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4xsD9OHtxHLVg90H21EOLACvtfcHk0lgCo2OpIZ62dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVaqtbs%253D&md5=70f0cb61ba1421cb2d30c51ef4044a43</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-201X.2007.01691.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-201X.2007.01691.x%26sid%3Dliteratum%253Aachs%26aulast%3DHermansson%26aufirst%3DN.%2BO.%26aulast%3DMorgan%26aufirst%3DD.%2BG.%26aulast%3DDrmota%26aufirst%3DT.%26aulast%3DLarsson%26aufirst%3DN.%26atitle%3DAdenosine%2520is%2520not%2520a%2520direct%2520GHSR%2520agonist-artificial%2520cross-talk%2520between%2520GHSR%2520and%2520adenosine%2520receptor%2520pathways%26jtitle%3DActa%2520Physiol.%26date%3D2007%26volume%3D190%26spage%3D77%26epage%3D86%26doi%3D10.1111%2Fj.1365-201X.2007.01691.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trinquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourrier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansanay, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durroux, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhaire, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernout, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrétien, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapleur, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, G.</span></span> <span> </span><span class="NLM_article-title">D-myo-Inositol 1-phosphate as a surrogate of d-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2006.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1016%2Fj.ab.2006.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=16965760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyktrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2006&pages=126-135&author=E.+Trinquetauthor=M.+Finkauthor=H.+Bazinauthor=F.+Grilletauthor=F.+Maurinauthor=E.+Bourrierauthor=H.+Ansanayauthor=C.+Leroyauthor=A.+Michaudauthor=T.+Durrouxauthor=D.+Maurelauthor=F.+Malhaireauthor=C.+Goudetauthor=J.+P.+Pinauthor=M.+Navalauthor=O.+Hernoutauthor=F.+Chr%C3%A9tienauthor=Y.+Chapleurauthor=G.+Mathis&title=D-myo-Inositol+1-phosphate+as+a+surrogate+of+d-myo-inositol+1%2C4%2C5-tris+phosphate+to+monitor+G+protein-coupled+receptor+activation&doi=10.1016%2Fj.ab.2006.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">D-myo-Inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation</span></div><div class="casAuthors">Trinquet, Eric; Fink, Michel; Bazin, Herve; Grillet, Florence; Maurin, Fabrice; Bourrier, Emmanuel; Ansanay, Herve; Leroy, Cedric; Michaud, Audrey; Durroux, Thierry; Maurel, Damien; Malhaire, Fanny; Goudet, Cyril; Pin, Jean-Philippe; Naval, Magali; Hernout, Olivier; Chretien, Francoise; Chapleur, Yves; Mathis, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-135</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phospholipase C β (PLC-β)-coupled G protein-coupled receptor (GPCR) activities traditionally are assessed by measuring Ca2+ triggered by D-myo-inositol 1,4,5-trisphosphate (IP3), a PLC-β hydrolysis product, or by measuring the prodn. of inositol phosphate using cumbersome radioactive assays.  A specific detection of IP3 prodn. was also established using IP3 binding proteins.  The short lifetime of IP3 makes this detection very challenging in measuring GPCR responses.  Indeed, this IP3 rapidly enters the metabolic inositol phosphate cascade.  It has been known for decades that lithium chloride (LiCl) leads to D-myo-inositol 1-phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase, the final enzyme of the IP3 metabolic cascade.  We show here that IP1 can be used as a surrogate of IP3 to monitor GPCR activation.  We developed a novel homogeneous time-resolved fluorescence (HTRF) assay that correlates perfectly with existing methods and is easily amenable to high-throughput screening.  The IP-One assay was validated on various GPCR models.  It has the advantage over the traditional Ca2+ assay of allowing the measurement of inverse agonist activity as well as the anal. of PLC-β activity in any nontransfected primary cultures.  Finally, the high assay specificity for D-myo-inositol 1 monophosphate (IP1(1)) opens new possibilities in developing selective assays to study the functional roles of the various isoforms of inositol phosphates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRFlTq9szK1LVg90H21EOLACvtfcHk0ljlVIylIrza8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyktrfJ&md5=fce292860fb4d99a590a9118772d9f58</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2006.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2006.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DFink%26aufirst%3DM.%26aulast%3DBazin%26aufirst%3DH.%26aulast%3DGrillet%26aufirst%3DF.%26aulast%3DMaurin%26aufirst%3DF.%26aulast%3DBourrier%26aufirst%3DE.%26aulast%3DAnsanay%26aufirst%3DH.%26aulast%3DLeroy%26aufirst%3DC.%26aulast%3DMichaud%26aufirst%3DA.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMaurel%26aufirst%3DD.%26aulast%3DMalhaire%26aufirst%3DF.%26aulast%3DGoudet%26aufirst%3DC.%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DNaval%26aufirst%3DM.%26aulast%3DHernout%26aufirst%3DO.%26aulast%3DChr%25C3%25A9tien%26aufirst%3DF.%26aulast%3DChapleur%26aufirst%3DY.%26aulast%3DMathis%26aufirst%3DG.%26atitle%3DD-myo-Inositol%25201-phosphate%2520as%2520a%2520surrogate%2520of%2520d-myo-inositol%25201%252C4%252C5-tris%2520phosphate%2520to%2520monitor%2520G%2520protein-coupled%2520receptor%2520activation%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D358%26spage%3D126%26epage%3D135%26doi%3D10.1016%2Fj.ab.2006.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergsdorf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropp-Goerkis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaehler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ketscher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boemer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parczyk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span> <span> </span><span class="NLM_article-title">A one-day, dispense-only IP-one HTRF assay for high-throughput screening of Gαq protein-coupled receptors: towards cells as reagents</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1089/adt.2007.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;key=10.1089%2Fadt.2007.108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=39-53&author=C.+Bergsdorfauthor=C.+Kropp-Goerkisauthor=I.+Kaehlerauthor=L.+Ketscherauthor=U.+Boemerauthor=K.+Parczykauthor=B.+Bader&title=A+one-day%2C+dispense-only+IP-one+HTRF+assay+for+high-throughput+screening+of+G%CE%B1q+protein-coupled+receptors%3A+towards+cells+as+reagents&doi=10.1089%2Fadt.2007.108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1089%2Fadt.2007.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2007.108%26sid%3Dliteratum%253Aachs%26aulast%3DBergsdorf%26aufirst%3DC.%26aulast%3DKropp-Goerkis%26aufirst%3DC.%26aulast%3DKaehler%26aufirst%3DI.%26aulast%3DKetscher%26aufirst%3DL.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DParczyk%26aufirst%3DK.%26aulast%3DBader%26aufirst%3DB.%26atitle%3DA%2520one-day%252C%2520dispense-only%2520IP-one%2520HTRF%2520assay%2520for%2520high-throughput%2520screening%2520of%2520G%25CE%25B1q%2520protein-coupled%2520receptors%253A%2520towards%2520cells%2520as%2520reagents%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2008%26volume%3D6%26spage%3D39%26epage%3D53%26doi%3D10.1089%2Fadt.2007.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QAK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QAK','PDB','3QAK'); return false;">PDB: 3QAK</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-8"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i45"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00322">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_04630"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00322">10.1021/acs.jmedchem.8b00322</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Vibrational circular dichroism assignment of absolute configuration of compounds <b>65a</b> and <b>65b</b>; homology model of ghrelin receptor with bound compound <b>8</b> in pdb format; analytical data of compounds <b>1</b>–<b>22</b>, <b>24</b>–<b>31</b>, <b>33</b>–<b>38</b>, and <b>41</b>–<b>43</b>; representative curves for a full and a partial agonist (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00322/suppl_file/jm8b00322_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00322/suppl_file/jm8b00322_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00322/suppl_file/jm8b00322_si_001.pdf">jm8b00322_si_001.pdf (703.2 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00322/suppl_file/jm8b00322_si_002.csv">jm8b00322_si_002.csv (3.12 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00322%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00322" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679944073e4023e0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
